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Summary in English  
 
 
Cell fate decisions during embryogenesis and in proliferation and regeneration competent adult tissues 
and organs are orchestrated by large numbers of regulators including transcription factors, non-coding 
RNAs, epigenetic modifiers and longer-range genomic interactions, each downstream of extrinsic 
signals and their intracellular signal transduction effector proteins. Zeb2 is a DNA-binding transcription 
factor that steers in such context many cellular processes during early and late embryogenesis, and 
knowledge is emerging about its role in various adult tissues/organs as well, especially in challenge 
conditions like tissue organ failure. Mutations in one allele of ZEB2 in humans cause Mowat-Wilson 
syndrome (MOWS) characterized by severe intellectual disability and, varying from patient to patient, 
epilepsy, Hirschsprung disease and other defects. In the mouse Zeb2 has been show, including by our 
laboratory, to regulate different aspects of central and peripheral nervous system (CNS, PNS, 
respectively) development as well as their post-natal functions. The same applies to embryonic and 
adult hematopoiesis, T-cell lineage development and function, and e.g. myelinogenesis in the CNS and 
(re)myelination by Schwann cells in the PNS. In addition, deregulation of the levels of Zeb2, e.g.. an 
abnormal increase, contributes (in this case) to many cancers and correlates with bad prognosis in 
humans, as supported by Zeb2 overexpression mouse models.  
The action mechanisms by which Zeb2, in concert with many of its emerging protein partners, 
steers neurogenesis and gliogenesis can be studied in cultured embryonic stem cells (ESCs) and the 
early CNS in vivo. In human ESCs, intact levels of ZEB2 were shown to be essential for effective 
neuroectoderm differentiation. The goals of this PhD project were to understand where, when and how 
Zeb2 functions (i) during mouse brain cortex development (using an in vivo approach) and (ii) in 
pluripotency and subsequent differentiation of mouse ESCs (in vitro approach).  
Genetic inactivation of both alleles of Zeb2 in early neural progenitors (using a Nestin-Cre 
approach), from dorsal telencephalon (Emx1-Cre) as well as in post-mitotic (NEX-Cre) upper layer 
neurons in the forming cortex in the embryonic forebrain causes a shift forward in the timing of first 
embryonic neurogenesis followed by embryonic and early post-natal gliogenesis. This leads to the 
expansion of the upper layers of the cortex at the expense of the (earlier born) cells of the deeper 
layers. Using gene expression profiling followed by validation, which is an essential part of this work and 
this PhD project, we identified neurotrophin-3 (Nt3) and fibroblast growth factor-9 (Fgf9) as extrinsic 
factors whose levels were significantly increased in the upper layer cells of the Zeb2 knockout (KO) 
embryonic brain cortex as compared to control. In this way, Zeb2 regulates the generation of 
subsequent waves of neurogenesis (steered by Nt3 that acts on its Trk receptor complex in the 
progenitor cells and promotes neurogenesis) and of gliogenesis (via Fgf9 that acts on its receptors 
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there) emanating from the Zeb2-negative progenitor cells in the cortex. Importantly, this work identified 
Zeb2 as the first transcription factor acting in a cell non-autonomous fashion in cortex development.  
In the second part of this PhD research the focus was on the role(s) and action mechanism(s) 
of Zeb2 in pluripotency and during differentiation of ESCs. For this, Zeb2-deficient (KO) ESCs were 
established. Using these novel, unique tools in combination with omics, this PhD project was able to 
add important new functional and mechanistic insight to previous findings. We discovered that Zeb2 is 
critical for exit from the epiblast state in mouse ESCs and links the pluripotency network and DNA-
methylation with irreversible commitment to neural and general differentiation. In particular, we show 
that Zeb2 KO ESCs display impaired differentiation in embryoid bodies by stalling in an epiblast-like 
state. Using RNA-Seq we further conclude that Zeb2 mainly acts here as a transcriptional repressor for 
many genes, either directly or indirectly, in differentiating conditions. Epithelial-mesenchymal transition 
(EMT), pluripotency, lineage commitment and DNA-(de)methylation genes are deregulated in Zeb2 KO 
embryoid bodies. By using methylome analysis, we demonstrate these mutant cells cannot maintain 
their initially acquired DNA-methylation marks in neural-stimulating condition and do not effectively 
downregulate Oct4, Nanog and Tet1 in differentiation conditions. Tet1 knockdown by RNA interference 
partially rescues the impaired differentiation of these KO cells. Another part of the PhD project 
investigated, starting again from the RNA-Seq data, the neuronal inhibitory REST gene, one of the 
genes whose expression was not silenced in Zeb2 KO ESCs, unlike in normal ESCs. Like for the Tet1 
studies, stable REST knockdown lines were established in the Zeb2 KO background. The neural 
differentiation capacity of such cells line was also partially restored, indicating that REST is another 
important Zeb2-dependent gene in ESCs. In a last set of experiments, which provide the strong basis 
for future structure-function analysis of Zeb2 (and hence insight into its functional domains) in this ESC 
system, the neurodevelopmental potential of Zeb2 Smad-binding domain (SBD) mutant cells was 
documented. We observed that deletion of the SBD from Zeb2 had a positive effect on neural 
differentiation, indicating that this Zeb2 domain, and hence possibly its interaction with Smads, co-
determines Zeb2’s neural-inducing activity. 
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Samenvatting in het Nederlands 
 
 
De beslissingen over het lot van cellen in het embryo en in proliferatie- en regeneratiecompetente 
adulte weefsels en organen worden georkestreerd door grote aantallen regulatorische molecules, 
inbegrepen transcriptiefactoren, niet-coderende RNAs, epigenetisch actieve eiwitten, en langere-
afstand genomische interacties, elk stroomafwaarts van extrinsieke signalen en hun intracellulaire 
effectoreiwitten van hun signaaltransductie. Zeb2 is een DNA-bindende transcriptiefactor die in 
dergelijke context meerdere cellulaire processen stuurt gedurende de vroege en late ontwikkeling van 
het embryo. Onze kennis groeit over zijn rol, ook in verschillende adulte weefsels/organen, vooral 
recent ook in uitdagende omstandigheden zoals weefsel- of orgaanfalen. Mutaties in één ZEB2 allel bij 
de mens veroorzaakt Mowat-Wilson syndroom (MOWS), gekarakteriseerd door ernstige verstandelijke 
beperkingen en, variërend van patiënt tot patiënt, epilepsie, ziekte van Hirschsprung en andere 
defecten. Er is aangetoond, ook door ons team, dat Zeb2 in de muis meerdere aspecten van centraal 
en perifeer zenuwstelsel (respectievelijk CZS, PZS) ontwikkeling, maar ook postnatale functies ervan, 
reguleert. Dit is ook het geval voor embryonale en adulte hematopoïese, T-cel ontwikkeling en functie 
en b.v. myelinogenese in het CZS en (re)myelinatie door Schwanncellen in het PZS. Bovendien is de 
deregulatie van de Zeb2 hoeveelheden, zoals een abnormale toename, een belangrijke factor (in dit 
voorbeeld) in meerdere kankers bij de mens en correleert het daar met barslechte prognose, wat 
bevestigd wordt door onderzoek met Zeb2 overexpressie muismodellen. 
 De door Zeb2, samen met vele van zijn groeiende lijst partnerwitten, gehanteerde 
actiemechanismen die neurogenese en gliogenese sturen, kunnen worden bestudeerd in culturen van 
embryonale stamcellen (ESC) alsook in het vroege CZS in vivo. In humane ESC zijn normale niveaus 
van ZEB2 essentieel voor effectieve mesendoderm differentiatie. De doelstelling van dit 
doctoraatsproject was om beter te begrijpen waar, wanneer en hoe Zeb2 functioneert (i) in de 
ontwikkeling van de hersencortex van de muis (door in vivo studies) en (ii) in pluripotentie en 
daaropvolgende differentiatie van muis ESC (door een in vitro benadering). 
 Genetische inactivatie van beide allelen van Zeb2 in vroege neurale voorlopercellen (door 
middel van een Nestin-Cre benadering), in de dorsale voorhersenen (Emx1-Cre) en ook in post-
mitotische (NEX-Cre) neuronen van de opperste lagen van de cortex in de embryonale voorhersenen 
veroorzaakt een vroegere start van eerst embryonale neurogenese gevolgd door vroegere embryonale 
zowel als vroeg-postnatale gliogenese. Dit leidt tot een expansie van de bovenste lagen van de cortex 
ten koste van de (vroeger geboren) cellen van de diepere lagen. Studies van de genexpressie gevolgd 
door validatie, een essentieel deel van dit onderzoek en dit doctoraatsproject, identificeerden 
neurotrophin-3 (Nt3) en fibroblast groeifactor-9 (Fgf9) als extrinsieke factoren waarvan de dosage sterk 
was verhoogd in de bovenste lagen van de Zeb2 knockout (KO) embryonale hersencortex, waar Zeb2 
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uitsluitend aanwezig is. Hierdoor reguleert Zeb2 de generatie van opeenvolgende golven van 
neurogenese (gestuurd door Nt3 dat zijn effect uitoefent via de Trk receptor complexen in de 
progenitorcellen, en neurogenese bevordert) en van gliogenese (via Fgf9 dat daar bindt op zijn 
receptors) die uitgaan van de Zeb2-negatieve progenitorcellen in de cortex. Zeer belangrijk is dat dit 
werk Zeb2 identificeerde als de eerste transcriptiefactor in hersencortex ontwikkeling die op een cel 
niet-autonome manier zijn effect uitoefent hierop. 
 In het tweede deel van dit doctoraatsonderzoek ging onze focus naar de rol(len) en 
actiemechanisme(n) van Zeb2 in pluripotentie en bij differentiatie van ESC. Hiervoor werden eerst 
Zeb2-deficiënte (knockout, KO) ESC aangelegd. Gebruik makend van deze unieke cellen en “omics” 
benaderingen kon dit doctoraatsonderzoek belangrijke nieuwe functionele en mechanistische inzichten 
toevoegen aan onze vroegere resultaten. Wij ontdekten dat Zeb2 kritisch is voor de uitstap van de 
epiblast status in muis ESC en dat Zeb2 het pluripotentie netwerk en de DNA-methylatie koppelt aan de 
onomkeerbare beslissing om neurale en algemene differentiatie te initiëren. Meer bepaald hebben we 
aangetoond dat Zeb2 KO ESC defecten vertonen in hun differentiatie, getest in zgn. embryoid bodies, 
omdat zij vast blijven zitten in een epiblast-achtige status. RNA-Seq toonde verder aan dat Zeb2 vooral 
functioneert als transcriptionele repressor voor meerdere genen, hetzij direct of indirect, in ESC 
differentiatie. Voorbeelden van gedereguleerde genen in Zeb2 KO embryoid bodies zijn die in 
epitheliaal-mesenchymale transitie (EMT), pluripotentie, differentiatie en DNA-(de)methylatie. Analyse 
van het methyloom toonde aan dat deze gemuteerde cellen hun initieel verworven DNA-methylatie 
signatuur niet kunnen behouden in neurale-stimulatie condities. Zij falen ook in de effectieve 
neerregulatie van Oct4, Nanog en Tet1 in differentiatiecondities. Tet1 knockdown door RNA-
interferentie redt partieel de defectieve differentiatie van deze KO cellen. Een ander deel van dit 
doctoraatsproject onderzocht ook, opnieuw startende van de RNA-Seq resultaten, het neuronaal-
inhibitorische REST gen, één van de genen waarvan de expressie niet werd neergereguleerd in Zeb2 
KO ESC, in tegenstelling tot normale ESC. Zoals in de Tet1 studies werden stabiele knockdown 
cellijnen aangelegd in de Zeb2 KO achtergrond. De neurale differentiatie van dergelijke cellen werd 
hierdoor ook partieel hersteld, hiermee aantonend dat REST een ander belangrijk Zeb2-afhankelijk gen 
is in ESC. In een laatste reeks van experimenten die de sterke basis leggen voor toekomstig structuur-
functie onderzoek van Zeb2 (en hiermee inzicht in zijn functionele domeinen), werd het neuro-
developmenteel potentieel van Zeb2 Smad-bindend domein (SBD) mutante cellen gedocumenteerd. 
Deletie van het SBD van Zeb2 had een positief effect op neurale differentiatie. Dit duidt op een 
belangrijke rol van dit Zeb2 domein, en mogelijk dus de interactie van Zeb2 met Smads, dat mee de 
neuraal-inducerende activiteit van Zeb2 bepaalt.       
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1 Chapter 1: General introduction 
 
 Early embryonic development and the first cell fate decisions 1.1
 
The first days of development after fertilization of the mouse oocyte involve cleavage of the embryo, i.e. 
a series of slow cell divisions, and subsequently eventually producing a ±32-cell, cavity-lacking embryo 
with cells at the outside (the trophectoderm) and the inside (inner cell mass, ICM). Immediately after, we 
can identify three major cell types that form the trophectoderm (TE), and within the ICM the primitive 
endoderm (PE, also named hypoblast) and epiblast (Epi, also named primitive ectoderm), respectively 
(for a schematic representation of the first stages of development, see Fig.1). The first molecular events 
in cell specification, but with retention of pluripotency of each blastomere, have been proposed to occur 
already in the 4-cell stage embryo, wherein heterogeneously distributed Prdm14 (PR Domain 
Containing 14), a member of the PRDI-BF1 and RIZ homology domain containing (PRDM) family of 
transcriptional regulators, together with Carm1 (Co-activator-Associated Arginine Methyltransferase 1), 
selectively directs the cells to become ICM by inducing H3 arginine methylation, coinciding with 
upregulation of Nanog and Sox2 mRNA in these cells (Burton et al., 2013; Torres-Padilla et al., 2007). It 
are then the next two rounds of cell division (from 8 to 16 and from 16 to32 cells) that produce two 
distinct cell types that will become TE and ICM, respectively. The future trophoblast cells occupy 
ultimately the outer layer of this embryo (see above), are larger than the rest of the embryonic cells and 
express high levels of Cdx2 mRNA, whereas future ICM cells are smaller and group together in the 
center of the embryo and loose Cdx2 mRNA (Jedrusik et al., 2008). TE specification thus occurs during 
transition from the 8 to 16-cell stage; it is controlled by the transcription factor Tead4 (TEA Domain 
Family Member 4) whose activities require two co-activators, Yap and Taz, regulated by the core Hippo 
signaling pathway kinases Lats1/2. The active Hippo pathway inhibits Yap and Taz activity and prevents 
them from reaching the nucleus where Tead4 is located, which on its turn prohibits Tead4 and Cdx2 
activation (Nishioka et al., 2009). 
 
In the first step towards Epi versus PE lineage segregation a subset of (future PE) cells 
acquires high FgfR2 levels while (the future) Epi cells induce Fgf4 (Morris et al., 2013). Prior to definitive 
lineage allocation, around E3.5 (±64 cells), the “salt and pepper” presence of Gata6 (in PE cells) and 
Nanog (in the Epi cells, at variable levels) becomes visible (Rossant et al., 2003). This differential gene 
expression is reinforced by Fgf signaling (Kang et al., 2013). Segregation of the Epi from the PE cells 
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occurs between E3.5 and 4.5. The late blastocyst (E4.5, 100-120 cells) is, as mentioned briefly above, 
composed of trophoblast (Cdx2, Eomes and Gata3 positive (+)) that surrounds the epiblast (Nanog+ 
and Oct4+), with the latter being separated from the blastocoel cavity by a thin layer of PE cells 
(Gata6+, Sox7+ and Sox17+).  
 
The mouse embryo hatches and transforms into an egg cylinder whilst implanting in the uterus 
shortly after E4.5. The TE serves and mediates implantation and gives rise to the extraembryonic 
ectoderm and the ectoplacental cone (which will contribute to the placenta). The PE gives rise to the 
parietal endoderm and the visceral endoderm, which will later give rise to the endoderm of the visceral 
yolk sac. The early epiblast undergoes a global reshaping to ultimately form a cup-shaped polarized 
epithelium that will give rise to the somatic tissues and germ cell lineage of the embryo proper 
(reviewed in Arnold and Robertson, 2009). 
 
 
 
 
Figure 1. Overview of early mouse development.  
Embryonic and extraembryonic cells are specified in the preimplantation embryo by two cell fate decisions. In the 
first cell fate decision, waves of cell divisions create inside and outside cells. Outside cells give rise to 
extraembryonic trophectoderm (TE), while inside cells form the pluripotent inner cell mass (ICM). In the second 
cell fate decision, cells of the ICM are segregated into the extraembryonic PE and the pluripotent epiblast (EPI) 
that will later give rise to all tissues of the body. These fate decisions are influenced but not determined by 
heterogeneity between individual cells within the embryo that is established by the 4-cell stage (shown by different 
shading of cells). At E4.5, the embryo initiates implantation, cell proliferation rapidly enhances and over the next 
24 h the implanted embryo invades the maternal tissues, continues to display cell proliferation and transforms into 
an egg cylinder. This new form serves as a foundation for EPI patterning, laying down the body axis and 
establishment of the germ layers. The parietal endoderm and the accompanying and the trophoblast giant cells 
originating from the mural TE, as well as the ectoplacental cone derived from the polar trophectoderm, are omitted 
from the drawing of the E5.5 embryo. (Firgue and legend taken from: Bedzhov et al., 2014) 
Abbreviations: ExE, extraembryonic ectoderm; PE, primitive endoderm; VE, visceral endoderm.  
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Starting from E6.5 the embryo undergoes gastrulation in which the three ultimate germ layers 
are generated and re-positioned by massive cell migration, laying down the primitive body plan of the 
embryo. Ectoderm, mesoderm and definitive endoderm (emanating from the mesendoderm) then give 
rise to all embryonic cells from which the embryo and further extra-embryonic tissues will develop. 
 
 Embryonic stem cells 1.2
 
In this section we address the current operational definition(s) of pluripotency, in vivo as well as in vitro, 
and we discuss various factors that influence the pluripotent state(s) of stem cells of the early embryo. 
 
 
1.2.1 ESC discovery 
 
The establishment of the first embryonic stem cell (ESC) lines was preceded by many years 
of study of embryonal carcinoma (EC) cells, the undifferentiated stem cells of teratocarcinomas, and 
their in vitro and in vivo differentiation capacities. Such studies, which actually led to the formulation of 
the stem cell theory of cancer, also helped to establish the initial and subsequently successful, ideal cell 
culture conditions for ESCs. Teratocarcinomas are malignant tumors, which indeed contain ECs and a 
differentiated component that can include cells representative of one of the three embryonic germ 
layers. Teratomas are tumors composed of somatic tissues only, hence are devoid of ECs and 
therefore these tumors are benign. The first experimental proof that ECs are multi-potent with regard to 
their developmental potential was obtained by Kleinsmith and Pierce back in the early 60s. Limiting 
dilution and ultimately single-cell transplant experiments demonstrated that ECs were able to 
reconstitute teratocarcinomas containing various differentiated types of cell. The ECs had the capacity 
to self-renew in culture, were pluripotent (i.e. could produce all somatic lineages upon injection in an 
immune-compatible or immune-deficient host) and also tumorigenic and cytogenetically abnormal 
(Kleinsmith and Pierce, 1964). A few years later the first stable EC cell lines were established and their 
multi-lineage differentiation potential was further demonstrated in vitro (Kahan and Ephrussi, 1970). The 
teams of Solter and Stevens showed that early embryos transplanted to mouse testis could generate 
teratomas. This collectively proved that an early embryo contains a pluripotent cell population and that - 
under the right cell culture conditions - these cells could be expanded in vitro (Solter et al., 1970; 
Stevens, 1970). 
 
In 1981 two groups reported the derivation of mouse ESCs from pre-implantation embryos 
using the same culture conditions as for the EC lines, and using mouse embryonic fibroblasts (MEFs) 
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as a feeder layer in a cell culture medium, which was supplemented with serum (Evans and Kaufman, 
1981; Martin, 1981). The authors showed that these ESCs could be propagated in vitro, were 
karyotypically normal (unlike most EC lines) and could contribute to various tissues in ESC: acceptor 
chimeric embryos, and also formed teratomas when injected into mice. 
 
 
1.2.2 States of pluripotency 
 
Pluripotent embryonic cells have the capacity to differentiate into any of the three germ layers 
of the embryo proper. In vivo, in the mouse, cells of the epiblast, in a time window between E3.5 till 
E7.5, display pluripotent potential (reviewed in Boiani and Schöler, 2005; Nichols and Smith, 2012). ICM 
cells of the E4.0-E4.5 embryo represent the often-referred-to ground-state of pluripotency with the 
least restricted lineage potential characterized by high, uniform expression of pluripotency genes (at 
least when assessed by population analysis, i.e. not at the single-cell level) and - in female embryos - 
reactivation of the paternal X chromosome (Mak et al., 2004; Nichols et al., 2009; Silva and Smith, 
2008). These ground-state pluripotent cells in vivo are naïve, i.e. they have unbiased developmental 
potential. Upon implantation, shortly after E4.5, lineage-specific genes start to be expressed and a 
global increase in DNA-methylation is observed, which indicates lineage priming hence referred to as 
the primed pluripotency state (Borgel et al., 2010). Pluripotency is eventually silenced around E7.5 
(Osorno et al., 2012). Interestingly, although the molecular signatures of the epiblast cells change 
during developmental progression between E3.5 and E7.5, all these cells retain their 3-lineage 
differentiation potential, in fact showing that a broader spectrum of pluripotent state may exist in vivo, 
which embryologists increasingly are trying to catch experimentally and characterize by a.o. extensive 
transcriptomics, including in vitro. 
 
Mouse ESCs (Evans and Kaufman, 1981; Martin, 1981), and later the isolated epiblast stem 
cells (EpiSCs) (Brons et al., 2007; Tesar et al., 2007) and embryonic germ cells (EGCs) (Leitch et al., 
2010; Matsui et al., 1992) are the three embryonic pluripotent cell types that currently can be 
maintained in vitro (see Fig. 2). ESCs and EGCs have similar transcriptional and epigenetic profiles and 
rely on the same signals and intracellular signaling pathways for maintaining their capacity of self-
renewal as undifferentiated cells (Leitch et al., 2013), whereas EpiSCs are more primed and require 
distinct culture conditions to maintain pluripotent potential (Brons et al., 2007; Sugimoto et al., 2015; 
Tesar et al., 2007). Interestingly, by simply manipulating cell culture conditions it is possible to derive 
EpiSCs from ESCs (Tosolini and Jouneau, 2015). It has also been shown that conversion of post-
implantation epiblast stem cells to ESCs is possible in a period of 14-35 days in the presence of serum 
and LIF (Bao et al., 2009; Gillich et al., 2013). However in order to obtain ESCs from EpiSCs with high 
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efficiency, single (Klf4, Guo et al., 2009) or - for more rapid conversion - double (Klf2 with Prdm14, 
Gillich et al., 2012) transgene overexpression was needed. 
 
ESCs cultured on feeder cells in growth medium containing serum (in this thesis text referred 
to as “serum ESCs”) – at the population level – are pluripotent. Detailed examination showed however 
high heterogeneity in terms of gene expression, and oscillation between naïve and primed states of 
pluripotency within such ESC populations (Abranches et al., 2013), believed to be due to simultaneous 
activation of multiple signaling pathways that together destabilize the naïve state and make the cells 
more prone to differentiation (reviewed in Nichols and Smith, 2009).  
 
Recently it was shown that ESCs cultured in chemically defined medium (referred to as “2i” in 
this manuscript, see for more details below), using the respective inhibitors of MEK and GSK3, have 
their pro-differentiation pathways inhibited, stabilize their naïve state and strongly resemble ground-
state cells of the E4.0-E4.5 epiblast. These “2i” cells are therefore named “ground-state” ESCs (Ying et 
al., 2008). It was shown that total numbers of differentially expressed genes are the lowest between 2i 
ESCs and E4.5 embryonic epiblast, whereas the period between E3.75 and E4.5 allows the most 
efficient ESC line generation, and numbers of colonies obtained are proportional to the epiblast size. In 
contrast, single cells from early blastocysts E3.25-E3.5 rarely give rise to ESC lines (Boroviak et al., 
2014). Pluripotency is a functional or operational definition that likely covers more than one stage of 
early embryonic development that can be caught in vitro, and certainly applies to ground-state and 
primed ESCs, and EpiSCs. The state of pluripotency should always be specified, especially in the 
context of studies of the gene regulatory networks in e.g.. ESCs and early cell fate decisions in the 
vertebrate embryo. 
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Figure 2. Embryonic origin and spectrum of pluripotent stem cell states. 
The pluripotent cells of a blastocyst between E3.5 and E4.5 can give rise to functionally naïve ESCs (blue). 
Between E5.5 and E8.0 post-implantation epiblast can establish EpiSCs (orange), which occupy a primed 
pluripotent state. Additionally, primordial germ cells (PGCs), which are the founders of the germline lineage, can 
give rise to naïve EGCs (green), which are highly comparable to ESCs. Depending on the culture/derivation 
conditions these pluripotent stem cells occupy discrete molecular states that can be broadly classed as naïve or 
primed. The most optimized state of naïve pluripotency, which closely recapitulates the naïve epiblast cells of the 
blastocyst, is termed ground state. An interchangeable spectrum of pluripotent states may arise that ranges from 
ground state to primed pluripotency. The state of pluripotency adopted in vitro is primarily dictated by the 
combination of extrinsic signals in the culture environment rather than the developmental source of the pluripotent 
cells.  
Other abbreviations: CH, Chiron, CHIR99021; PD, PD0325901(Figure and legend taken from: Hackett and Surani, 
2014) 
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1.2.3  Extrinsic signaling pathways in regulation of ESC states 
 
For schematic representation of the extrinsic signaling pathways in ESCs, see Fig.3. 
 
Ground-state pluripotency is displayed in the early embryo for a short period of time, for it is rapidly 
destabilized by intrinsic and extrinsic signals. Cells of the epiblast acquire new molecular signatures 
with every cell division with which they seem to progressively lose their potency. 
 
As mentioned above, ESCs can be maintained as self-renewing undifferentiated colonies for 
an unlimited period of time. Leukemia inhibitory factor (LIF) is the key extrinsic factor that sustains ESC 
self-renewal and propagation as undifferentiated cells (Smith et al., 1988; Williams et al., 1988). LIF 
binds to a high-affinity receptor complex composed of a low-affinity LIF binding chain (LIFR, also known 
as CD118) and a high-affinity converter subunit (Gp130) leading to phosphorylation and activation of 
the downstream, cytoplasmic transcription factor STAT3 (Yoshida et al., 1994). Phosphorylated STAT3 
accumulates in the nucleus and subsequently regulates expression of a large number of 
pluripotency/self-renewal genes including Klf4, Tfcp2l1, Gbx2 and c-Myc (Cartwright et al., 2005; Hall et 
al., 2009; Martello et al., 2013; Tai and Ying, 2013). Classic ESC culture conditions require LIF 
(produced by the feeder cells and/or supplemented as recombinant, bio-active cytokine in the medium) 
and serum. BMP4 that acts via Smad proteins to induce expression of downstream Id (Inhibitor of 
differentiation) family genes is a crucial component within serum added to these cultures. In fact, 
feeder-cell free ESC cultures supplemented only with both LIF and BMP4 retain their pluripotent and 
self-renewing capacity even in the absence of feeder cells. Upon BMP4 withdrawal (hence, in presence 
of LIF only) ESCs can acquire a neural phenotype, whereas removal of LIF (only leaving BMP4 present 
in the medium) results in non-neural differentiation (Finley et al., 1999; Ying et al., 2003). 
 
Pluripotency of ESCs seems to depend on the balance between pro-self-renewal and pro-
differentiation signals. ESCs themselves produce extrinsic factors that destabilize their ground state. 
One such factor is Fibroblast growth factor 4 (Fgf4). Stimulation by FGF leads to activation of the 
downstream Erk (Extracellular-signal-regulated kinase, also known as MAPK) pathway, which is 
believed to be an important trigger causing ESCs to switch from self-renewal to lineage commitment. 
Knockout of either Fgf4 or Erk1/2, or chemical inhibition of the Fgf-Mek-Erk pathway, helps to maintain 
ESCs in their uncommitted state (Kunath et al., 2007; reviewed in Lanner and Rossant, 2010). 
Activation of WNT signaling leads to inhibition of Gsk3 and – as a consequence – to increased stability 
and nuclear accumulation of the downstream effector of canonical Wnt signaling, β-catenin. This β-
catenin enhances Oct4 activity (Kelly et al., 2011) and – via the DNA-binding transcription factor Tcf3 – 
regulates expression of Esrrb, one of the key pluripotency genes (Martello et al., 2012). Wnt is essential 
for ESC self-renewal as it prevents the cells from transiting to the EpiSC state (ten Berge et al., 2011). 
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Conversely, Wnt inhibition allows efficient derivation of EpiSCs (Sugimoto et al., 2015). Also, chemical 
inhibition of GSK3 activity mimics the effects of WNT signaling activation and supports self-renewal 
(Ogawa et al., 2006; Sato et al., 2004). Chemical inhibition of both FGF (via MEK inhibitor PD0325901) 
and WNT (via GSK3 inhibitor CHIRON, CHIR 99021) pathways, together with added LIF, is the basis 
for the aforementioned “ground-state” ESC medium known as “2i” (Ying et al., 2008). 
 
 
 
Figure 3. Extrinsic signaling pathways that feed into reinforcing or antagonizing naive pluripotency. 
Simplified representation of various signaling cascades that affect self-renewal. Filled arrows indicate activation, 
whereas bars show inhibition or blockade of target activity. A solid line implies a direct or known downstream 
target and a dashed line indicates an indirect or inferred effect. Clockwise: BMP4 is present in serum and 
functions via SMADs to activate Id genes. LIF signaling affects many pathways but primarily acts via JAK-
mediated phosphorylation of STAT3, which activates Tcfp2l1 and Klf4. Canonical WNT signaling blocks GSK3 
activity leading to stabilization of β-catenin, which in turn abrogates TCF3-mediated repression of pluripotency 
genes including Esrrb. CHIRON closely mimics WNT signaling by inhibiting GSK3. FGF signaling activates the 
MAPK pathway leading to phosphorylation of MEK, which in turn phosphorylates and activates ERK. Activated 
ERK promotes transition to a “primed” state, which is therefore blocked by the MEK inhibitor PD03.(PD0325901) 
(Figure and legend taken from: Hackett and Surani, 2014) 
 
 
1.2.4 Transcription factors relevant for acquisition and maintenance of pluripotency 
and their networks     
 
For schematic representation of known key transcription factors (TFs) important for self-renewal of 
serum and 2i ESCs, see Fig. 4. 
 
TFs recognize specific DNA sequences present in the proximal gene promoter regions as 
well as in distal regions located often (up to) hundreds of kilobases away from the transcription start 
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sites. They recruit (or release) the transcriptional machinery of the cell and/or bind chromatin-modifying 
proteins to allow access of other TFs and TF complexes (Fuda et al., 2009; Li et al., 2007a). 
  
Oct4, Sox2 and Nanog are considered the core TFs in the pluripotency network of ESCs. They 
are induced during the establishment of pluripotency in vivo and together guard the pluripotent state in 
vitro (Chambers and Smith, 2004; Chambers et al., 2003; Nichols et al., 1998). Both knockdown (by 
more than 50%) and overexpression (by more than 150%) of Oct4 lead to ESC differentiation (Masui et 
al., 2007; Niwa et al., 2000). Surprisingly, lowering Oct4 levels by half (using Oct4+/- ESCs), seems to 
stabilize naïve pluripotency (Karwacki-Neisius et al., 2013). This shows that Oct4 levels need to be 
precisely controlled in ESCs, including for maintaining robust self-renewal of these cells. Sox2 null 
embryos die shortly after implantation (Avilion et al., 2003). Sox2 very often acts in concert with Oct4 to 
regulate target gene expression in stem cells. Moreover, Oct4 and Sox2 co-regulate and enhance each 
other’s expression in ESCs (Chew et al., 2005; Masui et al., 2007). Without Nanog, pluripotency does 
not develop in vivo (Silva et al., 2009). Surprisingly, Nanog is dispensable for the in vitro pluripotency 
maintenance and knockout of Nanog only slightly increases the ESC propensity to differentiate 
(Chambers et al., 2007). Although it is not crucial for pluripotency maintenance, Nanog overproduction 
bypasses the need for LIF to self-renew, which emphasizes its role in the pluripotency network 
(Chambers et al., 2003; Mitsui et al., 2003). Oct4 and Sox2 are in the center of the ESC transcriptional 
network where, together with Nanog, they form a positive auto-regulatory loop that enhances/stabilizes 
their mRNA expression. They were also shown to co-operate with a large number of claimed “non-
essential”, but still pluripotency-related genes that form the extended network of ESC pluripotency and 
reinforce the ESC ground state. Below, a number of such genes are briefly discussed.  
Esrrb is a direct target of Nanog and can substitute for Nanog in ESCs. It was also shown to 
act downstream of Gsk3/β-catenin and β-catenin/Tcf3. Forced production of Esrrb resembles both Gsk3 
inhibition and Tcf3 knockout phenotypes, and such Esrrb bypasses the need for cytokines to maintain 
the undifferentiated state (Festuccia et al., 2015; Martello et al., 2012). Tfcp2l1 is a target of both 
LIF/Stat3 and 2i-mediated self-renewal. Forced production of Tfcp2l1 can recapitulate the self-renewal 
promoting effect of LIF or either of the 2i components. Hence, Tfcp2l1 has been proposed to play a 
critical role in maintaining ESC identity (Martello et al., 2013; Ye et al., 2013). Klf4 also plays a role in 
preventing ESC differentiation by direct regulation of Nanog. Knockdown of Klf4 induces ESC 
differentiation, whereas overproduction of Klf4 reinforces ESC self-renewal and abrogates the 
requirement for LIF (Li et al., 2004; Zhang et al., 2010). Another member of the Klf family, Klf2 –
transcriptionally induced by Oct4 – has been shown to promote self-renewal (Hall et al., 2009). At the 
transcriptional level, Sall4 regulates Oct4. Knockdown of Sall4 in ESCs resembles Oct4 knockdown and 
results in a shift from self-renewal to trophoblast differentiation (Zhang et al., 2006). The 
aforementioned Prdm14 plays a dual function is ESC identity maintenance by antagonizing Fgf-induced 
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cells differentiation on the one hand and inhibiting de novo methylation mediated by DNA-
methyltransferases on the other hand (reviewed in Nakaki and Saitou, 2014; Yamaji et al., 2013). 
 
 
 
 
 
Figure 4. Genetic networks for maintenance of naive pluripotency. 
The pluripotency network includes essential core components (Oct4/Sox2) and multiple ancillary factors (shown in 
green) that collectively form a self-organizing circuitry. Ancillary factors generally act to buffer the network against 
fluctuations and perturbations that promote exit from self-renewal (shown in red). In serum (left), ancillary factors 
are heterogeneous among the population and thus render individual ESCs in varying states of susceptibility to 
inherent influences that promote exit from self-renewal such as the FGF/ERK pathway or NuRD complex activity 
(shown as canals in the ancillary bubble). When the pluripotency network is stabilized through blocking key 
differentiation influences and/or by directly reinforcing expression of ancillary factors (e.g. 2i/LIF, right), the 
influences that drive exit from self-renewal are mitigated and robust naïve pluripotency emerges. (Figure and 
legend taken from: Hackett and Surani, 2014) 
 
 
To identify the components and fully understand the transcription network properties that 
control cell state, one should examine undifferentiated versus differentiated (here also naïve versus 
primed) cell states, integrate time-course multi-lineage differentiation data, perform large-scale genetic 
perturbation screens, investigate promoter/enhancer occupancy and connected histone signatures 
and/or perform computational modeling (which should be subsequently experimentally validated). In 
recent years a number of genome-wide studies addressed the complex global architecture of the 
transcriptional network of ESC populations. More recently, such studies are being re-addressed at the 
single-cell level. One of the first large-scale studies that addressed ESC self-renewal were those by 
Ivanova et al. (2006). They combined gene perturbation (using shRNA) with dynamic, global analyses 
of gene expression and showed that Esrrb, Tbx3 and Tcl1, as well as the previously identified Nanog, 
Oct4 and Sox2, are required for efficient self-renewal of ESCs. Furthermore, they demonstrated that at 
least two independent signaling pathways supporting self-renewal exist in vitro: one was found to 
respond to perturbation of Nanog, Oct4 and Sox2 but not of Esrrb, Tbx3, Tcl1 or Dppa4; the other 
responded to perturbation of Esrrb, Tbx3, Tcl1 or Dppa4, but not of Nanog, Oct4 and Sox2 (on top of a 
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large subset of genes responding to knockdown of all TFs used in the study). This work, as one of the 
first, revealed the complexity of cell fate regulation in ESCs and showed that pluripotency factors are 
globally involved both in gene activation and repression (Ivanova et al., 2006).  
 
In another study, Boyer et al. (2005) interrogated the core transcriptional network of Oct4, 
Sox2 and Nanog in human ESCs and for this they combined ChIP analysis with microarray-based 
mRNA expression profiling. The authors demonstrated that Oct4, Sox2 and Nanog co-occupy the 
promoters of a large number of genes that encode developmentally important homeodomain 
transcription factors, and that these regulators contribute to specialized regulatory circuits in ESCs. 
Importantly, the authors showed that the expression of Oct4, Sox2 and Nanog, as proteins bound 
together to the promoters of their own genes, are interconnected via autoregulatory loops (Boyer et al., 
2005). Similar results were obtained by Loh et al. who used ChIP-PET in combination with knockdown 
and overproduction of a.o. Nanog and Oct4 in mouse ESCs (Loh et al., 2006). 
 
Chen et al. (2008) expanded the ESC network studies to 13 factors that were previously 
shown to play a role in self-renewal, in reprogramming and/or were a component of the LIF or BMP 
signaling pathways. They mapped the binding sites for Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, 
n-Myc, Klf4, Esrrb, Tcfcp2l1, E2f1 and CTCF, and of two other transcriptional regulators, p300 and 
Suz12. They found that specific genomic regions extensively targeted by multiple TFs (called multiple 
transcription-factor-binding loci) function as ESC enhanceosomes. The authors showed that - among 
these 13 TFs - Nanog, Sox2, Oct4, Smad1 and STAT3 tend to co-occupy the same regions, as do 
members of a second, distinct group comprised of n-Myc, c-Myc, E2f1 and Zfx. Based on the 
associations between binding of the studied TF and mRNA expression level of the presumptive, closely 
located (and – in general – ideally TF-dependent) target genes (i.e. the expression data taken from 
Ivanova et al., 2006; Zhou et al., 2007), the authors constructed a transcriptional regulatory network 
model that integrates LIF and BMP signaling pathways with intrinsic factors in ESCs (Chen et al., 2008). 
 
Recently, new computational modelling defining the essential program for naïve pluripotency 
was applied and validated. This allowed to define the simplest version of the self-renewal network in 
ESCs: it comprises 16 interactions only, achieved by 12 components and three inputs, and can predict 
responses to compound and genetic perturbations with high accuracy. The essential network to 
propagate the naïve transcriptional state contains Oct4, Sox2, Nanog, Klf4, Klf2, Sall4, Esrrb, Gbx2, 
Tfcp2l1 together with inputs from Stat3, Tcf3 and Erk/Mek signaling pathways (Dunn et al., 2014). 
 
In conclusion, the transcriptional regulatory network of ESCs is very complex as it contains 
multiple interconnected autoregulatory loops together with nodes that allow smooth and reversible 
transitions between e.g. the ground and primed pluripotent state and ensures extraordinary self-renewal 
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robustness. Recent pioneering work in mouse ESCs at single-cell level, for example by the team of 
Timm Schroeder and colleagues (Basel), is re-addressing these. This work will also be discussed in the 
General Discussion section of this PhD thesis. 
 
1.2.5 Non-coding RNAs important for stemness maintenance 
 
Regulatory non-coding RNAs  (ncRNAs) can be divided into two broad classes, small (<200 nucleotides 
(nt) long, including micro-RNAs (miRNAs or miRs), endogenous small-interfering RNAs (endo-siRNAs), 
Piwi-interacting RNAs (piRNAs)) and large/long non-coding RNAs (lncRNAs, >200 nt long). Biogenesis 
of the main subclasses of the small ncRNA depends on different proteins and protein complexes. 
miRNAs are generated via sequential post-transcriptional processing by the Drosha-DGCR8 and the 
RNaseIII;Dicer complexes, followed by assembly with Ago proteins into an RNA-induced silencing 
complex (RISC). The miRNA then guides the RISC complex to the target mRNA(s).  
 
In contrast to miRNAs, the silencing effects of endo-siRNAs are dependent only on Dicer, and 
do not require Drosha-DGCR8 action. Finally, piRNAs require neither Drosha-DGCR8 nor Dicer, bind to 
PIWI-subfamily (instead of Ago-subfamily) Argonaute proteins, and silence their targets by mediating 
mRNA degradation, or possibly DNA-methylation (reviewed in: Huo and Zambidis, 2013). ncRNA 
biogenesis is reviewed in detail elsewhere (Kim et al., 2009). Below, I present a selection of studies that 
highlight the importance of ncRNAs in stem cell biology.  
 
It was shown that Dgcr8, which is required for miR processing, is essential for silencing of ESC 
self-renewal. In absence of Dgcr8, a global loss of miRs is observed and such ESCs do not silence the 
pluripotent genes efficiently and significantly delay the onset of lineage differentiation program (Wang et 
al., 2007). Similarly, gene inactivation of Dicer, which is another important gene for miRNA and piRNA 
processing, leads to defects in small ncRNA biogenesis and ESC differentiation (Kanellopoulou et al., 
2005). Members of the miR-290/295 (in mouse ESCs) and miR-302-367 (in human ESCs) gene 
clusters are among the most abundantly expressed miRNA-encoding genes in ESCs. Overexpression 
of these miRNAs can partially rescue the phenotype caused by removal of Dgcr8, demonstrating their 
functional significance in the regulation of self-renewal of ESCs (Wang et al., 2008). Interestingly, the 
core pluripotency factors Oct4, Sox2 and Nanog, and Tcf3, occupy a large fraction of miRNA promoters 
in ESCs (i.e. 20% of the annotated mammalian miRs). miRs whose promoters are bound by the core 
TFs are more abundant in ESCs as compared to differentiated cell types (for example MEFs) or neural 
precursor cells. Moreover, miRs inactive in ESCs (but active in other cell types) whose promoters are 
occupied by the core factors are often co-bound by the PRC2 complex associated with transcriptional 
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silencing, which suggests another level of complexity in gene expression regulation (Marson et al., 
2008). 
 
lncRNAs do not encode functional proteins, however they are similar to mRNAs, for they are 
transcribed by RNA polymerase II and contain a 3’ poly-A tail. lncRNAs can be encoded by sequences 
within introns of protein-coding genes (in sense and antisense direction), also overlap with protein-
coding genes (in antisense direction) or be located in the intergenic regions of the genome (such RNAs 
are named large-intergenic RNAs, lincRNAs). The most comprehensive study to date addressing the 
role of lncRNAs in ESC self-renewal is the one by Guttman et al. and focuses on lincRNAs. They first 
identified over a thousand previously unknown conserved lincRNAs (Guttman et al., 2009, 2010). Next, 
they performed a large-scale and systematic loss-of-function study, successfully targeting 147 (out of a 
total of 226 tested) lincRNAs that were active in ESCs, using a Nanog promoter-based luciferase 
reporter line as readout. The authors identified 15 lincRNAs whose knockdown affected ESC self-
renewal. To investigate whether any of the 147 lincRNAs affected ESC lineage differentiation programs, 
the authors combined their loss-of-function data with previously published data sets of gene expression 
profiles for primitive endoderm, trophoblast and primitive ectoderm/neural ectoderm, respectively (Aiba 
et al., 2009). Doing so, they identified 30 lincRNAs whose knockdown resulted in transcriptional 
changes similar to early lineage differentiation programs. This indicates that normally these lincRNAs 
have inhibitory effects on lineage commitment gene expression. Furthermore, the authors showed that 
75% of the ESC-lincRNAs were bound by at least one of the pluripotency regulators, with a median of 3 
TFs bound by each promoter, and at least 50% of these interactions were functional as knockdown of 
pluripotency TFs resulted in changes of the target lincRNA expression (ChIP data taken from Chen et 
al., 2008). In addition, the authors demonstrated that many of the ESC-associated lincRNAs were 
bound by chromatin-modifying complexes such as PRC2, PRC1 and Jarid1b (Guttman et al., 2011). 
 
In conclusion, several lines of evidence support the concept that non-coding RNAs are “wired” 
in the self-renewal network of ESCs and co-control lineage commitment. 
 
 
1.2.6 Divergent epigenetic landscapes of ground, primed and differentiating ESCs. 
Enzymes  and protein complexes that modify the epigenetic changes. 
 
DNA-methylation and hydroxylation, modifications of histones (especially methylation and acetylation) 
and chromatin remodeling complexes together shape the epigenetic landscape and add complex, 
interconnected and as such extra regulatory mechanisms to stem cell state control. Pluripotent cells 
have a specific epigenetic signature that changes when the cells enter differentiation. Below, I discuss 
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each (of these three) epigenetic modifications separately and give examples of how these modifications 
influence/reflect ESC states. I also summarize the epigenetic signatures of different pluripotent cell 
types. 
 
For the summary of selected knockout and knockdown phenotypes in mouse and ESCs, see Table1 
(p.37-38). 
 
1.2.6.1 DNA-methylation 
 
De novo DNA-methylation is controlled by DNA (cytosine-5)-methyltransferases (Dnmts) that together 
form a small family (Dnmt3a, Dnmt3b, Dnmt3l), members of which are highly active in ESCs and early 
embryos where they establish new methylation patterns. Another Dnmt, known as the maintenance 
methyltransferase Dnmt1, copies the methylation pattern onto daughter cells during somatic cell division 
(Okano et al., 1999; Goll and Bestor, 2005). Dnmt3a, Dnmt3b together with Dnmt3l modify the 
epigenome of ESCs into a primed EpiSC-like state. Their genes are repressed by Prdm14 (Yamaji et 
al., 2013). Conversely, upon ESC differentiation, Dnmt3a/3b expression increases and both encoded 
enzymes synergistically methylate the Nanog and Oct4 promoter (Li et al., 2007b). Gene inactivation of 
Dnmt1 or Dnmt3b in the mouse results in perinatal death due to multiple developmental defects, 
whereas Dnmt3a-deficient animals survive till 1 month after birth (Li et al., 1992; Okano et al., 1999). 
Surprisingly, deletion of both alleles of all three Dnmts (i.e. Dnmt1, 3a and 3b) in mouse ESCs - causing 
loss of CpG methylation - does not affect their self-renewal or global chromatin architecture (Tsumura et 
al., 2006). In contrast to mouse ESCs, simultaneous deletion of Dnmt3a, 3b and Dnmt1 in human ESCs 
results in rapid cell death (Liao et al., 2015). 
 
Active demethylation is orchestrated by members of the Ten-eleven translocation (Tet) family 
of methylcytosine dioxygenases Tet1, Tet2 and Tet3 (Tahiliani et al., 2009; for a recent review, see 
Kohli and Zhang, 2013). Tet1 and Tet2 are highly expressed in ESCs whereas Tet3 is induced upon 
differentiation. Tet1 knockdown in pre-implantation embryos results in a bias to TE formation, 
highlighting Tet1’s role in early embryonic lineage decisions (Ito et al., 2010). Similarly, Tet1 mutant 
mouse ESCs display altered differentiation potential and skewing to mesendodermal and TE lineages 
(Koh et al., 2011). Simultaneous deletion of all Tet genes causes promoter hypermethylation, 
deregulation of developmental genes and restricts developmental potential of the mouse ESCs 
(Dawlaty et al., 2014). 
 
Genome-wide mapping of 5mC and 5hmC in ground-state ESCs in 2i ESCs, serum ESCs and 
EpiSCs revealed characteristic methylation/hydroxylation patterns for each cell state. Such ground-state 
	  
 
33 
ESCs exhibit an altered distribution of 5mC and 5hmC and lower absolute levels relative to serum ESCs. 
EpiSCs - which are more primed - exhibit increased promoter 5mC coupled with reduced 5hmC, most 
probably contributing to their reduced developmental potential. Remarkably, a switch to 2i triggers rapid 
onset of both the ground-state gene expression program and global DNA demethylation. Repression of 
Dnmt genes by Prdm14 drives DNA demethylation at slow kinetics, whereas Tet1/Tet2-mediated 5hmC 
conversion enhances both the rate and extent of hypomethylation. These enzymatic systems thus act 
synergistically during transition to ground-state pluripotency and promote a robust, hypomethylated 
state (see Fig.4; Hackett et al., 2013) 
 
 
 
Figure 5. Schematic representation of Dnmt and Tet levels with 5mC and 5hmC state and "serum ESCs" and 
in EpiSCs.  
Ground-state ESCs exhibit high 5hmC levels and Prdm14 activity that represses Dnmt genes. EpiSCs exhibit 
increased promoter 5mC coupled with reduced 5hmC and high Dnmt expression. ESCs in serum conditions are 
metastable (Figure modified from: Hackett et al., 2013).  
 
1.2.6.2 Histone signatures 
 
Polycomb group proteins (PcG) modify chromatin structure by (i) depositing methyl marks on H3K27, 
which leads to repression of target gene expression (Cao et al., 2002) and (ii) mono-ubiquitination of 
H2A (H2AK119ub1) (reviewed in Campos and Reinberg, 2009). There are two types of Polycomb 
repressive complex: PRC1 (encompassing canonical and non-canonical PRC) and PRC2.  
 
The canonical PRC1 complex is composed of Cbx, Pcgf, Ring and Phc proteins. Cbx 
proteins recognize and bind H3K27 and facilitate recruitment of PRC2 to the target genes. The 
noncanonical PRC1 complex is composed of Rybp/Yaf2, Ring1a/b, and one of Nspc1/Pcgf1, 
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Mel18/Pcgf2 (or Mblr/Pcgf6), and it can function more independently - for example - to repress 
germline-specific genes (Turner and Bracken, 2013). 
 
The PRC2 complex - composed of the core components Ezh2, Eed, and Suz12 - mediates 
trimethylation of H3K27 (H3K27me3). Ezh2 is one of the core components of the PRC2 complex as it 
catalyzes the H3K27 trimethylation reaction. Ezh2 null embryos die before the end of gastrulation 
(O’Carroll et al., 2001). Ezh KO ESCs can be maintained in vitro but show defects in differentiation, 
especially towards mesoderm (Shen et al., 2008). Eed KO embryos fail to develop beyond the 
gastrulation stage (Faust et al., 1995) and Eed KO ESCs show even more severe differentiation defects 
than Ezh2 KO cells (Shen et al., 2008). Suz12 is essential for PRC2 activity and its gene inactivation 
results in early lethality (E8.5) of mouse embryos (Pasini et al., 2004). Suz12 KO ESCs are 
characterized by global loss of H3K27me3, higher expression levels of differentiation genes and lack of 
proper downregulation of pluripotency genes (Pasini et al., 2007). The PRC1 complex mediates 
compaction of the chromatin marked by H3K27Me3. Ring1 is the key mediator of this process 
(Eskeland et al., 2010). In absence of Ring1b the expression of other genes encoding PRC1 
components is reduced, which ultimately leads to derepression of lineage gene expression in ESCs 
(Leeb and Wutz, 2007). It is also important to note that PRC1 and PRC2 are also crucial for establishing 
and maintaining long-range interactions during transition from ground to primed state of pluripotency in 
ESCs (See section 1.2.7 and Joshi et al., 2015; Schoenfelder et al., 2015) 
 
Chromatin where both repressing and activating marks are present (e.g. H3K27me3 and 
H3K4me3, respectively) is referred to as bivalent. In serum ESCs bivalent chromatin marks can be 
found on key developmental genes where it is thought to keep these genes silenced, but yet poised for 
activation (Bernstein et al., 2006). Interestingly, prevalence of H3K27me3 and bivalent marks are 
reduced in 2i ESCs (Marks et al., 2014). H3K4me3 is catalyzed by Trithorax group (TrxG) proteins and 
is associated with transcriptional activation. TrxG proteins display opposing functions to PcG proteins 
during development (Mikkelsen et al., 2007; Ringrose and Paro, 2004).  Yet, little is known about the 
role of TrxG protein complexes in ESCs. Wdr5 (one of the key members of the TrxG group) regulates 
ESC self-renewal through direct protein-protein interaction with Oct4, and Wdr5 knockdown leads to a 
similar phenotype as found in Nanog inactivation or LIF depletion  (Ang et al., 2011).  
 
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) control the acetylation 
status of histones. HATs add acetyl groups to the histone tails, neutralizing them and weakening their 
nucleosome interactions. HDACs remove acetyl groups from histones and drive chromatin compaction 
and gene silencing (reviewed in Yang and Seto). ESC chromatin is open (Gaspar-Maia et al., 2011). 
The histone acetyltransferase Mof plays a key role in the regulation of the core transcriptional network 
in ESCs. Predominantly it binds together with Nanog to its target genes (79% of Mof-binding sites were 
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also bound by Nanog). Mof deletion leads to loss of self-renewal and defects in embryoid body (EB) 
formation. Interestingly, overproduction of Nanog in Mof-deficient ESCs partially rescues the self-
renewal defects, suggesting that Nanog acts downstream of Mof in ESCs (Li et al., 2012a). 
 
HDACs comprise a large group of enzymes (HDAC1 to HDAC11 and the sirtuin family 
members SIRT1 to SIRT7). They remove acetyl groups from the histones, thereby increasing their 
overall positive charge, and allowing closer interaction with DNA.  They are very often part of large 
chromatin remodeling complexes such as NuRD, Sin3 and co-REST (see below and reviewed in 
Delcuve et al., 2012). Hdac1 and Hdac2 KO mouse embryos die perinatally due to multiple defects 
including in the heart (Montgomery et al., 2007). 
 
Recently, it was shown that Sirt6 controls stem cell commitment via regulation of Tet1-
dependent DNA hydroxylation. In absence of Sirt6, these KO ESCs subjected to a general 
differentiation protocol show skewing towards neuroectoderm, do not properly downregulate the 
pluripotency genes, increase Tet1 expression and - as a consequence - accumulate 5hmC marks. We 
mention this here as we will report here on similar observations in our Zeb2 research. Sirt6 directly 
represses Oct4 and Sox2. The authors hypothesize that absence of Sirt6 leads to derepression of these 
factors that maintain high Tet1 levels, which leads to an increase of 5hmC on neural gene promoters and 
induction of neural gene expression. Knockdown of Tet1 in the Sirt6 KO ESC rescues the Sirt6 KO 
phenotype. This study elegantly links histone deacetylation with DNA-methylation and cell fate 
(Etchegaray et al., 2015). 
 
 
1.2.6.3 ATP-dependent chromatin remodeling complexes 
 
The chromatin state can be altered by chromatin remodeling complexes, which change the histone-
DNA contacts, and use the released energy of ATP hydrolysis for this. They can be divided into the 
SWI/SNF (switch/sucrose non-fermentable), CHD (chromodomain helicase DNA-binding) and ISWI 
(imitation switch) complexes (reviewed in de la Serna et al., 2006). 
 
BRG- or BRM-associated factor (BAF) and polybromo BAF (PBAF) are the two main 
complexes in the SWI/SNF family (Moshkin et al., 2007). BRG1 (also known as SMARCA4) is the 
catalytic subunit of the BAF complex in ESCs (EsBAF). It is downregulated upon ESC differentiation. 
Knockdown of Brg1 results in decreased proliferation rate and reduced differentiation capacity of such 
ESCs (Ho et al., 2009). Moreover, the BAF complex was shown to occupy the same regions as the key 
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pluripotency factors suggesting that this complex is involved in the regulation of stemness (Kidder et al., 
2009). 
 
The CHD family consists of Chd1, 2, 7 and 8 as well as the Nucleosome remodeling and 
deacetylation complex NuRD. Chd1 is required for the ESCs to maintain their open chromatin state, and 
knockdown of Chd1 leads to accumulation of heterochromatin (compacted chromatin). Moreover, Chd1 
binding strongly correlates with that of H3K4me3 (active mark) whereas bivalent domains are largely 
devoid of Chd1. Knockdown of Chd1 impairs ESC self-renewal, leads to downregulation of Oct4 and to 
an increase in neural gene expression in pluripotency-supporting conditions. Also, when subjected to 
general EB differentiation, Chd1 knockdown ESCs displayed defects in mesodermal and endodermal 
differentiation and such cells were more prone to acquire a neural fate (Gaspar-Maia et al., 2009). 
 
The NuRD complex consists of HDAC1 and HDAC2, the histone-binding proteins RbAp46 and 
RbAp48, the metastasis-associated proteins MTA1 (or MTA2 / MTA3), the methyl-CpG-binding domain 
protein MBD3 (or MBD2) and the ATP-dependent CHD3 (also named Mi-2alpha) or CHD4 (Mi-2b) (Xue 
et al., 1998). The repressive activity of NuRD is required for ESC differentiation. In Mbd3-deficient ESCs 
the NuRD complex does not assemble. Mbd3 KO ESCs continue to self-renew in absence of LIF and 
have the capacity to initiate early differentiation, but such cells fail to lineage-commit (Kaji et al., 2006). 
The NuRD-mediated repressive effect produces transcriptional heterogeneity, also observed in ESCs 
cultured in serum and LIF conditions; NuRD directly controls this transition out of the self-renewal state 
by enabling cells to silence expression of a number of pluripotency-associated genes including Klf4, 
Klf5, Tbx3 and Zfp42 (Reynolds et al., 2012). 
 
The ISWI family chromatin remodeling complex consist of three distinct complexes: 
nucleosome-remodeling factor (NURF), chromatin accessibility complex (CHRAC) and ATP-utilizing 
chromatin assembly and remodeling factor (ACF), but the role of these complexes in not yet well 
studied in the context of ESCs. Bptf is the largest subunit of the NURF complex. Bptf KO embryos die 
around E8.0 due to multiple defects and Bptf KO ESCs subjected to general differentiation display 
abnormal meso-, endo- and ecto-dermal development (Landry et al., 2008). 
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Examples of knockout and/or knockdown phenotypes of selected epigenetic modifiers 
  Mouse KO and/or KD phenotypes Mouse KO and/or KD phenotypes 
DNA-methylation Dnmt3a KO: die at 1 month; (Okano et al., 1999)  
Triple KO in mESCs does not affect self-
renewal; (Tsumura et al., 2006)  
Triple KO in hESCs results in rapid cell 
death; (Liao et al., 2015) 
 Dnmt3b KO: perinatal death; (Li et al., 1992)  
 Dnmt1 KO: perinatal death; (Li et al., 1992) 
DNA-hydroxylation Tet1 
KD in preimplantantation embryos results 
in bias to trophoectoderm formation; (Ito 
et al., 2010)  
Depending on the laboratory where the 
Tet1 KO mice were made, the phenotype 
can differ: 
1) Tet1 (paternal) knockout mice exhibit 
various phenotypes, including fetal and 
postnatal growth defects, and neonatal 
and embryonic lethality;  (Kohli and 
Zhang, 2013) 
 2) Tet1 mutant mice are viable, fertile 
and grossly normal though some mutant 
mice have a slightly smaller body size at 
birth; (Dawlaty et al., 2011) 
KD results in skewing towards 
mesendoderm and trophoectoderm;  
(Koh et al., 2011) 
 Tet2 
KO leads to myeloid malignancies;  
(Li et al., 2011) 
Simultaneous KO of Tet1,Tet2 and Tet3 
results in restricted developmental 
potentialand gene promoter 
hypermethylation;  (Dawlaty et al., 2014)  Tet3 
In Tet3-deficient zygotes, paternal-
genome conversion of 5mC into 5hmC 
fails to occur. Deficiency of Tet3 also 
delays activation of a paternally derived 
Oct4 transgene in early embryos 
Oocytes lacking Tet3 have a reduced 
ability to reprogram the injected nuclei 
from somatic cells; (Gu et al., 2011) 
Polycomb Repressor Complex 2 Ezh2 KO embryos die before the end of gastrulation; (O’Carroll et al., 2001) 
KO show differentiation defects, 
especially towards mesoderm; (Shen et 
al., 2008) 
 Eed 
KO embryos fail to develop beyond 
gastrulation stage; (Faust et al., 1995) 
KO show severe differentiation defects; 
(Shen et al., 2008) 
 Suz12 
KO is embryonic lethal (E8.5); 
 (Pasini et al., 2004) 
KO display global loss of H3K27me3, 
higher expression levels of differentiation 
genes and lack of proper downregulation 
of pluripotency genes  
(Pasini et al., 2007). 
Histone Acetyltransferases Mof 
KO embryos fail to develop beyond the 
expanded blastocyst stage and die at  
the implantation stage;  
(Thomas et al., 2008) 
KO leads to loss of self-renewal and 
defects in embryoid body (EB) formation; 
(Li et al., 2012a) 
Histone Deacetylases HDAC1 
die perinatally due to multiple defects 
including in the heart;  
(Montgomery et al., 2007) 
Double HDAC1/HDAC2 KO results in 
loss of cell viability, which is associated 
with  chromosome segregation defects;  
(Jamaladdin et al., 2014) 
 HDAC2 
die perinatally due to multiple defects 
including in the heart;  
(Montgomery et al., 2007) 
 Sirt6 
KO leads to genomic instability and 
aging-like phenotype; 
 (Mostoslavsky et al., 2006) 
KO show skewing towards 
neuroectoderm, do not properly 
downregulate the pluripotency genes, 
increase Tet1 expression and - as a 
consequence - accumulate 5hmC marks; 
(Etchegaray et al., 2015) 
	  
 
38 
ATP-dependent chromatin 
remodeling complexes: SWI/SNF BRG1 
KO die perimplantation;  
(Bultman et al., 2000) 
KD of Brg1 results in decreasedcell 
proliferation and reduced differentiation 
capacity; (Ho et al., 2009) 
ATP-dependent chromatin 
remodeling complexes: CHD Chd1 
KO results in arrest of epiblast 
development at E5.5-6.5, prior to the 
onset of gastrulation;  
(Guzman-Ayala et al., 2015) 
KD leads to accumulation of 
heterochromatin, Chd1 impairs ESC self-
renewal, KD cells were more prone to 
acquire a neural fate;  
(Gaspar-Maia et al., 2009) 
ATP-dependent chromatin 
remodeling complexes: CHD Mbd3 
KO die shortly after implantation; 
(Hendrich et al., 2001) 
KO ESCs are able to self-renew in 
absence of LIF and have the capacity to 
initiate early differentiation, but such cells 
fail to lineage-commit; (Kaji et al., 2006)  
ATP-dependent chromatin 
remodeling complexes: ISWI Bptf 
Bptf KO embryos die around E8.0 due to 
multiple defects; (Landry et al., 2008) 
KO display abnormal meso-, endo- and 
ecto-dermal development;  
(Landry et al., 2008) 
Table 1 Examples of knockout and/or knockdown phenotypes of selected epigenetic modifiers 
 
 
 
1.2.7 Long-range interactions 
 
Since it was shown that transcriptional regulation of β-globin depends on clustering by proximity of 
regulatory elements that are key to creating and maintaining active chromatin domains, looping was 
acknowledged as one of the mechanisms of gene expression regulation (Tolhuis et al., 2002). Dixon et 
al. demonstrated the existence of large “topology associated domains” (TADs) within the genome. 
These TADs, which are on average 880 kb in size, make-up fundamental structures of mammalian 
genomes (Dixon et al., 2012). 
 
Kagey et al. showed that Mediator and Cohesin physically and functionally connect gene 
expression and chromatin architecture in ESCs. Mediator complex functions as transcriptional co-
activator while cohesin protein complex is a key partner of CTCF and regulator of chromatin looping. 
shRNA-mediated knockdown of Mediator, Cohesin or Nipbl (Cohesin-loading factor) resulted in 
phenotypes resembling the knockdown of key pluripotency genes. ChIP-seq analysis of Med1 and 
Med12 (both subunits of the Mediator complex) showed that at least 60% of actively transcribed genes 
in ESCs - including enhancer and promoter regions of Nanog, Oct4 and Sox2 - were bound by 
Mediator. ChIP-seq for Smc1a and Smc3 (subunits of the Cohesin complex) showed that Cohesin 
occupies target sites together with or independently of CTCF and Mediator. Interestingly, sites occupied 
by only Cohesin and Mediator were also associated with RNAPol II (marking active promoters in ESCs). 
These sites were also bound by Nipbl. Mediator and Cohesin were shown to partner-up to create 
distinct DNA looping patterns between the gene enhancer(s) and promoter; these loops are cell-type 
specific and linked to tissue-specific gene expression programs within the cells (Kagey et al., 2010). 
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The chromatin conformation at the Nanog locus in pluripotent cells is dependent on Oct4 
presence. Analysis of a 160 kb-long region on chr6 (including Gdf3, Dppa3 and Nanog) showed that 
DNAse-I hypersensitive sites (HSs) and potential regulatory elements are present in this region. Upon 
Oct4 depletion, the 3D organization of the chromatin changed significantly and the contacts between 
the HSs within the 160kb-region were greatly diminished (Levasseur et al., 2008). Recently, it was 
shown that two transcriptional co-activators, p300 and CPB, also play an important role in ESC 
chromatin looping. P300 and CBP are recruited to the Nanog locus to mediate the formation of long-
range chromatin looping structures with regions showing enhancer activities (Fang et al., 2014). 
 
Recently, Joshi and colleagues used high-resolution chromosome conformation capture 
technique (Hi-C) to study spatiotemporal changes in long range interactions during transition from 
ground to primed state in mESCs and vice versa (Joshi et al., 2015). They showed that “extremely long-
range promoter-promoter interactions” (ELRIs, defined as long-range interactions - intra and 
interchromosomal – but excluding intra-TAD interactions) are present exclusively in serum ESCs and 
that their formation depends on the action of the Polycomb repressive complex PRC2 and is associated 
with PRC1 activity. Deposition of H3K27me3, mediated by the PRC2 complex, correlated with ELRIs 
and overlapped at the promoters of genes involved in cell fate determination like the Hox gene cluster 
indicating that lineage priming in serum conditions involves formation of ELRIs. Notably, ELRIs 
gradually disappeared upon changing ESC culture medium to 2i. To validate the role of PRC2 complex 
in the formation of ELRIs, the authors used Eed KO ESCs. In these cells the PCR2 complex does not 
form what leads to absence of H3K27me3 marks. Hi-C evaluation of Eed KO ESCs in serum revealed 
that ELRIs did not form properly and chromosome conformation resembled that of 2i. Moreover, the 
authors, based on the dynamics of the PRC1 complex binding to H3K27, speculated that it might be 
involved in fine-tuning and mediation of ELRIs formation. 
Another study by Schoenfelder and co-workers, published around the same time as the study by 
Joshi et al. provided supportive evidence for the role of Polycomb complexes as important regulators of 
chromosome conformation (Schoenfelder et al., 2015). Using Ring1A-Ring1B-double (d)KO mESCs, 
the authors showed that ELRIs cannot be established because these dKO mESCs cannot form 
functional PRC1 complex. Together, these two studies show that PCR1 and PRC2 complexes are 
master regulators of three-dimensional interaction networks in the genome of mESCs. 
 
In summary, the 3D architecture of the genome and its rearrangements influence transcriptional 
regulation at various cellular states. Chromatin structures include highly conserved, stable TADs as well 
as cell-type specific, but dynamic loops. Dynamics of chromatin looping is not only dictated by the 
actions of key proteins (such as the aforementioned Cohesin, CTCF, Mediator) but can be influenced by 
various TFs (including pioneer TFs) and chromatin-modifying complexes including PCR1 and PRC2. 
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 Neurogenesis 1.3
 
1.3.1 In vivo 
 
1.3.1.1 Early neural development (E7.5-E10.0) 
 
The epiblast of the embryo acquires neural fate as default in the controlled inactivity of Wnt, Nodal and 
Bmp signaling, which otherwise act as mesoderm-inducing and endoderm-permissive signals (Stern, 
2005). The activity controlling Bmp antagonists Chordin, Noggin and Follistatin, and the Wnt inhibitor 
Dkk1 (of the Dickkopf family), and the Nodal inhibitors Lefty and Cerberus (the latter also binding Bmp 
and Wnt) are key to epiblast cells acquiring neural fate. Neural induction in the mouse embryo starts 
around E7.5 and rapidly produces a single-layered sheet of cells (the neural plate) that acquires 
progressively an anterior-posterior identity. The neural plate undergoes reshaping (neurulation) and 
ultimate closes to make the neural tube. Following the closure, neural progenitors that start to proliferate 
at the rostral side of the embryo causes the future telencephalon to “balloon out” and generate two brain 
hemispheres. The remaining neural tube in the cranial region undergoes regional specification and also 
gives rise to the midbrain and hindbrain (Smith, 1997).  
 
Two signaling centers pattern the early central nervous system (CNS): the anterior neural ridge 
(ANR), which is responsible for forebrain patterning, and the midbrain-hindbrain border (MHB, also 
named the isthmus or the isthmic organizer), which regulates early midbrain and hindbrain specification 
(reviewed in Wurst and Bally-Cuif, 2001). Fgf8, secreted by both ANR and MHB is an important 
regulator of early CNS development (Martinez et al., 1999). Retinoic acid (RA) is important for anterior-
posterior CNS patterning; it is well known for its co-regulation of Hox gene expression and is required 
for hindbrain and spinal cord development (reviewed in Maden, 2002). Further development of the 
telencephalon and dorso-ventral patterning is orchestrated by opposing actions of Fgf8 and Bmp 
(secreted by the roof plate) and Shh (secreted by the ventrally located prechordal plate and in the 
neural tube by the floor plate cells, as well as by the underlying notochord) (Hoch et al., 2009). 
 
 
1.3.1.2 Corticogenesis 
 
The early embryonic brain can be subdivided into three parts: forebrain (prosencephalon), midbrain 
(mesencephalon) and hindbrain (rhombencephalon) (see Fig.6A). The forebrain later consists of the 
more anteriorly located telencephalon and the posteriorly located diencephalon. The ventral part of the 
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telencephalon (subpallium) contains ganglionic eminences that give rise to basal ganglia, whereas the 
dorsal part of the telencephalon (pallium) consists of the (neo)cortex ((neo)pallium), hippocampus 
(archipallium) and the olfactory lobe (paleopallium) (see Fig. 6A, right panel). 
 
The (neo)cortex is considered to be the “latest evolutionary addition” to the brain structure of 
mammals in comparison with other vertebrates like Xenopus. It first appeared in the small mammalian 
species during the transition from Triassic to Jurassic period (±200 million years ago). Since, it has 
undergone significant enlargement during evolution (Finlay and Darlington, 1995) and is considered to 
be responsible for the mental prowess and extraordinary cognitive abilities of the human species (Rakic, 
2009). The mammalian cortex is a six-layered structure composed of possibly hundreds of different 
types of neuron and glial cell (reviewed in Franco and Müller, 2013). Neurons of the cortex in the 
forebrain can be subdivided into two main classes: projection (pyramidal, glutamatergic, excitatory cells) 
that extend their axons not only within the cortex but also to other distant regions within the brain and 
spinal cord and into local circuit neurons (cortical interneurons, GABAergic, inhibitory cells), which make 
local synapses. Proper brain function requires balance between excitation and inhibition that is 
achieved by excitatory and inhibitory neurotransmitters, respectively. Glutamate (produced by the 
projection neurons) is the main excitatory and GABA (produced by the interneurons) is indeed the main 
inhibitory neurotransmitter in the mammalian cortex. Disproportions in numbers of excitatory versus 
inhibitory neurons nearly always lead to seizures and epilepsy (Powell et al., 2003). 
 
Corticogenesis in the mouse starts with the neural tube closure around E10 when a single 
layer of fast-dividing neuroepithelial progenitors, the ventricular zone (VZ) is formed within the thin 
cortex. Neuroepithelial progenitors can undergo symmetric cell division generating two identical 
daughter cells (i.e. two neuroepithelial progenitor cells) or divide asymmetrically to generate one 
neuroepithelial progenitor cell and one postmitotic neuron, which around E11 migrates out from the VZ 
to the pial surface to form the preplate (PP, see grey cells in Fig. 6). The second wave of neurogenesis 
takes place around E13 when the newly formed projection neurons split the PP into a superficial 
marginal zone (MZ, which contains the first-born Cajal-Retzius neuronal cells, also called layer I of the 
cortex) and the subplate (SP) and thereby create the cortical plate in-between (CP, see blue cells in Fig. 
6; for a recent review on SP neurons, see: Hoerder-Suabedissen and Molnar, 2015). At this time point 
(E14) the CP contains only one layer of neurons (layer 6), but at the end of neural development it will 
consist of five layers of distinct subtypes of neurons (numbered 2-6 with layer 6 being the deepest and 
first formed neuronal layer of the cortex) that originate from a common precursor cell called radial glia 
(characterized by the presence of GFAP, GLAST and BLBP). Between E14 and E18 layers 2-5 are 
subsequently formed as the new waves of post-mitotic neurons leave the VZ, migrate radially out and 
position themselves on top of previously formed neurons (see Fig. 6B). This process is also referred to 
as the “inside-out” model of neocorticogenesis, is accompanied by visible reduction of the VZ thickness 
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(reviewed in Gupta et al., 2002) and involves lineage determination of neuroepithelial cells, radial glial 
cells and neurons. Importantly, the temporal waves of neurogenesis can be recapitulated and are 
respected in vitro, which has prompted the field to mainly think of intrinsic, transcription factor 
combination based  control of neurogenesis.  
 
Our work a.o. in this PhD thesis has however identified, via work on Zeb2 in vivo in 
corticogenesis, the existence of extrinsic control achieved via non-autonomous actions of Zeb2, thereby 
providing a feedback mechanism from upper layer neurons to the VZ (see Chapter 3 of this thesis). 
More recently, basal progenitor cells able to divide away from the VZ have been identified as cellular 
intermediates in the generation of neurons via symmetrical neurogenic division (Molyneaux et al., 2007) 
In addition to the principles summarized above also polarized organization and interkinetic nuclear 
migration of neuroepithelial cells, radial glial cells and basal progenitors in the cortex show interesting 
differences (see also: Fietz and Huttner, 2011; Molyneaux et al., 2007). 
 
Each of the six cortical layers contains neurons with distinct molecular signatures and 
connectivity. Different neuronal subtypes can be characterized by sets of markers that are specific for 
one or more layers (one or more). For example, layer 1 contain Reelin and Lhx5, layer 2/3 and 5 are 
marked by Brn2, and Ctip2 is an often used characteristic marker of the deep layers 5 and 6 (for more 
markers, see Molyneaux et al., 2007). Substantial efforts are directed towards obtaining a full set of 
markers that can define all subtypes of neuron, or for some their partial overlap in gene expression 
profile, in the brain based on their molecular (mainly mRNA expression) signatures (Cahoy et al., 2008; 
Sugino et al., 2006; Wichterle et al., 2013). 
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Figure 6. The location of cortex in the central nervous system. 
A lateral view of an E16 mouse brain (left). The red dashed line indicates the plane of section from which a 
coronal section (right) has been taken, which shows the location of the cortex.  b. The organization of the adult 
cortex into distinct neuronal layers. Key developmental stages (E: embryonic day) of the radial component of 
neocortical-layer formation are shown.  
Abbreviations: VZ: ventricular zone, IZ: intermediate zone, SP: subplate, CP: cortical plate, MZ: marginal zone, 
PS: pial surface (Gupta et al., 2002) 
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Figure 7. Three basic classes of cortical projection neurons: associative, commissural and corticofugal. 
a. Commissural; Callosal projection neurons. Projection neurons of small to medium pyramidal size that are 
primarily located in layers II/III, V and VI, and extend an axon across the corpus callosum (CC) (panel a). At least 
three major types of callosal neuron can be classified. These maintain: single projections to the contralateral 
cortex (black); dual projections to the contralateral cortex and ipsilateral or contralateral striatum (blue); and dual 
projections to the contralateral cortex and ipsilateral frontal cortex (green). These never project axons to targets 
outside the telencephalon. Str, striatum. b. Corticofugal (subcortical); Corticothalamic neurons. Projection neurons 
primarily located in cortical layer VI, with a smaller population in layer V, that project subcortically to different 
nuclei of the thalamus (Th) (panel b). c. Subcerebral projection neurons; Also referred to as type I layer V 
projection neurons (panel c). These include pyramidal neurons of the largest size, which are located in deep-layer 
V and extend projections to the brainstem and spinal cord. They can be even further subdivided into several 
distinct projection neuron subtypes. Amongst them: Corticotectal neurons (orange), Corticopontine neurons (pink), 
Corticospinal motor neurons (purple).  
Other abbreviations: Crb, cerebellum; OB, olfactory bulb; SC, spinal cord. (Figure and legend taken from: 
Molyneaux et al., 2007) 
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Based on the combination of molecular signature with connectivity, there are grossly three 
subclasses of projection neuron. i.e. associative projection neurons (that extend axonal projections 
within one hemisphere of the brain), commissural projection neurons (that project to the opposite 
hemisphere via the corpus callosum, i.e. the callosal neurons or the anterior commissure) and 
corticofugal projection neurons (that project outside of the cortex, referred to as subcerebral and 
corticothalamic projections). Commissural neurons primarily occupy layers 2/3 (for about 80% of these 
cells), 5 and 6 (20%). Corticofugal neurons are located in layer 6 and 5, while associative neurons can 
be found in all layers of the cortex (Fig.7) (reviewed in Custo Greig et al., 2013). 
 
There are two major types of glial cell in the brain, i.e. macroglia and microglia. Astrocytes, 
oligodendrocytes and ependymal cells represent the three differentiated macroglial cell types. They are 
derived from precursor cells located in the VZ of the developing cortex. Astrocytes are star-shaped cells 
that provide support to other brain cells, regulate calcium influx and synaptic transmission, and maintain 
the brain-blood barrier (reviewed in Molofsky et al., 2012). Oligodendrocytes provide insulation for the 
axons, which is critical for rapid nerve impulse conduction (Emery, 2010). Ependymal cells are derived 
from radial glial precursors (the 4th glial cell type present in the developing brain, giving rise to neurons 
and glia in the brain, see above) and they play major role in the transport of cerebrospinal fluid and 
brain homeostasis (Spassky et al., 2005). Microglia originate from hematopoietic stem cells and function 
as macrophage-like cells to immune-protect the CNS (Kettenmann et al., 2011); more recently 
additional roles of distinct microglia cells have been identified to support adult neurogenesis (Ribeiro 
Xavier et al., 2015) and neural precursor cells in general  (Su et al., 2014).  
 
Forebrain interneurons are born in a progenitor cell zone in the ventral telencephalon. The 
ventral telencephalon can be divided into four major parts - medial ganglionic eminence (MGE), lateral 
ganglionic eminence (LGE), caudal ganglionic eminence (CGE) and preoptic area (POA) - each of 
which produces specific (identifiable) subtypes of interneuron that populate the cortex during 
development (see Fig. 8). 
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Figure 8. Cortical interneurons are born in the subpallium and migrate tangentially to the cortex.  
The scheme represents an E13.5 embryo brain hemi-section. The arrows show representative migratory routes. 
POA-derived interneurons (blue) have a bias to invade the cortex through its rostral region, while CGE-derived 
interneurons (yellow) primarily reach the cortex by its caudal pole. The LGE (red) is a major source for many 
olfactory bulb interneurons, although some of the latter are also produced in other regions. For easier 
representation, the septum and the thalamus are not depicted in the schema.  
 
 
Cortical interneuron diversity emerges from distinct progenitors pools that are spatially 
segregated within the VT (via the respective MGE, LGE, CGE and POA pools). Approximately 50-60% 
of all cortical interneurons originate from the MGE, 30-40% originate from the CGE, a small fraction of 
cortical interneurons emerges from POA, whereas LGE is the primary source of the olfactory bulb 
interneurons see Fig. 9) and an important source for stem/progenitor cells of the subependymal zone 
(SEZ, now often designated as SVZ) of the lateral ventricles in the adult forebrain, an acknowledged 
stem cell compartment (Furutachi et al., 2015; Lin and Iacovitti, 2015; Urbán and Guillemot, 2014), 
where Zeb2 also plays a role (Stappers et al., unpublished results).  
 
All interneurons follow distinct routes of tangential migration to reach their final destination 
within the brain (for a simplified schematic representation of the interneuron routes, see Fig. 9) in a 
process that starts around E12.5 and lasts till birth. Because of the enormous diversity of the 
interneuron types (considering their birth place and the precursor cell type, final destination in the brain, 
morphology, connectivity, molecular signature and electrophysiological properties) there is no 
comprehensive list/scheme yet describing all subtypes of interneurons present in the brain. The most 
commonly used and somewhat old system to distinguish between the different interneuron subtypes is 
(still) based on the presence of calcium binding proteins such as parvalbumin (PV), calbindin (CB) or 
calretinin (CR) and neuropeptides such as somatostatin (SST), vasoactive intestinal peptide (VIP), 
neuropeptide Y (NPY), or cholecystokinin (CCK) (Flames and Marín, 2005), in addition to their origin 
(Xu et al., 2004) and their mode of firing (Gelman, Marín, 2012). Obviously, any dysfunction in 
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generation, specification, migration, maturation and/or function of cortical pyramidal neurons and/or 
interneurons and/or glia is likely to contribute to severe neurodevelopmental disorders. 
 
 
 
 
Figure 9. Patterns of interneuron migration in the developing telencephalon.  
This scheme shows a rostral and caudal hemi-section through the mouse telencephalon at the mid-embryonic 
(E15) stage. The major decision-making steps (1–6) involved in the migration of cortical interneurons derived from 
the subpallium are illustrated. Interneurons derived from the medial ganglionic eminence (MGE) (green), the 
preoptic area (POa) (purple), or the caudal ganglionic eminence (CGE) (orange) exit the proliferative zones and 
initiate their migration toward the developing cortex and striatum. Arrows indicate net directionality of movement.  
Abbreviations: LGE, lateral ganglionic eminence; Str, striatum; VZ, ventricular zone (Guo and Anton, 2014). 
 
 
1.3.2 In vitro 
 
Since the establishment of the first ESC lines, a number of protocols for their neural differentiation have 
been published, however, it is still a challenge to produce efficiently sufficient pure subtypes of neuron 
and glia in a dish (reviewed in Cai and Grabel, 2007; Germain et al., 2010). The simplest protocol for 
neural differentiation (ND) of ESCs was inspired by the in vivo data showing that in absence of anti-
neurogenic signals cells of the epiblast acquire neural fate (see Chapter 1.3.1.1). This monolayer 
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differentiation protocol, which varied depending on the ESC line used, produces relatively pure neural 
populations, however without additional signaling activation/inhibition it is not possible to direct the 
ESCs to differentiate to a desired neuronal subtype (Ying et al., 2003).  
 
Recently, it was shown that by applying small modifications to the Ying protocol (Ying et al., 
2003) it is possible to mimic cortical development in a dish. For example, Gaspard et al. (2009) showed 
that ESCs cultured in chemically-defined medium in the absence of morphogens and in the presence of 
the Shh inhibitor cyclopamine (again, inspired by the in vivo data, see Wilson and Rubenstein, 2000) 
could recapitulate most important steps of neuron development and ultimately produce pyramidal 
neurons displaying layer-specific identity (Gaspard et al., 2009). Aggregation of ESCs into EBs exposed 
to neural-inducing activity of RA (based on older experiment that used EC cells) was shown to result in 
almost pure neural populations even when serum was present in the medium (Bain et al., 1996). In fact, 
this protocol represents a good alternative for the ESC lines that do not perform well in the monolayer 
differentiation protocol of Smith and co-workers. One should note however that RA acts in 
concentration-dependent manner and high RA induces more caudal fate (Okada et al., 2004).  
 
Several protocols where EB formation was combined with signal inhibition were also 
established. EB formation in medium containing knockout serum replacement (called “serum-free 
suspension culture”, SFEB) and Wnt and Nodal inhibitors (Dkk1 and Lefty1, respectively) induced very 
efficient ND and production of Bf1-positive telencephalic neurons, which could be further specified by 
introducing Wnt3a (for pallial) or Shh (for basal) telencephalic specification (Eiraku et al., 2008; 
Watanabe et al., 2005). 
 
A promising study done by Lancaster et al. described derivation of an organoid-type culture 
system, named “cerebral organoids”, obtained from human ESCs, in which development of various 
discrete brain regions occurred in the course of 30-75 days. This protocol involved EB formation (d0-d4, 
in human ESC medium) that was followed by transfer to neural induction medium (d4-d11), embedding 
in matrigel, stationery differentiation (d11-d15) and, finally, transfer to a spinning bioreactor for the rest 
of the duration of the protocol. Interestingly, the neural induction media did not contain inhibitors of 
known neural-inhibitory pathways. The cerebral organoids differentiation showed remarkable 
resemblance to cerebral cortex development. The “mini-brains” were composed of progenitor zone cell 
populations with abundant radial glia layer and forebrain-specific neurons with highly organized layered 
structures (Lancaster et al., 2013). 
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 Zeb2 in development  1.4
1.4.1 Discovery of Sip1/Zeb2  
 
Sip1/Zeb2 was identified in a yeast 2-hybrid screening partners for receptor-regulated Smads by using 
the transcriptionally active Smad1-MH2 domain (Meersseman et al., 1997) as a bait and polypeptides 
expressed from an in-house made (L. Nelles, unpublished results) E12.5 mouse embryo cDNA library 
as a prey.  
 
The screening in yeast resulted in ±80 candidate Smad-interacting proteins (SIPs), about 
half of which have meanwhile in the field been identified by others as well and confirmed as SIPs 
(Zwijsen et al., 2003; unpublished results). In our laboratory the decision was made to first continue 
working on the protein encoded by the picked th12 partial cDNA sequence (later renamed Sip1 as full-
length coding cDNA sequence, see below), for its coding sequence showed high homology with the 
previously characterized DNA-binding zinc finger, (non-DNA-binding) homeodomain-like domain 
containing TF δEF1 (Funahashi et al., 1991; Sekido et al., 1996), later also identified by many other 
teams and given multiple alternative names, including a.o. Zfhx1a and eventually Zeb1). This high 
similarity between th12 and δEF1 was confirmed for the full-length cDNA coding sequence of Sip1 
(Verschueren et al., 1999). 
 
Sip1’s interaction with full-length Smads in mammalian cells was shown to depend on 
receptor-mediated Smad activation, and Sip1 was found to bind to all such Smads tested, i.e. Smad2/3 
for TGFβ/activin signalling and Smad1/5 for BMP signalling (later followed by Smad8; Yoshimoto et al., 
2005) Meanwhile in our lab, using th12 as a bait, also Smad2 was picked-up in a yeast 2-hybrid 
screening, together with many other candidate th12-interacting polypeptides (van Grunsven, 
unpublished results).  
 
Like δEF1, and considering the very high identity between the DNA-binding zinc fingers in 
the two zinc finger clusters in the proteins, SIP1 was found to bind to 5'-CACCT sequences in different 
promoters, including the Xenopus Bra promoter. Overexpression from in vitro made, injected sense 
RNA of either full-length Sip1 or a N-terminally truncated polypeptide encompassing the C-terminal zinc 
finger cluster, and which both bind to the Xbra2 promoter in vitro in a short region conferring activin 
responsiveness, prevented expression of the endogenous Xbra gene in early Xenopus embryos. 
Therefore, Sip1, like δEF1, was proposed to be a transcriptional repressor, which may be involved in 
the regulation of at least one immediate response gene in Xenopus for Nodal/Activin-dependent signal 
transduction pathways (Verschueren et al., 1999). 
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Subsequent work in our lab mapped the DNA-binding mode of full-length members of this 
small family of vertebrate TFs. From a number of in vitro DNA-binding experiments it was proposed that 
each zinc finger cluster binds independently to a separated repeat of the 5'-CACCT sequence in order 
to bind the promoter regions of candidate target genes like Xenopus Xbra2, human alpha4-integrin, E-
cadherin (later identified as an important Sip1 target in EMT, including in cancer; Comijn et al., 2001) 
and follistatin, hence forming high-affinity bipartite elements composed of one CACCT and (often) one 
CACCT(G) sequence, the orientation and spacing of which can indeed vary (Remacle et al., 1999). 
Using transgenic Xenopus embryos (collaboration with J. Smith, London), our laboratory then 
demonstrated that the integrity of these two sequences is necessary for correct spatial-temporal 
expression of a Xbra2 promoter-driven reporter gene (Lerchner et al., 2000). We also found that both 
zinc finger clusters must be intact for the high-affinity binding of Sip1 to DNA and for its optimal 
repressor activity. Our results showed further that Sip1 likely binds as monomer and contacts one target 
sequence with the first zinc finger cluster, and the other with the second cluster. Hence, our work 
redefined the optimal binding site and, consequently, candidate target genes for vertebrate members of 
the (later renamed as) Zeb family. 
 
1.4.2 Sip1/Zeb2 protein partners 
 
Besides Sip1-Smad interaction (which depends on 4aa in the Sip1 SBD; Conidi et al., 2013), also Sip1 
interaction with the co-repressors CtBP1/2 (van Grunsven et al., 2003) and the NuRD complex 
(Verstappen et al., 2008) respectively, were identified and further documented in our laboratory.   
 
Recently, R. Poot and co-workers (Erasmus MC, Rotterdam) identified Zeb2 as a partner of 
Sox2 in NSCs (Engelen et al., 2011), later confirmed by A. Conidi in mESCs (unpublished). The overlap 
between Mowat-Wilson syndrome (See Chapter 1.5.1) and SOX2 anophtalmia syndrome (SAS, caused 
by SOX2 mutations) and accompanying intellectual disability (ID) may point to one or more pathways 
wherein Sox2 and Zeb2 co-operate. This is further being investigated and combined with the 
identification of the Zeb2 (in various cell systems, including NSCs) and Sox2 interactome and of the 
bHLH factor Tcf4 (E2-2) in NSCs. TCF4 mutations cause Pitt-Hopkins syndrome (PHS), a severe ID 
syndrome that shares many features with non-mild MOWS, including the complete lack of speech in 
patients. Intriguingly, among the identified Tcf4 partners were both Sox2 and Zeb2. This suggests a 
complex between these three factors that each cause ID, albeit with different penetrance and severity. 
Currently, in collaboration with the laboratory of R.Poot, our lab is exploring functional 
relationships between Zeb2, Tcf4 and Sox2 and their significance during cell differentiation and 
specification. 
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In addition, using a flag-V5-tagged Zeb2 overexpression construct, our laboratory performed new 
proteomic screen in neural stem cells (unpublished data). We confirmed interaction of Zeb2 with Tcf4, 
Tcf12, NuRD (Chd, Mta, Smarc and others), i.e. ATP-dept chromatin remodelers, CtBPs-Wiz-histone 
methyltransferases, co-repressors Ctbp-1 and -2, SWI-SNF subunit-related proteins and we identified 
novel interacting partners for Zeb2 that include: Sox2/5/6, many Zfps , Sall proteins, Rcor-REST, 
Mediator complex proteins, HDACs, Ehmt (H3K9me), Lys-specific demethylases, Protein phosphatase 
regulatory and catalytic subunits, SUMO binders and activators, Ub binders, Trim proteins, some of 
which are a E3 ubiquitin-protein ligase, importin-7,  a number of RNA-binding proteins, Nono , caseine 
kinase subunits, Man1-Lemd3, YY1, Menin-1, Tet1 and OGT (See also General Discussion in this PhD 
thesis). 
 
1.4.3 Neural phenotype of the Zeb2 conventional knockout mouse  
 
During embryogenesis, the first Zeb2+ cells can be detected from neural plate-late bud (NPLB) stage in 
the entire mesoderm (of the embryo and in extraembryonic mesodermal tissues) (Fig. 10a). Zeb2+ were 
first detected in the anterior neural plate starting from E7.5 (Fig. 10b”)  (with the exception of the most 
anterior part of the neural plate, see Fig. 10b’) and later spread to the posterior part of the neural plate 
(Fig. 10 c”). Also, Zeb2 was detected in the migrating neural crest cells (Fig. 10 c’) and in the somites 
(Fig. 10 c”, PhD thesis Debruyn, 2010). 
 
To understand the role of Zeb2 in early development, a conventional Zeb2 knockout mouse 
model was generated using a ubiquitous Cre-deleter strain removing the critical exon 7 from a floxed 
mouse Zeb2 allele (Higashi et al., 2002). Conventional Zeb2-deficient (Higashi et al., 2002) i.e. 
homozygous mutant embryos develop normally until the late headfold stage (E7.5-7.75). The first 
defects become visible from the onset of somitogenesis (around E8.0-8.5), but also include lack of 
neural tube closure with reduced expression of Sox2 and overexpression of E-cadherin mRNA and 
protein (Van de Putte et al., 2003), defects in the delamination/migration of cranial neural crest cells 
(which are still formed there) and lack of vagal neural crest cell production (Van de Putte et al., 2003), 
disappearance of Krox20+ cells in the rhombomeres 3 and 5 of the hindbrain due to excessive 
apoptosis (Van de Putte 2003, 2007 and unpublished results), abnormal  development of allantois 
(Debruyn, 2010) and aberrant morphology of the somites (Maruhashi et al., 2005). Conventional Zeb2 
KO embryos die around E9.5 and show severe growth retardation and never undergo embryonic turning 
(Higashi et al., 2002; Maruhashi et al., 2005; Van de Putte et al., 2003). 
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Figure 10. Zeb2/Sip1 is present in the neural plate from the headfold stages onwards.  
(A) Sip1 is detected both in the extra‐embryonic (a’) and the embryonic mesoderm (a”) at the NPLB stage. (B) 
Sip1 is first detected in the neural plate at the headfold stages; no Sip1 protein can be detected in the most 
anterior forebrain (b’) while Sip1 is already clearly present in the rest of the future brain region (b”). (C) At the 5s 
stage, Sip1 is present in the entire neural plate, but remains absent in the ANR (c’). Sip1 can also be detected in 
the migratory neural crest cells (c’). Sip1 is never expressed the non‐neural surface ectoderm (b”, c’,c”). (A) 
Saggital section; (B and C) are lateral views of whole embryos, anterior is towards the left in (A‐C). All other 
sections are transversal, anterior is towards the left in (a’ and a”), dorsal is towards the top in (b’‐c”). All results are 
obtained by immunohistochemistry.  
Abbreviations: al, allantois; ANR, anterior neural ridge; ec, ectoplacental cavity; em,extra‐embryonic mesoderm; 
fb, forebrain; hb, hindbrain; im, intraembryonic mesoderm; mb, midbrain; md, mesoderm; ncc, neural crest cells; 
ng, neural groove; ps, primitive streak; se, surface ectoderm. (PhD thesis: Debruyn, 2010) 
 
 
Later in development and in the adult wild-type mouse Zeb2 expression becomes restricted to 
specific cell types especially within the embryonic CNS cortex (Seuntjens et al., 2009), but it can also be 
detected and plays a role in other parts of the CNS (van den Berghe et al., 2013; McKinsey et al., 2013; 
Miquelajauregui et al., 2007; Roy et al., 2012), the peripheral nervous system (PNS) (Jeub et al., 2011; 
Weng et al., 2012) and the enteric nervous system (ENS) (Stanchina et al., 2010), the hematopoietic 
and innate immune system, and cardiac repair, where our lab – in collaboration with experts in the 
respective systems – studied also its functional role in vivo in the meantime (Goossens et al., 2011) as 
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well as in certain cancers (Denecker et al., 2014; Goossens et al., 2015), (see section  1.4.2 for a 
selection). 
 
 
1.4.4 Zeb2 conditional, cell-type specific knockouts 
 
Zeb2 was shown to play multiple roles during brain development. Here, we discuss published data 
addressing the role of Zeb2 in hippocampus development as well as recent studies on the role of Zeb2 
in developing interneuron migration and specification. In Chapter 3 we specifically focus on the role of 
Zeb2 in the development of the projection neurons in the mouse brain cortex and we show that Zeb2 
controls both the numbers and timing of the projection neurons and glia generated (see Chapter 3 and 
Seuntjens et al., 2009). 
 
 
1.4.4.1 Brain development 
 
Hippocampus is the part of the brain responsible for memory consolidation as well as spatial memory 
and navigation (Burgess et al., 2002). Our lab – in collaboration with V. Tarabykin (Göttingen, now in 
Berlin) – showed that Zeb2 is essential for correct hippocampal formation in the developing brain 
(Miquelajauregui et al., 2007). Zeb2 is strongly expressed in the hippocampus during development (see 
also Chapter 3, Fig. 12) and genetic inactivation of Zeb2 from the cortical progenitors (using the Emx1-
Cre deleter mouse) affects hippocampal development from E15.5 onwards. The defects include overall 
smaller hippocampus and almost absent dentate gyrus and are caused by decreased cell proliferation 
and increased apoptosis. Since these defects strongly resemble phenotypes resulting from deletion of 
some of the key components of the Wnt signaling pathway (including knockouts of β-catenin, Frizzeld-9 
and Emx2), the expression of the known Wnt pathway inhibitors Sfrp1 and Sfrp2 was examined. The 
expression of Sfrp2 mRNA was not altered in the Zeb2 mutants, whereas Sfrp1 mRNA expression was 
dramatically increased in the post-mitotic cells of the hippocampus of the Zeb2 knockout brains. Next, 
direct binding of Zeb2 to the Sfrp1 promoter was shown. Zeb2 was also shown to specifically regulate 
the non-canonical (JNK-dependent and β-catenin-independent) signaling in the developing 
hippocampus. Taken together, this data shows that in the hippocampus Zeb2 functions as a positive 
regulator of non-canonical Wnt signaling a.o. by repressing the expression of Sfrp1. 
 
In mouse brain cortex interneurons (INs) comprise 20-30% of the neurons. They provide the 
crucial inhibitory neurotramsmitter GABA, which balances the exitatory glutamate output of the 
pyramidal neurons. Recently our lab showed, using first loss and thereafter gain-of-function 
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approaches, that Zeb2 also plays a role in interneuron (IN) guided migration (van den Berghe et al., 
2013). Zeb2 is present in the VZ and the mantle zones of the MGE, LGE, CGE and in POA and in the 
interneuron populations migrating along well-defined routes (Bartolini et al., 2013; Métin et al., 2006) to 
the cortex. Using Sip1|Nestin (Nestin-Cre mediated Zeb2, at that time still named Sip1, inactivation in 
the entire CNS; mice die at birth) and Sip1|Nkx2.1 (Nkx2.2-Cre mediated Sip1 inactivation in POA and 
MGE with exception of the most dorsal part; mice are viable, but suffer from mycolonic seizures and/or 
motor deficiencies) the authors showed that Zeb2 is essential for the interneuron guided migration as 
the process is severely impaired in absence of Zeb2 and only very few INs reach the cortex.  
 
Using focal electroporations in organotypic slice culture model van den Berghe and co-workers 
selectively inactivated Zeb2 in small IN populations and demonstrated that neurons lacking Zeb2 
(compared to the control slices/brain regions where Zeb2 was not deleted) displayed the migration 
defects, which indicated the cell-autonomous function of Zeb2 in the IN migration. Next, using RNA-seq 
the authors showed that the transcript levels of guidance cues (especially those of the Netrin/Unc5 
system, in particular Unc5b) were deregulated in the Zeb2 knockout brains. Furthermore, the authors 
confirmed (by RT-qPCR and ISH) that Unc5b (a short and long-range repulsive Netrin receptor, 
depending as to whether DCC joins in the receptor complex) was upregulated in the Sip1|Nkx2.1 
model. They then demonstrated - by electroporating Unc5b shRNA expression construct in the 
organotypic Sip1|Nkx2.1 slice cultures with upregulated Unc5b - that the IN migration in the mutant was 
partially restored. Taken together Zeb2 was found essential for the IN guided migration of MGE-derived 
interneurons; also careful conclusions on subtle impact on cell fate of these mutant INs were found and 
discussed (van den Berghe et al., 2013). 
 
The second study (published back-to-back with the work of van den Berghe et al., 2013) on the 
role of Zeb2 in the process of IN specification and migration  – in collaboration with our lab – proposes 
Zeb2 more firmly as the crucial factor dictating the cortical versus striatal IN fate switch (McKinsey et al., 
2013). To understand Zeb2 function, the authors make use of two Cre-deletion mouse models: Nkx2.1-
Cre (like in van den Berghe et al., 2013), which deletes in the VZ of the MGE starting from E9.5, and 
Dlx1/2b-Cre, which drives Cre production in the SVZ and MZ of the entire subpallium from around 
E10.5. MGE is the source of both cortical and striatal interneurons during development. The homeobox 
TF Nkx2.1 plays the key role in specifying both cell types. The interneurons destined to become striatal 
maintain Nkx2.1 whereas those that migrate to the cortex loose Nkx2.1 expression. Upon Zeb2 gene 
inactivation (using Nkx2.1-Cre), an increase in Nkx2.1 was observed and these INs failed to populate 
the cortex, migrated to the striatum and acquired a striatal-like fate instead. Similar results were 
obtained in the Dlx1;2b-Cre mouse model.  
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Next, the authors asked whether Dlx1 and Dlx2 - known to play an important role in the 
subpallial development including in interneuron migration to the cortex - could influence Zeb2 
expression. ISH of Zeb2 mRNA in the Dlx1;2 null mutants showed that Zeb2 expression was strongly 
decreased in the subpallium (epecially in the SVZ), indicating that Zeb2 acts downstream of Dlx1/2, and 
that Dlx1/2 activate Zeb2. The authors also confirmed the direct binding of Dlx2 protein to candidate 
enhancer regions of Zeb2 by ChIP. Furthermore, microarray analysis of control, Zeb2 KO (via Nkx2.1-
Cre) and Dlx1;2 conventional knockout samples, respectively, at E15.5 (i) revealed that Dlx1;2 
conventional KO and Zeb2 conditional KO display similar IN-related gene expression changes as 
compared to the control samples, (ii) proposed Maf, MafB and Cxcr7 mRNA as new signature for 
migrating interneurons and (iii) showed that upon Zeb2 inactivation (or Dlx1;2 deletion) the expression 
of these markers is lost hence the IN cell identity is perturbed. Taken together, these two studies 
confirmed the crucial role of Zeb2 in IN guided migration and cell specification, while the second study 
demonstrated that Zeb2 acts directly downstream of Dlx1/2 and that Dlx1/2-Zeb2 axis is crucial for 
migrating IN specification. 
 
 
1.4.4.2 Hematopoiesis 
 
Hematopoietic stem/progenitor cells (HSCs/HPCs) give rise to many different cell types present in the 
adult blood. Hematopoietic development in the mouse occurs in two waves, i.e. the primitive and the 
definitive wave (Orkin and Zon, 2008). The primitive wave takes place in the yolk sac at around E7.5. A 
second induction takes place in the dorsal aorta and is followed by hematopoiesis in the dorsal aorta – 
gonadal – mesonephros (AGM) region with the emergence of the first cells that will become definitive 
HSCs (Medvinsky and Dzierzak, 1996; Müller et al., 1994). Next, around E12, HSCs migrate to the fetal 
liver, and this migration wave is followed by the migration to the bone marrow (around birth) that later 
becomes the source of HSCs throughout life (reviewed in Mikkola and Orkin, 2006).  
 
Zeb2 is also present in adult HSCs (self-renewing) and hematopoietic progenitor cells (HPCs, 
non-self-renewing multipotent progenitors) and in aortic hematopoietic clusters from the earliest stages 
of definitive embryonic hematopoiesis. To assess the role of Zeb2 in embryonic hematopoiesis, our lab 
– in collaboration with J. Haigh (Gent) and E. Dzierzak (Rotterdam) – knocked-out Zeb2 using the Tie2-
Cre deleter mouse (deletes in all endothelial cells and their progeny including HSCs, and in all definitive 
blood cells). No obvious defects were present before E11.5 suggesting that Zeb2 is not essential for 
primitive hematopoiesis. From E11.5-E12.5 the mutant embryos showed severe hemorrhages in the 
brain and heart malformations. Loss of Zeb2 (Zeb2 -/Tie2-Cre) resulted in embryonic lethality around 
E12.5-13.5. 
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To address the role of Zeb2 in adult hematopoiesis, the authors inactivated Zeb2 in 
hematopoietic stem cells after the initial stem cell formation, using the Vav-iCre mouse line. Most of the 
resulting Zeb2-/Vav-iCre mice died at birth and displayed intracranial bleedings resembling the Zeb2-/Tie2-Cre 
phenotype. CFU assays on HSCs derived from Zeb2-/Tie2-Cre E10.5 yolk sacs, E11.5 AGM regions, 
E11.5-E12.0 fetal livers, and E12.0 peripheral blood were analyzed and all showed a dramatic 
impairment in hematopoietic colony formation compared with the controls, indicating a severe block in 
hematopoietic differentiation in all lineages. Also, a similar impairment of hematopoiesis in the fetal 
livers of Zeb2-/Vav-iCre mice was observed. Consistent with these findings Zeb2-deficient ESCs were 
unable to undergo hematopoietic differentiation in vitro. 
 
The authors also showed that loss of Zeb2 alters HPCs located in the fetal liver probably due 
to increased adhesive properties (accompanied by an increase in Integrinβ1, Cxcr4 and E-cadherin 
levels), leading to a defective homing and hence a decrease in the HSC numbers within the bone 
marrow. Lastly, the authors showed that hematopoietic-specific loss of Zeb2 leads to a decrease in 
Ang1/Tie2 and affects pericyte coverage of the vasculature in the developing brain. This could explain 
the severe hemorrhages in the Zeb2 mutant embryos studied here. Taken together, this study 
addressed for the first time role of Zeb2 in hematopoiesis and showed that Zeb2 is dispensable for the 
formation of HSCs/HPCs, but is essential for their differentiation potential and stemness (Goossens et 
al., 2011). This work, addressing the role of Zeb2 further in adult hematopoiesis, is now continued in 
collaboration with J. Haigh (Melbourne) and V. Janzen (Bonn). 
 
 
1.4.4.3 Melanocyte development 
 
Melanocytes are specialized and pigmented skin cells that produce melanin responsible for skin and 
hair color and for protection against UV light. During development melanocytes originate from the neural 
crest cells. These are transient multi-potent cells that arise by delamination from the developing dorsal 
neural tube between E8.5 and E10.5 (via an accompanying EMT process) and later form the immature 
glial cells innervating the skin. Mitf (Microphthalmia-associated transcription factor) is the key regulator 
of melanocyte development and induces melanocyte differentiation and initiates pigment production 
(reviewed in Ernfors, 2010). 
 
Zeb2 is present in the melanocytes of skin, as well as in the differentiated melanocytes of hair 
follicles. To address the role of Zeb2 during melanocyte development our lab – in collaboration with G. 
Berx (Gent) - deleted it in the melanocyte lineage using the Tyr hydroxylase-Cre mouse (deletes from 
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E10.5). Zeb2 inactivation leads to loss of hair pigmentation and severely impaired melanoblast 
development and differentiation. Moreover, Mitf was severely reduced in absence of Zeb2, indicating 
that Zeb2 is an important regulator of Mitf-dependent melanocyte differentiation. Zeb2 KD (by siRNA) in 
cultured immortalized melanocyte cells (Melan-a line as well as the human SKMel28 melanoma cell 
line) leads to a similar phenotype. Mitf overexpression in the Zeb2 KD lines rescued the melanocyte 
differentiation defect, suggesting that the process is Mitf-dependent. Interestingly, Zeb2 down regulation 
that leads to Mitf down regulation and impairs melanocyte differentiation, was inversely correlated with 
Zeb1 levels, which were found increased upon Zeb2 KO (or Zeb2 KD). Zeb1 is present in melanocyte 
stem cells and an increase in Zeb1 level may indicate that the Zeb2-depleted cells maintain their 
stemness. Taken together this data shows that Zeb2 is involved in the regulation of the levels of Mitf 
mRNA and thereby coordinates the development and differentiation of the melanocyte lineage. 
 
 
 Zeb2 in disease 1.5
 
 
1.5.1 Mowat-Wilson syndrome 
 
Heterozygous mutations in Zeb2 cause Mowat-Wilson syndrome (MOWS; OMIM ♯235730). MOWS 
was recognized for the first time in 1998 (Mowat et al., 1998) as an independent syndrome and the 
genetic link was described by Cacheux and co-workers (Cacheux et al., 2001) and by the Wakamatsu 
team (Wakamatsu et al., 2001). All MOWS patients display moderate-to-severe intellectual disability 
and delayed motoric development. They often present a wide range of additional developmental 
anomalies in eye and renal tract development (>50%), agenesis of corpus callosum (>50%), congenital 
heart defects (>50%), epilepsy (70%) (Cordelli et al., 2013) and Hirschsprung disease (>50%) 
(reviewed in Zweier et al., 2005). The patients are diagnosed based on typical facial features combined 
with intellectual disability. The facial features of MOWS patients include hypertelorism, thick eyebrows 
with lateral flaring, open mouth expression and posteriorly rotated ear lobes often described as “donut-
shaped” (see Fig. 11). Currently, there are more than 200 patients diagnosed in detail in the world and 
in most of them the Zeb2 mutation has been mapped. To date, over 100 different mutations have been 
described (Garavelli and Mainardi, 2007). Mutations are scattered around the gene with a large 
proportion in exon 8, which is the biggest exon of Zeb2 (and the equivalent of exon 7 used for targeting 
in our KO mouse models) and there is no clear genotype-phenotype correlation (Dastot-Le Moal et al., 
2007; Zweier et al., 2005). 
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Figure 11. Mowat-Wilson syndrome, highlighting some of the clinical features of MOWS patients evolving 
with age.  
The ages shown are: (A) 1 year and 6 months; (B-C) 5 years; (D-E) 13 years and 8 months; (F-G) 18 
years.(Garavelli and Mainardi, 2007) 
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1.5.2 Cancer 
 
Epithelial-to-mesenchymal transition  (EMT) is a key cellular event in cancer spreading and it is a major 
contributor of aggressive cancer metastasis originating from epithelial-derived cancers, which is the 
most prevalent class. During EMT epithelial cells lose their cell-cell adhesions and apical-basal polarity 
and acquire mesenchymal phenotype what allows them to invade the extracellular matrix. 
 
One of the key features of EMT is the downregulation of epithelial cadherin (E-cadherin, E-cad, 
Cdh1) which is a tumor invasion suppressor (Vleminckx et al., 1991). E-cadherin gene expression is 
regulated by a number of known transcription factors (TFs), including Twist, Snail family members, and 
Zeb1 and Zeb2. Zeb2 was shown to downregulate E-cadherin and contribute to loss of cell adhesion 
and hence more invasive phenotype in a number of cell lines (Comijn et al., 2001). Moreover, a number 
of studies have documented elevated Zeb2 mRNA and/or protein levels in specific types of cancers, 
negatively correlating with E-cad levels and indicating bad prognosis, including due to increased 
invasion, with high Zeb levels. These cancers include primary colorectal cancer and liver metastasis 
(Kahlert et al., 2011),  gastric cancer (Rosivatz et al., 2015), hepatocellular carcinoma cells (Miyoshi et 
al., 2004) and ovarian and breast carcinomas (Elloul et al., 2005).  
 
Recently, Zeb2 was shown to be involved in a reciprocal negative feedback regulation together 
with the miR-200 cluster (reviewed in Brabletz and Brabletz, 2010; Bracken et al., 2008). miR-200 down 
tunes Zeb2 (and the invasive phenotype of Zeb2high cells) in the NCI-60 cancer cell line (Park et al., 
2008). It was also shown that NMuMG cells avoid EMT by enhancing E-cadherin levels through direct 
targeting of Zeb2 by miR-200 (Korpal et al., 2008). Taken together, this data strongly suggests that (i) 
the balance between Zeb2 and miR-200 members co-determines the epithelial versus mesenchymal 
phenotype and hence aggressiveness of tumor cells, and (ii) that Zeb2 is involved in cancer progression 
and metastasis. This interaction with a.o. miR-200 may also be relevant for Zeb2’s functions in ESCs 
studied here.
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2 Chapter 2: Objectives 
 
 
The overall objective of my PhD research was to contribute to a number of stem cell-based and in vivo 
studies (in the mouse) aiming at understanding (i) what Zeb2’s role is in selected processes in 
embryogenesis (functional analysis) and (ii) ideally in such context, combine this with the question how 
Zeb2 regulates cell fate decisions during development (action mechanism(s)). Therefore, the focus of 
the first part of my PhD thesis is on the role of Zeb2 in mouse brain development performed in 
collaboration with many team members, and the second part – and more extensive, and predominantly 
own work (together with the bio-informatics done by R. Dries) - will do so for Zeb2’s role in cultured 
mouse ESCs, in particular in their transition from pluripotent state cells to commitment and subsequent 
differentiation into mesoderm, endoderm and neuroectoderm lineages. The respective specific aims of 
my research can be summarized as follows: 
 
 
 To identify and validate Zeb2-dependent and/or candidate target genes 2.1
during mouse brain cortex development 
 
In the first part of my PhD I joined an ongoing pioneer project within the laboratory that took us into 
functional studies in CNS development, more specifically the embryonic forebrain, for the very first time. 
This work ultimately led to unraveling the molecular mechanism by which Zeb2, surprisingly – also for 
the cortex development field - as a non-autonomous factor, regulates the timing of neurogenesis and 
gliogenesis in brain cortex development (Seuntjens et al., 2009). My specific contribution was to identify 
Zeb2-dependent and/or candidate target genes candidate during cortex development and amongst 
these identify the genes that help to mechanistically explain the cortical phenotype observed in a 
(growing) series of conditional Zeb2 KO mice and validate these candidates subsequently by a 
combination of a.o. ChIP, RT-qPCR and ISH (see Chapter 3, sections 3.1-3.4). 
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 To develop an embryonically relevant cell culture system to assess 2.2
Zeb2’s function and action mechanism  
 
To gain more insight into the likely multiple mechanisms of action of Zeb2 during neurogenesis, my aim 
was to establish a simplified, robust cell differentiation system. My choice was to use mouse ESCs and 
– based on a number of in vivo observations in the lab’s parallel projects in mouse embryos – model 
neurogenesis in vitro. 
 
The ESC system I used throughout (for a number of reasons) is based on embryoid body 
formation and retinoic acid-based neural induction; it yielded pure neural cell populations in control 
ESCs in a period of 15 days. Griet Verstappen, Leo van Grunsven and I next generated Zeb2 KO ESCs 
and I subsequently subjected these (together with control ESCs) to the neural differentiation protocol. I 
observed that neural development in absence of Zeb2 was abolished. 
 
To validate in parallel whether absence of Zeb2 leads also to defects in differentiation towards 
mesodermal and endodermal lineages, we subjected Zeb2 KO and control lines also to an 
acknowledged general EB-based differentiation protocol. We observed that differentiation to all three 
lineages was impaired indicating that Zeb2 plays a role in early cell fate decisions, possibly including 
exit from pluripotency in ESCs (see Chapter 4, sections 4.1-4.3). 
 
 
 To identify Zeb2-dependent genes during in vitro neural differentiation 2.3
using transcriptomics 
 
As an important part of my PhD project, made possible via the establishment of the aforementioned 
ESC system, I applied RNA-sequencing to identify Zeb2-dependent genes at three essential time-
points: d0 (pluripotent stem cell, very low Zeb2 levels), d4 (multipotent progenitor, low Zeb2 levels) and 
d6 (early neural progenitor, high Zeb2 levels). Gene ontology analysis confirmed that neural 
development in the Zeb2 KO ESCs was affected, but also that expression of genes meanwhile linked to 
pluripotency and DNA-methylation was deregulated in those cells on d0, d4 and d6. As this part of my 
work was performed in a period where major new insights and omics approaches were used in the field, 
I continuously applied new types of analysis in order to meet the increasingly stringent requirements in 
the field (see Chapter 4, sections 4.3.1-4.3.9) 
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 To compare dynamic changes in DNA-methylation during Ctrl and 2.4
Zeb2 KO ESC differentiation 
 
Our RNA-seq data revealed that many of the DNA-methylation and hydroxylation genes were 
deregulated in Zeb2 KO. We asked whether this transcriptional deregulation had an effect on the actual 
DNA-methylation status of the Zeb2 KO cells in pluripotency and during differentiation. Temporal 
reduced representation bisulfate sequencing revealed that Zeb2 KO cells initially correctly acquire 
methyl marks but do not maintain those later during differentiation what is in line with our observations 
on transcriptional changes in genes related to DNA-methylation and pluripotency in the Zeb2 KO cells 
(see Chapter 4, sections 4.3.5-4.3.6). 
 
 
 To validate selected candidate direct target genes and gain insight 2.5
into possible mechanisms of action of Zeb2 during ESC differentiation 
 
My comparative RNA-sequencing data yielded large numbers of deregulated genes in Zeb2 KO ESCs 
at each of the three time points analyzed. I decided to then focus on maintenance of and exit from 
pluripotency and on methylome-related genes since our working hypothesis rapidly took us to the 
defects in pluripotency exit as primary cause for the subsequent failure in cell lineage commitment. 
Doing so, we also hoped to contribute to new insight into pluripotency exit in particular (see Chapter 4, 
sections 4.3.4, 4.3.7). 
 
Taken together, I managed to show that Zeb2 KO ESCs do not downregulate acknowledged 
pluripotency genes during differentiation and that these cells retain their self-renewal capacity over 
prolonged periods of time. In addition, I was able to show show that Nanog and Cdh1 are direct targets 
of Zeb2 in ESCs. I also identified Tet1 as a Zeb2-dependent gene and demonstrated that, upon Tet1 
knockdown, the Zeb2-deficient ESCs can again exit from pluripotency and partially regain their 
differentiation capacity.  
 
I also identified REST (a neural-inhibitory gene) as another gene whose expression depends 
on Zeb2. After investigating this further, I propose a second action of Zeb2 through which it may 
regulate neurogenesis (see Chapter 4, section 4.3.8).  
 
 
	  
 
64 
 To explore the neurodevelopmental potential of Zeb2 domain mutant 2.6
and Zeb1 knock-in mouse ESC lines 
 
To understand how Zeb2 functions during neural development and which of the many new Zeb2 protein 
partners (identified in parallel work in our laboratory) are crucial for its multiple roles during pluripotency 
exit and in neurogenesis we generated – in collaboration with the team of Jody Haigh (Gent, then 
Melbourne) and Steven Goossens (Gent) – by homologous recombination a series of Zeb2 domain 
mutant ESCs that express the transgene Zeb2 (wild-type, see above, and mutant) cDNA from the R26 
locus (i.e. under the control of the endogenous R26 promoter) in a Zeb2 KO ESC context.  
 
Importantly, the insertion of wild-type (WT) Zeb2 cDNA (both mouse and human) were able to 
rescue the neural differentiation defect seen in Zeb2 KO cells. Interestingly, ESCs with the insertion of 
the mutant Zeb2 (with a deletion in its Smad-binding domain, SBD) performed better in the neural 
differentiation protocol yielding more pure neural cell populations than the R26-driven WT Zeb2. This 
indicates also that Zeb2-Smad co-operation (possibly via direct interaction) has an inhibitory effect on 
neurogenesis. In line with this, insertion of wild-type Zeb1 (which does not detectably bind to Smads in 
our hands) in the R26 locus of the Zeb2 KO ESCs also efficiently rescues the neurodevelopmental 
potential of the Zeb2 KO cells (see Chapter 4, section 4.3.12). To obtain a full picture of how Zeb2 
functions in concert with its (meanwhile more, Conidi et al., unpublished results) partners, this initial 
work in this PhD research provides the possibility of generating additional mutant lines with deletions in 
e.g.. the NuRD-interaction motif and other motifs, including protein partner binding ones, in Zeb2.  
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3 Chapter 3: Role(s) of Sip1/Zeb2 in the development of the 
mouse brain cortex 
 
Parts of this Chapter were published in: Nat Neurosci. 2009 Nov;12(11):1373-80. doi: 
10.1038/nn.2409.  
 
In the original publication, the nomenclature used was Sip1. We kept this initial nomenclature in the 
figures and legends in Chapter 3 in order not to modify the figures from the published paper, whereas in 
the text, for keeping the consistency throughout the thesis, we use Zeb2. Chapter and section titles 
however use double “Sip1/Zeb2” nomenclature. 
 
 Introduction 3.1
During brain cortex development its pyramidal neurons are born in an orderly sequence, which 
ultimately – after radial migration of the neuronal cells – is reflected by the ordered, multi-layer nature of 
the mammalian brain cortex (see Chapter 1). Cell proliferation and specification is orchestrated here by 
both intrinsic and extrinsic signals.  
 
The first studies addressing cortical cell specification during corticogenesis demonstrated that 
cell fate is encoded within the individual neural progenitor cells (NPCs). Experiments where such 
progenitor cells from early embryonic brains were transplanted to developmentally older brains (and 
vice versa) showed that their developmental potential decreases with gestation time and that the fate of 
these progenitors is to a large extend, and sometimes claimed exclusively, intrinsically determined. The 
early progenitors transplanted in the older brains could produce late-born neurons, however the late 
progenitors had lost their potency with time and could only generate late-born neurons, regardless of 
the environmental cues provided by the host. In addition, it was shown in parallel experiments that 
cortical pyramidal neuron progenitors retained their neurogenic timing in vitro and that the 
developmental potency of even co-cultured cells from different cortical stages is not dictated by the cell 
environment (Desai and McConnell, 2000; Frantz and McConnell, 1996; McConnell and Kaznowski, 
1991; Shen et al., 2006). Interestingly, the developmental potential is restricted rather gradually: the 
progenitor cells that give rise to neurons of a particular cortical layer maintain their competence for 
longer than needed for the production of that layer only, suggesting that an additional cell non-
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autonomous mechanism plays a role in the coordination of the appropriate timing of neurogenesis 
(Desai and McConnell, 2000). 
 
Regulation of development by signaling proteins that act on cells directly to induce cellular 
responses in a concentration-dependent manner has long been known as one of the crucial 
mechanisms that determine cell fate and steer embryonic tissue patterning as well (reviewed in Ashe 
and Briscoe, 2006), but the concept of extrinsic regulation of corticogenesis was introduced rather 
recently. The extrinsic queues in the brain originate locally, e.g. from within the progenitor zone, but 
could during development also come from remote sources such as blood vessels, meninges or 
cerebrospinal fluid in the neighborhood of the VZ.  
 
Retinoic acid (RA) produced by the meninges was shown to regulate neuron generation in the 
cortex. The transcription factor Foxc1 is – in addition to other tissues – present in the meninges and 
head mesenchyme. Genetic removal of Foxc1 leads to severe defects in meninges development, which 
lead to abnormalities in skull and cerebral cortex formation with very prominent cortical layer 
disorganization, reduction in intermediate progenitors and neuron number, as well as in overall 
elongation of the neuroepithelium (Zarbalis et al., 2007). In absence of Foxc1, the mRNA expression of 
a number of genes involved in RA-signaling, including Rdh10 and Raldh2 that are crucial for atRA (all-
trans retinoic acid; Sandell et al., 2007) synthesis, is also reduced. Interestingly, injection of atRA into 
pregnant mice carrying Foxc1 mutant embryos partially rescues the Foxc1 phenotype. Treatment with 
atRA leads to a decrease in the length of the neuroepithelium and increase in numbers of early and 
late-generated neurons. The cortex still showed defects in the laminar organization that are most 
probably caused by the meningeal/basement membrane defects that are present in atRA-treated 
mutants. This important study shows that corticogenesis not only depends on the cell-intrinsic program 
but is dictated also by extrinsic input (here atRA) from the surrounding meningeal cells (Siegenthaler et 
al., 2009). 
 
Pals (Protein associated with Lin7) and Pten (Phosphatase and tensin homolog), both present 
in the progenitor zone of the cortex, play opposing roles in cortex development and balance the 
responses to polypeptide growth factors present in the CSF. Genetic inactivation of Pals leads to a 
decrease in progenitor cell numbers and premature cell-cycle exit, coupled to excessive production of 
deep layer neurons followed by massive cell death, which collectively induces abrogation of the entire 
cortex (Kim et al., 2010). Knockout of Pten results in enlarged brain size due to increased cell 
proliferation and decreased cell death (Groszer et al., 2001). Interestingly, Pten deficiency in the Pals1 
mutant background results in an almost normally sized brain. Both proteins have been shown to 
regulate the localization of IgfR to the apical surface of the cells lining the ventricles of the developing 
forebrain.   
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Manipulation of Igf/IgfR signaling results in phenotypes similar to those observed in Pals/Pten 
defeciencies: IgfR deficiency causes a decrease in the progenitor proliferation and microcephaly (Liu et 
al., 2009), while induction of Igf signaling results in brain overgrowth and macrocephaly (Ye et al., 
2004). IgfR responds to CSF-containing Igf2, which promotes progenitor proliferation. These studies 
show how Pals and Pten spatially restrict and expand, respectively, IgfR expression in the progenitor 
zone to modulate the cellular response to Igf2 signals present in the CSF (Lehtinen et al., 2011). 
Various other trophic factors have meanwhile been shown to modulate cell proliferation and migration, 
but for many of these the mechanism(s) of action remain to be clarified. Bmp7 present in the choroid 
plexus, meninges and the cortical hem is one of such factors that is present in the CSF. Bmp7 was 
found to regulate fundamental properties of radial glia and neural progenitors and their survival. In a 
collaboration with the team of Daniel Graf (in Zürich, presently in Alberta) our laboratory could show that 
in the absence of Bmp7 the overall thickness of the cortex was reduced and that the radial glia no 
longer attached to the meninges (Segklia et al., 2012). It was postulated that Bmp7 exerts its function 
via regulating the well-characterized neurogenic Pax6/Ngn2 axis in the developing cortex (Scardigli et 
al., 2003; Segklia et al., 2012).  
 
Brain-derived neurotrophic factor (BDNF, a neurotrophin) is one of the key extrinsic factors that 
together regulate laminar formation in the developing brain cortex. Administration of BDNF into the VZ 
of E13.5 mouse brains shortens the cell cycle of the progenitors in the VZ by accelerating completion of 
the S-phase of the cell cycle what causes a more rapid release to the basal VZ and their migration. This 
results in a switch from the generation of layer 4 neurons to neurons typical for deep layers 5 and 6, 
whereas administration of a function-blocking anti-BDNF antibody induces a fate switch and the 
neurons acquire fate of the upper layers 2/3 (Fukumitsu et al., 2006). 
 
 
3.1.1 Sip1/Zeb2 levels are high in post-mitotic neocortical cells 
 
Zeb2 transcripts (not shown) and protein (Fig. 12) are detected during neurogenesis in the post-mitotic 
cells of the mouse cortex, with barely detectable levels in progenitors. (Fig.12a–c). In the 
medial/cingulate cortex, the Zeb2 domain at late gestation (E18.5) became restricted to cells of the 
deep layers (Fig. 12c). 
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Figure 12. Expression of Sip1/Zeb2 in the embryonic cortex. 
(a) Sip1 immunostaining at E13.5 was found in the ventricular zone of the ventral telencephalon and in the post-
mitotic cells of the cortex. (b) At E15.5, Sip1 expression was intense in the post-mitotic cells of the cortex, where 
invading Sip1-positive cells from the ventral telencephalon could be seen as well. (c) At E18.5, Sip1 synthesis was 
area specific; in the lateral cortex, it was maintained in the entire cortical plate, whereas it was downregulated in 
the upper layers of the cingulate cortex. (d) Conditional knockout of Zeb2 (shown here using Nestin-Cre) resulted 
in the almost complete loss of Zeb2 protein from the cortex and the ventral telencephalon. (Seuntjens et al., 2009) 
 
 
3.1.2 Sip1/Zeb2 knockout mouse models 
 
To document the effects of Zeb2 removal on cortex development, three Cre-deleter strains were used: 
Nestin-Cre to inactivate Zeb2 in the entire CNS, Emx1-IRES-Cre to ablate Zeb2 exclusively in 
neocortical progenitors starting from E9.5, and Nex-Cre to separate Zeb2's function in early cortical 
progenitor cells from its role in post-mitotic neurons. Zeb2|Nestin mice died at birth, whereas both 
Zeb2|Emx1 and Zeb2|Nex mice survived until 3-4 weeks after birth. Notably, the neocortical phenotype 
observed in all three models was nearly identical. 
 
	  
 
69 
3.1.3 Lack of Sip1/Zeb2 causes premature generation of upper layers at the expense 
of deep layers 
 
The absence of Zeb2 leads to a reduction in numbers of deep layer neurons (See Fig. 13) marked by 
Ctip2 (layer 5) and Tbr1 (layer 6) (Fig. 13 a-c), whereas upper layers marked by Satb2 (layers 2-4, Fig. 
13 d-f) are significantly expanded at E17.5 (Fig.13h). 
 
 
 
Figure 13. Sip1/Zeb2-deprived brain cortex contains excessive numbers of upper layer neurons at the 
expense of deep layer neurons whilst maintaining their relative position within the cortex.  
(a–c) Double immunolabeling for Tbr1 (layer6) and Ctip2 (layer5) showed a reduction of deep layers when Sip1 
was removed from either the entire brain (Sip1|Nestin; b) or post-mitotic neurons (Sip1|Nex; c). (d–f) Double 
labeling of Satb2 (layers 2–4) and Ctip2 showed increased size of upper layers. (g) The regions (boxes in right 
panel) chosen for quantification in sagittal and coronal sections of mouse E17.5 brain are indicated, as well as the 
plane of sectioning used for quantification. (h) Quantification of the proportion of neurons of a certain layer in the 
total number of cells present in the cortical plate. # P = 0.006, ## P = 0.00057, ### P = 0.000051, * P = 0.00014, 
** P = 0.000057, *** P = 0.000063. Error bars indicate s.e.m. Scale bars represent 50 µm. (Seuntjens et al., 2009) 
 
 
A birth-dating study done by immunolabeling mitotically active precursors with BrdU (by 
intraperitoneal injections of the pregnant females) in combination with layer-specific markers showed 
that the peaks of production of Ctip2+ layer 5 neurons and Brn2+ layer 2–4 cells had shifted to 1 day (d) 
earlier in Zeb2 mutants (Fig. 14 a,b,c), whereas the generation of Tbr1+ layer 6 neurons remained 
unchanged (Fig. 14 a). This suggests that the onset of neurogenesis in Zeb2 conditional mutants was 
not altered, but subsequent neuronal subtypes were prematurely generated, indicative of a forward shift 
of neurogenesis. This is confirmed by staining for Brn2, especially at E14.5 (Fig. 14). 
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Figure 14. Sip1/Zeb2 deletion in neocortical post-mitotic cells causes premature generation of layer 2-5 
neurons.  
(a) Pulse-chase experiments with BrdU administered at different time points during development (shown on the x 
axis) followed by analysis of the indicated layer-specific markers at E18.5. Quantification of percentages of cells 
that were stained for both BrdU and the layer-specific marker at the time of analysis, corresponding to different 
time points of BrdU administration in control and Zeb2|Nestin (mut) mice. There was no difference in the timing of 
production of Tbr1-positive neurons. A higher proportion of Ctip2-expressing neurons incorporated BrdU label at 
E12.5 (* P = 0.002) and more Brn2-positive cells were generated at E13.5 (** P = 0.036) in the mutant cortex. At 
E15.5, no layer 5 and 6 neurons were born in either the control or mutant, whereas the generation of layer 2–4 
neurons was nearly complete in the latter. Error bars indicate s.e.m. (b) Similar pulse-chase experiments at E12.5 
and E13.5 in Zeb2|Nex and control mice showed increased generation of layer 2–5 neurons (# P = 0.0047 and *## 
P = 0.013) at E12.5. Error bars indicate s.e.m. (c–e) Immunostaining for upper-layer marker Brn2 at E14.5 
revealed neurons with upper-layer characteristics in the mutant (Zeb2|Nestin and Zeb2|Nex) cortical plate at a 
stage when such neurons were absent in the control. Scale bars represent 50 µm. (Seuntjens et al., 2009) 
 
 
3.1.4 Sip1/Zeb2 is also crucial for appropriate control of the timing of gliogenesis 
 
Gliogenesis in the mouse cortex starts after the onset of neurogenesis, i.e. at E17.5, and proceeds 
beyond birth. We observed that in the Zeb2 KO brain there were significantly more GFAP+ cells 
dcompared to control (Fig. 15 e,f). Staining with anti-Ki67 (which marks proliferating cells) showed that 
the number of dividing cells at this stage was significantly higher in the Zeb2 mutant brains and that 
more dividing cells were present in the IZ (and not in the VZ) of the Zeb2 KO brains as compared to the 
control at E17.5 (Fig. 15 a-d). BrdU pulse-chase experiments done to document further the precocious 
generation of glial cells in the Zeb2-deficient brains revealed that at E16.5 about 45% more Olig2+ cells 
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were generated in mutant compared to control embryos (Fig. 15 h,j,l,n). In addition, we detected more 
cells born at E16.5 that differentiated into GFAP+ astrocytes at P2 and P4 in the mutant cortex (Fig. 15, 
g,i,k,m). In conclusion, the shift forward in neurogenesis in Zeb2 KO mice paves also the way for 
precocious and enhanced proliferation of glial precursors, which in turn leads to the production of higher 
numbers of astrocytes at early postnatal stages. 
 
 
Figure 15. Enhanced astrocytic proliferation and premature and increased gliogenesis in Sip1/Zeb2 
conditional mutants.  
(a–c) Shown here is the expression of proliferation marker Ki67 at E17.5 in control (a), Zeb2|Emx1 (b) and 
Zeb2|Nex (c) mice in a region close to the medial cortex. (d) The increase in proliferation in the mutant cortex was 
quantified over an entire radial unit and is represented as the percentage of the total number of cells counted in 
this unit that were labeled for Ki67. * P = 0.0063. (e,f) Expression of astrocytic marker GFAP was found to be 
twofold higher in the cingulate cortex in Zeb2|Nex at P2 (immunostaining for GFAP at P4 shown in e and f; 
quantification in m). (g–l) To trace the origin of these astrocytes, we pulse-labeled dividing cells in the cortex with 
BrdU at E16.5 and chased them at P2. Double immunostaining for BrdU and GFAP (g,i,k) and for BrdU and Olig2 
(h,j,l) indicated that precocious production of glial cells was occurring in Zeb2|Emx1(i,j) and Zeb2|Nex (k,l) 
conditional knockout mice. Scale bars are 50 µm. (m) We measured the area of GFAP expression in a specific 
region of the cortex in both control and mutant and normalized the mutant values with regard to the control. * P = 
0.0018. Error bars indicate s.e.m. (n) Twice as many Olig2-expressing glial progenitors were born at E16.5 in 
Zeb2|Nex brains as in control. * P = 0.0077. Error bars indicate s.e.m. (Seuntjens et al., 2009) 
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 Methodology and Materials 3.2
 
3.2.1 Expression profiling by microarray analysis 
 
In the first series of arrays, we examined gene expression in cortex and hippocampal tissue from two 
control (Zeb2loxP/+; Nestin-Cre) and two mutant (Zeb2loxP/; Nestin-Cre) E18.5 littermates, each taken from 
two different litters. In a separate experiment, we used E14.5 cortex and hippocampal tissue from two 
control (Zeb2loxP/+; Nex-Cre) and two mutant (Zeb2loxP/; Nex-Cre) littermates. RNA from cortex and 
hippocampus tissues was isolated using an RNeasy kit according to the manufacturer's protocol 
(Qiagen). The isolated RNA was inspected for integrity and purity using an Agilent Bioanalyzer and a 
NanoDrop spectrophotometer, respectively. All samples were of similar RNA quality. Starting with 1 µg 
of total RNA, we amplified RNA by in vitro transcription with a biotin labeling reaction (Amersham 
Biosciences). The probes were purified and analyzed again for yield (>20 µg) and purity (260:280 and 
260:230 nm). We fragmented 10 µg of the resulting antisense RNA according to the manufacturer's 
protocols (Amersham Biosciences) and resuspended it in 260 µl of hybridization buffer. 
 
Codelink Mouse Whole Genome array is a single array representing ~35,000 transcripts. The 
gene array ChIPs were hybridized in a shaker-incubator at 37 °C at 300 rpm for 18 h and washed and 
stained with Cy5-streptavidin according to manufacturer's protocols (Amersham Biosciences). The 
Agilent DNA Microarray scanner was used for scanning and image analysis was performed with 
Codelink Expression Analysis 4.1 software (Applied Microarrays). 
 
3.2.2 RT-qPCR and ISH 
 
The expression of Nt3 and Fgf9 mRNA was validated by RT-qPCR (ABI Prism 7000, Applied 
Biosystems) on E14.5 cDNA synthesized from mutant and control cortex mRNA. Nt3, Fgf9, Fgfr2, Fgfr3 
and TrkC mRNA was detected on brain slices (6 µm) by cold ISH using an automated platform 
(Ventana Discovery, Ventana Medical Systems; details of procedures can be obtained at request). The 
Fgf9 probe was a kind gift from D. Ornitz (Washington University), and the TrkC probe from L. Lei (UT 
Southwestern Medical Center, Texas, USA). All other probes were cloned from PCR fragments using 
the PCR-Script Amp cloning kit (Stratagene). 
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3.2.3 ChIP analysis 
 
In silico analysis of the Nt3 and Fgf9 genes, including a 5,000-bp region upstream of the coding 
sequence, revealed several potential Zeb2-binding sites. Qualitative PCR primers were designed 
(Vector NTi) to cover 500-bp regions 4 kb upstream of the first exon. For Fgf9, we also included regions 
covering Zeb2 sites (fragments containing at least two CACCT(G) half-sites separated by less than 100 
bp) in the introns. The performance of these primers was first validated on an AbiPrism qualitative PCR 
platform using a dilution series of genomic DNA. Later, these primers were used to assess the quality of 
the sheared or enzymatically digested chromatin (input DNA). To prepare the chromatin, we dissected 
mouse cortex and hippocampus tissue from E16.5–17.5 CD1 embryos in ice-cold Hank's solution, cut 
the tissue into smaller pieces, and dispersed by pipetting and counted the cells. The whole-cell 
suspension was then cross-linked in 1% formaldehyde (vol/vol) for 10 min at 24 °C. Cross-linking was 
stopped by addition of Glycine to a final concentration of 0.125 M. After several washes with PBS, the 
cell pellet was dissolved in lysis buffer (5 mM PIPES (pH8.0), 85 mM KCl and 0.5% NP40 (vol/vol) and 
kept on ice for 1-1.5 h to lyse the cells. The lysates were then passed 20 times through a 26G-needle to 
release the nuclei. Nuclei were lysed in nuclear lysis buffer (50 mM Tris-HCl (pH 8.1), 10 mM EDTA, 1% 
SDS (wt/vol) for 10–15 min before shearing. Chromatin was sonicated eight times for 30 s in a Branson 
Sonifier 450 (power setting 3) and with a constant duty cycle to obtain chromatin fragments of 500 bp 
(mean size). Samples were cooled for 1 min on ice between each pulse. An aliquot of the sheared 
chromatin was reverse-crosslinked and purified to check shearing efficiency and to measure DNA 
concentration. Samples were further processed according to the protocol provided with the ChIP-IT kit 
(Active Motif). For each immunoprecipitation reaction, 25 µg of chromatin was used. 
Immunoprecipitation was performed using 5 µg of crude anti-Zeb2 rabbit antibody or 5 µg of rabbit IgG 
as a negative control (Abcam). After recovery of the Zeb2-bound DNA fragments from the 
immunoprecipitation, fragments of Nt3 and Fgf9 promoters were detected by qualitative PCR on 20 ng 
of DNA (immunoprecipitate) per sample in triplicate, using the validated primers described above. For 
each region, at least three independent immunoprecipitation reactions were carried out. Next, the 
relative enrichment of the bound versus the unbound regions (after ChIP with antibody to Zeb2) was 
calculated relative to negative control rabbit IgG. 
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 Results 3.3
 
In this project my aim was to (i) identify and validate direct target genes of Zeb2 during cortex 
development, which (ii) explain the underlying mechanism of the cortical phenotype in this series of 
conditional Zeb2 KO mice. In addition, this was the first time in our laboratory we performed this on 
basis of global comparative gene expression profiling (at that time micro-array based, whereas it is now 
replaced by RNA-Seq). 
 
We first carried out micro-array analysis of Zeb2 KO versus (Zeb2) control (CTRL) forebrain 
tissue at E14.5 and E18.5. We selected the top-20 candidate genes (see Table. 1) that were 
upregulated in the Zeb2 KO brains and therefore could be repressed by Zeb2.  
 
List of potential target genes of Zeb2 in developing cortex 
 Gene Name UP at E14.5 UP at E18.5 
1 Car7 carbonic anhydrase 7 yes yes 
2 BC049730 cDNA sequence BC049730 yes no 
3 Ap1m2 adaptor protein complex AP-1, mu 2 subunit yes yes 
4 Nt3 neurotrophin 3 yes yes 
5 Trhr thyrotropin releasing hormone receptor yes yes 
6 Grm1 glutamate receptor, metabotropic 1 yes yes 
7 BC027061 hypothetical protein LOC232491 yes no 
8 Gpr88 G-protein coupled receptor 88 yes yes 
9 Gpr73l1 prokineticin receptor 2 yes no 
10 Dbpht2 DNA binding protein with his-thr domain yes no 
11 Tesc tescalin yes no 
12 Rasgef1c RasGEF domain family, member 1C yes no 
13 Fgf9 fibroblast growth factor 9 yes yes 
14 Gm337 Mus musculus dual specificity phosphatase 5 yes no 
15 Ebf1 early B-cell factor 1 yes no 
16 Hrk harakiri yes yes 
17 AI427515 expressed sequence AI427515 yes yes 
18 Bmp2 bone morphogenetic protein 2 yes yes 
19 AK140273 hypothetical protein yes yes 
20 Lad1 ladinin yes yes 
 
Table 2. List of potential target genes of Zeb2 in developing cortex. 
 
The list of transcripts downregulated upon Zeb2 KO at E14.5 and E18.5 was significantly 
shorter and contained only four protein-encoding genes: Mc4R, Crk7, Efcbp1 and Ldb2. This indicated 
that Zeb2 indeed acts mostly as a transcriptional repressor. 
 
My focus was on the validation of these potential target genes by RT-qPCR and in situ 
hybridization (ISH), to prioritize the list of candidates based on whether or not a candidate could confirm 
the obtained micro-array expression data. Zeb2 is expressed in the upper layers of the cortex, but the 
phenotype (premature generation of the upper layers at the expense of the deep layers and premature 
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gliogenesis, see introduction to this Chapter) was pointing out towards defects in the progenitor zone 
where Zeb2 is absent. Because of this we focused on the secreted/diffusible factors whose expression 
could be (directly) regulated by Zeb2 in the upper layers and which could feed back to the progenitor 
zone to orchestrate timing of neurogenesis and numbers of neurons/glia generated.  
 
Neurotrophin 3 (Nt3) and Fibroblast growth factor 9 (Fgf9) mRNA were strongly upregulated in 
the micro-array data set in the Zeb2 KO versus Zeb2 CTRL samples. We subsequently found that 
Nt3 and Fgf9 transcripts were strongly over-expressed (RT-qPCR) in the mutant brains at E14.5 and 
18.5, respectively (Fig.16 A,E). Nt3 and Fgf9 mRNA were detected in Zeb2-deficient cortical plate as 
early as E12.5. At E13.5, 14.5 and 15.5, Nt3 mRNA was markedly upregulated (even visible by ISH) 
when more post-mitotic cells began to populate the cortical plate (Fig.16 C, D and Fig. 17 B,D). 
Increased Fgf9 mRNA levels were detected prematurely at E16.5 in the mutant cortex (Fig. 16 G,H, Fig. 
17 F). 
 
To determine whether Fgf9 and Nt3 alone could mimic the Zeb2 KO phenotype in vitro, we 
added these factors separately to the WT organotypic slice cultures of E16.5 brains. We could not 
reproduce the phenotype using Nt3. Notably, addition of Fgf9 (to the medium or as Fgf9-coated beads 
implanted in the E16.7 and E17.5 cortex slices) resulted in enhanced generation of Olig2+ glial 
precursors in the VZ and in the CP validating our Zeb2-dependent feedback theory (experiments done 
by A.N. and E.S., data not shown here; see Seuntjens et al., 2009). 
 
To verify if Fgf9 and Nt3 are direct targets of Zeb2, we carried out ChIP, using a polyclonal 
anti-Zeb2 antibody, on sheared chromatin isolated from cortical tissue at E16.5–17.5. Zeb2 was known 
to interact with regulatory elements containing a separated tandem of two sequences (CACCT(G) 
and/or, in fewer cases, CACANNT (Remacle et al., 1999). We designed several primer pairs within 5 Kb 
upstream of the first exon of mouse Nt3 and Fgf9, respectively, and analyzed the immunoprecipitate via 
RT-qPCR. We found a significantly higher (P = 0.044) level of interaction of Zeb2 with the fragment 
encompassing the −1,300 region of Nt3, but we could not detect any preferential binding of Zeb2 with 
the Fgf9 upstream region. We also tested three intronic regions of Fgf9 that contain putative Zeb2- 
binding sites, but none of these were preferentially enriched for Zeb2-binding.  
 
Taken together, I showed that Zeb2 interacts directly with the promoter region of mouse Nt3, 
possibly downregulating its transcription (Fig.16 I). Although Fgf9  was clearly dependent on intact Zeb2 
levels, it remains unclear as to whether this is mediated via direct interaction of Zeb2 with a promoter or 
promoter-proximal regulatory element in Fgf9 (Fig. 16 I).  In order to respond to the growth factor cues a 
cell has to express the factor-specific receptors. So, we had also to investigate whether the expression 
domain and/or level of relevant receptor genes was altered. TrkC is the Nt3 receptor here, and FgfR2 is 
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the major candidate Fgf9 receptor here. We documented (by ISH) that both TrkC (E14.5) and FgfR2 
(E16.5) were present in the proliferative zone of the cortex, but did not observe any differences, at least 
using ISH, between control and mutant brains (Fig. 16 j,m) 
 
 
Figure 16. Expression Nt3 and Fgf9 and their receptors, verified by ISH, in developing cortex. ChIP 
analysis for Sip1 on Nt3 and Fgf9 promoters.  
(a–f) ISH of Nt3 (a–c) and Fgf9 (d–f) mRNA at E14.5 and 16.5 respectively, showed upregulation of both in the 
Zeb2-deficient cortical plate. Fgf9 was found more in the cingulate cortex, whereas Nt3 was detected in the entire 
cortical plate (line with star). (g) Different regions (R) within 5-kb upstream of the first exon of 
the Nt3 and Fgf9 genes were tested for interaction with Sip1 by ChIP. The graph shows the relative enrichment of 
these regions for rabbit antibody to Zeb2–immunoprecipitated DNA versus rabbit IgG–immunoprecipitated DNA. In 
the sketch, gray rectangles depict the regions that were amplified by validated primer sets. Putative tandem Zeb2-
binding sites are represented by red ellipses. Only R3 seems to be bound by Zeb2 (* P = 0.047 and** P = 0.044, 
error bars indicate s.e.m.). In the Fgf9 regulatory region, we could not detect specific interaction with four regions 
in the upstream regulatory region and two regions in intronic sequences. (h,k) ISH for the Nt3 receptor TrkC at 
E14.5 showed high mRNA expression levels in the entire cortex. (i,l) ISH for the Fgf9 receptor Fgfr2 showed 
mRNA expression localized to the ventricular zone of the ganglionic eminences at E16.5. (j,m) Fgfr3 at E16.5 was 
highly expressed in the cortical ventricular zone (Seuntjens et al., 2009). 
	  
 
77 
 
 
 
Figure 17. Nt3 and Fgf9 are expressed at low levels in developing cortex.  
In situ hybridizations for NT3 at E13.5 (a-b), E15.5 (c-d) and for Fgf9 at E17.5 (e-f) show that their expression 
remains low in the control cortex (arrows). NT3 overexpression can already be detected at E13.5 (double arrows). 
(Seuntjens et al., 2009) 
 
 
 Discussion 3.4
 
The fate of cortical progenitors that generate neurons and glial cells during development is determined 
by temporally and spatially regulated signaling mechanisms. We show that Sip1/Zeb2, which is present 
at high levels in post-mitotic neocortical neurons and cannot be detected in the precursor cells lining the 
embryonic (fore)brain ventricles, regulates progenitor fate. Furthermore, it does this in a non-
autonomous fashion. Conditional genetic inactivation of Zeb2 in induced premature production of upper-
layer neurons at the expense of deep layers, precocious and increased generation of glial precursors, 
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and enhanced postnatal astrocytogenesis. Such premature upper-layer generation coincided with 
overexpression of Nt3 and upregulation of Fgf9 (and not of their respective cognate receptors) 
expression. 
 
Nt3 was previously shown to play a role in neurogenesis. When cultured in presence of 
function-blocking Nt3 antibodies, cortical progenitors show decreased proliferation and survival what 
resulted in Mek/Erk-dependent inhibition of neurogenesis (Barnabé-Heider and Miller, 2003). Also, more 
recently, a similar study addressing the role of Nt3 in cortex development showed that injection of Nt3 
along the VZ of E13.5 brains altered cell fate decisions and cell migration; neurons destined to become 
layer 4 switched now are part of upper layer production (layers 2/3). This phenotype was mimicked in 
vitro and could be rescued by inhibition of Mek/Erk signaling (Ohtsuka et al., 2013).  In a recent study 
Parthasarathy and co-workers (Parthasarathy et al., 2014) showed that overproduction of Nt3 in the 
post-mitotic neurons at the onset of corticogenesis resulted in a switch from deep layers to upper layers 
cell generation. In contrast, loss of Nt3 caused an increase in deep layer 6 neurons, but added Nt3 did 
not rescue the Zeb2 KO phenotype suggesting other parallel mechanisms control the cell fate switches 
and the timing of neurogenesis. This data is in line with the phenotype observed in the Zeb2 KO brains 
where overproduction of Nt3, seen at the mRNA level, leads to an enhanced generation of the upper 
layer neurons at the expense of the deep layers. Our data is further substantiated by precocious 
activation of Mek/Erk, downstream of neurotrophins (reviewed in Kaplan and Miller, 2000).  
 
Fgf9 was previously implicated in the gliogenic switch in retinal pigment epithelium (Zhao et al., 
2001), and addition of Fgf9 to the Muller glial cell cultures (Muller glia are the main glial cell type of the 
retina) induced their proliferation (Cinaroglu et al., 2005). Presently ongoing collaborative work between 
our lab and R. Ashery-Padan (Tel Aviv) on the role of Zeb2 in retinogenesis is addressing this as well. 
Recently, it was shown that Mek is a key regulator of gliogenesis in the developing brain. Mek1 and 
Mek2 are the core components of the Mek/Erk pathway here. It was shown that deletion of Mek1/2 in 
the developing brain results in a reduction of glial progenitors whereas higher Mek1 levels promote 
precocious glial progenitor specification and termination of neurogenesis in a cell-autonomous way (Li 
et al., 2012b). 
 
This work shows that Zeb2 restrains the production of signaling factors in post-mitotic neurons 
that feed back to progenitors to regulate the timing of cell fate switch and the numbers of neurons and 
glial cells throughout corticogenesis. It could be that in absence of Zeb2, Nt3 is derepressed in the 
upper layers of the cortex, which causes precocious activation of the Mek/Erk pathway. Precociously 
activated Mek/Erk signaling subsequently induces premature glial progenitor specification program 
enhanced by Fgf9 overproduction. Thus, Fgf9 upregulation and induced gliogenesis could be secondary 
to the Nt3 induction and could be triggered by Mek/Erk pathway activation. 
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It has previously been shown that extrinsic factors from CSF, blood vessels, meninges or 
produced locally within the VZ of the cortex influence cell fate decisions during development (see 
Introduction section to this Chapter). We have shown, for the first time in the field, that a transcription 
factor (Zeb2) acts non-autonomously in the post-mitotic cells of the brain cortex and, doing so, regulates 
the timing of neurogenesis and gliogenesis in the remote progenitor zone of the cortex.  
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4 Chapter 4: Role(s) of Zeb2 in pluripotency and differentiation 
of embryonic stem cells 
 
Previously published studies on the role of Zeb2 in early cell fate decisions in human ESCs and mouse 
EpiSCs using shRNA-mediated knockdown of Zeb2 and in parallel overproduction of Zeb2 showed that 
it is an important regulator or ectodermal vs. mesendodermal fate (Chng et al., 2010).  
 
Our laboratory was the first to derive and study Zeb2 knockout ESCs. We hypothesized that 
permanent genetic inactivation of Zeb2 may result in a different, possibly more severe phenotype than 
knockdown, allowing us to better understand Zeb2’s mechanisms of action that otherwise were masked 
by incomplete silencing of Zeb2. The first goal of this part of the project was to develop a convenient 
and simple, robust differentiation system(s) for mouse ESCs that would allow us to get insight into how 
Zeb2 regulates cell fate decisions starting from the ground pluripotent state. Because of the well-
documented link between ZEB2 gene mutations and severe and milder forms of Mowat-Wilson 
syndrome, the emphasis was put on developing an efficient neural differentiation protocol from 
pluripotent cells. The second goal was to document - at mRNA and DNA-methylation level - and to 
further study the consequences of Zeb2 genetic inactivation in ESCs both for their pluripotent state as 
well as  for general and directed neural differentiation, respectively (for protocols see Methodology and 
Materials section below). Because of the observed Zeb2 KO phenotype, my focus was on the relation 
between Zeb2, pluripotency network and enzymes regulating DNA-methylation status in ESC 
pluripotency and during differentiation. The aforementioned part of my work (see also Chapters 4.1, 
4.3.1- 4.3.7, 4.4.1) is currently under revision. We also explored additional mechanisms by which Zeb2 
could regulate ESC differentiation and doing so we identified the neuronal-inhibitory factor REST) which 
forms multiple complexes) as downstream target of Zeb2 (Chapter 4.3.8). 
 
In addition we performed teratoma formation assays and we discovered that Zeb2 KO ESCs 
injected into immunodeficient mice could generate teratomas comprised of cells of either of the three 
germ layers (Chapter 4.3.9). The results from the teratoma experiments prompted us to study cell-
autonomous vs. cell non-autonomous action of Zeb2 in vitro. For this we performed co-culture 
experiments where we mixed labeled Ctrl and Zeb2 KO ESCs in different ratios, subjected them to 
neural and general differentiation, respectively, and assessed whether Ctrl cells were able to direct in 
this set-up the differentiation of Zeb2 KO ESCs (Chapters 4.3.10 and 4.4.3). To test the in vivo 
developmental potential of Zeb2 KO ESCs, we performed chimera experiments (Chapter 4.3.11).  
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 We also asked whether interaction between Zeb2 and its Smad partners would be beneficial 
or inhibitory for neural differentiation of ESCs. For this we generated a series of ESC lines where we 
inserted wild-type and (the appropriate) mutant Zeb2 cDNAs in the R26 locus of the Zeb2 KO ESCs 
(Chapters 4.3.12 and 4.4.4). 
 
 Introduction  4.1
This introduction specifically addresses the main part of my ESC-related project  (Chapters 4.3.1- 4.3.7, 
4.4.1) and is currently under revision (Stryjewska, Dries et al.). 
 
Naïve mouse embryonic stem cells (mESCs) (Evans and Kaufman, 1981; Martin, 1981), primed 
epiblast stem cells (EpiSCs) (Brons et al., 2007; Tesar et al., 2007) and embryonic germ cells (Matsui et 
al., 1992; Leitch et al., 2010) are pluripotent cells that can be propagated in vitro and used as cell 
models to study pluripotent cell states and subsequent fate decisions that occur at different stages of 
embryonic development, transitions that require changes of the transcriptome and methylome. For 
cultured populations of ESCs, both adherent cells and embryoid bodies (EBs) are used. The ground-
state (more stable than the metastable, naïve state) of self-renewing mESCs can be achieved by 
simultaneous addition of LIF and chemical inhibitors (referred to as 2i) of MAPK and GSK3 signaling 
(Ying et al., 2008). When compared to a population of naïve ESCs, ground-state ESCs are 
characterized by higher and more homogeneous expression of key pluripotency genes, lower levels of 
differentiation markers and reduced DNA-methylation (Marks et al., 2012; Leitch et al., 2013).  
 
DNA-methylation status has profound effects on embryonic gene expression. It is controlled by 
DNA (cytosine-5)-methyltransferases (Dnmts; Dnmt3a/3b/3l) that are highly active in ESCs and early 
embryos and establish new methylation patterns, and by Dnmt1 (the maintenance methyltransferase) 
that copies the patterns onto daughter cells (Okano et al., 1999; Goll and Bestor, 2005). Active 
demethylation is orchestrated by Ten-eleven translocation (Tet) methylcytosine dioxygenases (Tahiliani 
et al., 2009; Kohli and Zhang, 2013). Tet1 levels are high in ESCs and decrease upon differentiation, 
correlating with exit from pluripotency, and Tet1 steers mesendoderm versus trophectoderm decisions 
in the pre-implantation embryo (Ito et al., 2010; Koh et al., 2011). Tet1 is also important during somatic 
reprogramming for genome demethylation as well as activation and maintenance of Oct4/Nanog 
functions (Takahashi and Yamanaka, 2006; Costa et al., 2013; Gao et al., 2014).  
 
The transcription factor Zeb2 (Sip1, Zfhx1b) downregulates E-cadherin (Cdh1) and thereby 
contributes to EMT (Comijn et al., 2001), which is relevant to stem cell fate but also to tumorigenesis 
(Kim et al., 2014; Pieters and van Roy, 2014). Mutations in ZEB2 cause Mowat-Wilson syndrome 
(OMIM #235730), including defects in the central and peripheral nervous system (CNS, PNS) (Mowat et 
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al., 1998; Cacheux et al., 2001; Wakamatsu et al., 2001). Many in vivo studies confirm the critical roles 
of Zeb2 in embryogenesis and neurodevelopment in particular. Zeb2 KO mouse embryos die shortly 
after E8.5 and have multiple defects including in somitogenesis (Maruhashi et al., 2005), the neural 
plate and its flanking, future neural crest cells (Van de Putte et al., 2003). Cell-type specific Zeb2 KO 
mice develop defects in the CNS (Seuntjens et al., 2009; McKinsey et al., 2013; van den Berghe et al., 
2013) and PNS (Van de Putte et al., 2007; Jeub et al., 2011; Weng et al., 2012). Such studies in the 
embryonic brain cortex revealed cell-autonomous, but also non-autonomous Zeb2 actions. In human (h) 
ESCs, Zeb2 regulates cell fate: upon Zeb2 KD they commit towards mesendoderm, while Zeb2 
overproduction leads to enhanced neurogenesis (Chng et al., 2010). ZEB2 is controlled by Nanog, Oct4 
and Sox2 in hESCs, but key genes downstream of Zeb2 in m/hESCs, and during early neural 
development, remain to be determined, and Zeb2 KO hESCs have not been reported yet. 
 
In order to enter lineage commitment, the pluripotency network in ESCs and EpiSCs needs to 
be distinguished (Festuccia et al., 2013; Trott and Martinez Arias, 2013). The list of factors promoting 
exit from naïve or ground state is growing, yet more key players remain to be identified (Kaji et al., 
2006; Betschinger et al., 2013; Leeb et al., 2014). Exit from pluripotency beyond the primed epiblast 
state requires efficient, irreversible silencing of the transcriptional pluripotency network (including Oct4 
and Nanog silencing, which persist in EpiSCs), acquisition and maintenance of DNA-methyl marks, and 
initiation of differentiation. Using Zeb2 KO cells we identified Zeb2 as a new, critical player in ESCs to 
initiate and execute their three-lineage differentiation program. Upon withdrawal of LIF+2i, Zeb2 KO 
ESCs only sometimes commit to differentiation, instead they usually stall as a pluripotent, epiblast-like 
cell population that maintains the ability to re-adapt to 2i even after prolonged exposure to differentiation 
protocols. The defective silencing of the pluripotency program prevents these Zeb2 KO cells from 
undergoing neural and general (including mesendodermal) differentiation. RNA-seq revealed that Dnmt 
and Tet family mRNA levels are deregulated in Zeb2 KO cells. Zeb2 KO cells correctly acquire methyl 
marks early during neural differentiation, but do not maintain these and revert to a more naïve 
methylome state. Tet1 levels depend on the presence of Zeb2 and in Zeb2 KO cells (displaying 
elevated Tet1) Tet1 KD rescues their ability to exit from their pluripotent state and re-enter lineage 
commitment. 
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 Methodology and Materials 4.2
 
4.2.1 ESC lines 
All experiments on live mice used for deriving the embryos for establishing the ESC lines were 
performed in accordance with relevant institutional (KU Leuven approved project P153/2012), national 
(lab license LA1210584 issued by the Belgian federal government) an international (directive 
2010/63/EU) guidelines and regulations. The KU Leuven Ethical Committee approved the experiments 
and confirmed that all experiments were done conform to the relevant regulatory standards. 
Two independent ESC derivations were performed. First, control lines were derived by 
interbreeding Zeb2flox/flox mice (CD1 background: Higashi et al., 2002). From these ESC lines, Zeb2 KO 
lines were derived by transient transfection of vector-encoded Cre. Five control ESC lines and two KO 
lines were established. Secondly, Zeb2+/- mice were crossed with R26-iPSC mice that contain an RMCE 
cassette in the ROSA26 locus (Haenebalcke et al., 2013a). The second ROSA26 allele contained the 
LacZ reporter  (Soriano, 1999). New control and RMCE-compatible Zeb2 KO ESC lines (3 clones; 
mixed 129/Bl6 background) were derived using a protocol (Pieters et al., 2012) in which pluripotin was 
replaced with 1 µM PD0325901 (Axon, 1408) and 3 µM CHIR99021 (Axon, 1386). To obtain R26_Zeb2 
lines, RMCE technology (Haenebalcke et al., 2013b) was used to insert N-terminally flag-tagged, wild-
type Zeb2 cDNA into the Rosa26 locus of the Zeb2 KO ESCs. 
 
4.2.2 ESC maintenance 
ESCs were maintained feeder-cell free in 2i+LIF. N2B27 was prepared as described (Gaspard et al., 
2009). For 2i+LIF medium, 0.4  µM PD0325901 (Axon, 1408) was added together with 1  µM CHIR99021 
(Axon, 1386; 1  µM) (Ying et al., 2008). LIF (Millipore, ESG1107) was added to a final concentration of 
1,000 U/ml.   
 
4.2.3 Neural differentiation 
On d0, 3x106 ESCs were plated in a 10-cm bacterial petri dish in EB medium (KO DMEM (Invitrogen, 
10829018), 15% FBS (Life Technologies, 10270106), 0.1 mM non-essential amino acids, 1 mM sodium 
pyruvate, 0.1mM 2-mercaptoethanol, 50 U/ml of penicilline/streptomycine). On d2 the EB medium was 
refreshed. On d4 the medium was changed to N2B27 medium and retinoic acid (Sigma, R2625) was 
added to a final concentration of 500 nM. On d6 the medium was refreshed. Between d8 and d15 the 
EBs were cultured in N2B27, and this medium was refreshed every other day 
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4.2.4 General differentiation 
On d0, 3x106 ESCs were plated in a 10-cm bacterial petri dish in EB medium (KO DMEM (Invitrogen, 
10829018), 10% FBS (Life Technologies, 10270106), 0.1 mM non-essential amino acids, 1 mM sodium 
pyruvate, 0.1mM 2-mercaptoethanol, 50 U/ml of penicilline/streptomycine). EB medium was changed 
every other day till d15. 
 
4.2.5  EB dissociation and sorting of living cells 
EBs on d15 were dissociated using Liberase (Roche, 05401020001). Living cells were stained with 
propidium iodide  (Sigma-Aldrich, P4864) shortly before sorting. 
 
4.2.6 Teratoma formation assay 
For teratoma formation assay Rag2c -/-;Gamma(c) -/- mice  were injected  1x106 ESCs in 50µl PBS. 
Four mice were injected with Zeb2 KO ESCs (clone 13 and clone 18) and 4 mice were injected with 
Zeb2 Ctrl ESCs (clone 2 and clone1). All injected ESC clones gave rise to teratomas. The animals were 
sacrificed 5-6 weeks after injection.  
 
4.2.7 Morula aggregations 
Morula aggregations were performed by Zhiyong Zhang from InfraMouse (KU Leuven).  
Briefly, E2.5 morulae were isolated from pregnant superovulated CD1 females and the zona pellucida 
was removed. ESCs colonies were dissociated into small, 5-15-cell clumps using Accutase and 
resuspended in 2i medium prior to aggregation. Next, morulae and ESCs were transferred into a single 
drop of KSOM medium and aggregated overnight in a cell culture incubator (37°C, 5% CO2). The 
following day blastocysts and compacted morulae were transferred into pseudopregnant female mice 
(10-20 blastocysts/mouse).The chimeric embryos were analyzed on E9.5. 
 
4.2.8 RNA-sequencing and data analysis 
Total RNA isolation was performed using a Qiagen RNeasy mini kit (Qiagen, 74104) according to the 
manufacturer’s instructions. cDNA libraries were generated with Truseq RNA kit and sequenced 
according to the Illumina TruSeq v3 protocol on the HiSeq2000 with a single read 36 bp and 7bp index. 
Sequenced read fragments were mapped to the mouse genome assembly GRCm38 (Ensembl) using 
Tophat2 (v2.0.13). A count table for annotated genes was generated using featureCounts (v1.4.6). 
Genes were further classified in different biotypes based on Vega gene and transcript annotation 
(http://vega.sanger.ac.uk/info/about/gene_and_transcript_types.html). 
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RNAseq expression data: To compare counts between samples we converted them to Transcript Per 
Million (TPM) values. To retain only informative genes we filtered based on biotype, expression and 
standard variability using aforementioned TPM values. First we removed all genes that belong to short  
non-coding categories,  in the next step we selected only these genes that have at least 5 
transcripts/million in minimum 3 samples and finally we removed the 20% lowest variable genes. The 
raw counts were imported in the R Package DESeq2 (Love et al., 2014) to test for differential 
expression between pairwise time-points of KO and Ctrl samples.  
RNAseq clustering: All samples were clustered using Principal Component Analysis (PCA) or 
unsupervised hierarchical clustering based on 1 – Spearman correlation distance scores with average 
linkage. 
RNAseq gene ontology: To identify biological processes that are negatively enriched in Zeb2 KO, we 
sorted genes according to their pi-value (-log10(q-value) * logFC) based on DESeq2 timeseries 
analysis. The obtained ranked list was used as input for the GseaPreranked tool with only parameters –
nperm 3000, -set_max 500 -set_min 10 deviating from the default parameters.  
RNA-seq motif sequence analysis: To perform simple motif sequence analysis between KO and Ctrl at 
d6 we defined promoter regions as ± 2Kb from the transcription start site (TSS) and counted the 
occurrences for the putative binding site of Zeb2 (double YACCTG sequences with maximum gap of 40 
bases) for all (up and down) DEGs (p<0.01 and absolute log2 FC > 1); and, as background, the 
promoter regions of all genes. One-sided Fisher’s exact test was used to determine significant over or 
underrepresentation of this motif in promoter regions of DEGs relative to the genome wide promoter 
regions. 
 
4.2.9 RRBS analysis 
Total genomic DNA was isolated by proteinase K digestion and precipitation with isopropanol. RRBS 
was performed by NXT-Dx (http://www.nxt-dx.com/) using the premium RRBS kit (Diagenode) 
according to the manufacturer’s instructions. 
RRBS processing: Quality of sequencing reads was first assessed by FastQC (v0.11.3_devel) and Trim 
Galore (v0.3.7) in –rrbs mode. These reads were then mapped to mouse genome GRCm38 (Ensembl) 
using bismark (v0.14.1) with parameters –bowtie2 –maxins 1000, allowing a maximum insert size of 
1000 bp for paired-end sequences. To extract methylation information in a CpG context from both 
strands we used bismark_methylation_extractor with parameters –paired-end –no_overlap –
comprehensive. We used the R package methylKit  (Akalin et al., 2012) and custom R scripts to further 
analyze the data. In brief, we considered only CpGs with a minimum sequencing depth of 5x and 
removed the top 0.1% with highest coverage. To visualize global percentage methylation histograms 
were created with 5%-methylation bins. For all further analyses we only retained CpGs that were 
present in all samples.  
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RRBS genomic regions: Genomic coordinates for genes were retrieved from the GRCm38 (Ensembl) 
annotation and only coordinates for protein-coding genes were used. We downloaded mm9 enhancer 
coordinates provided at http://chromosome.sdsc.edu/mouse/download.html ,converted them to mm10 
coordinates using CrossMap (v0.1.8) and extended them in both directions with 1kb. CpG islands (CGI) 
and transposable elements (TE) were retrieved via the UCSC table browser for the GRCm38/mm10 
genome, with respectively the CpG Islands and RepeatMasker track. The genomic coordinates for 
Canyons were retrieved from a published dataset (Jeong et al., 2014a). We used a CpG 
observed/expected ratio of 0.29 to distinguish low- and high-CpG density promoters as described 
(Etchegaray et al., 2015). Regions that do not belong to any of the aforementioned regions (e.g.. 
intergenic space) are described as “other” for simplification. To annotate demethylated enhancers to 
topological associated domains (TADs) we downloaded mouse ESC specific topological domains 
provided at http://chromosome.sdsc.edu/mouse/hi-c/download.html. We selectively used the combined 
HindIII dataset after converting to mm10 coordinates as described before. 
RRBseq data analysis: To identify differentially methylated regions (DMRs) and analyze global 
methylation dynamics and differences we averaged methylation in 400bp tiles containing at least three 
CpGs. Tiles with more than 20% difference in methylation and a q-value < 0.05 were assigned as 
significant DMRs, or simply DMRs. 
 
4.2.10 Analysis of published Tet1 binding peaks in mESCs 
Data for Tet1 ChIP-seq for mouse ESCs was downloaded from GEO (GSM659803 and GSM659799). 
Reads were aligned to GRCm38 using bowtie with parameters –e 70 –k 1 –m 1 –n 2 –concise. Peaks 
were called with MACS software using default parameters. To study enrichment of Tet1 at 
demethylated regions, peaks were assigned to the closest demethylated region. 
 
4.2.11 shRNA-mediated knockdown 
Control and Tet1 lentiviruses were produced by standard methods: 
(https://www.addgene.org/tools/protocols/pLKO/).  
Control shRNA was used by combining MISSION Target shRNA in control vector SHC002 (Sigma).  
The Tet1 shRNA (shTet: 5′-tcatctacttctcacctagtg-3′) was cloned into pLKO1 vector. 
REST knockdown line was generated by simultaneous infection with two RESTshRNA-encoding 
lentiviruses (TRCN0000321488 and TRCN0000071345) from the Sigma Mission Library. 
 
4.2.12 ChIP analysis 
10x106 ESCs (R26_Zeb2) were used per experiment. Cells were cross-linked for 10 min with ice-cold 
1% formaldehyde. Cross-linked ESCs were sonicated using Branson Digital Sonifier (10 pulses, 30 sec 
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ON;60 sec OFF, amplitude 10). 10µg of Flag (Sigma, F3165) and 10µg of control mouse IgG (Santa 
Cruz, sc-2025) were used. Chromatin isolation and ChIP were done as described (Lee et al., 2006). 
Phenol-chloroform purified DNA was used as template for qPCR to amplify proximal promoters of 
Nanog and E-cadherin.  Primer sequences are listed in Table 1, section 4.2.11. 
 
4.2.13 Immunohistochemistry and immunofluorescence 
EBs were fixed overnight with 4% paraformaldehyde in PBS followed by progressive alcohol-assisted 
dehydration and paraffin embedding. 6-µm thick sections were used for IHC and IF.  IHC and IF 
analyses were carried out on the Ventana Ultra Discovery platform (Roche). The following antibodies 
against the indicated proteins were used: Zeb2 (custom antibody; Seuntjens et al., 2009), BIII-Tubulin 
(Abcam, ab78078), Oct4 (Abcam, ab19857), Nanog (Abcam, 80892), E-cadherin (BD Transduction 
Laboratories, 610182), Tet1 (Millipore, 09-872) and Alexa Fluor–tagged secondary antibodies (Jackson 
Immunoresearch) . 
ESCs were fixed for 10 min with ice-cold 4% paraformaldehyde in PBS. Cells were blocked for 
30 min at 24°C with 0.1% Triton X100-1% BSA in PBS. Anti-Oct4 (Abcam, ab19857;1/1000) and anti-
Nanog (Abcam, 80892; 1:1000) were used as primary antibodies and DAPI was used as a nuclear 
counterstain (Life Technologies, D1306). Alexa Fluor–tagged secondary antibodies (Jackson 
Immunoresearch) were used at a dilution of 1:1000. 
 
4.2.14 RT-qPCR primers 
 
RT-qPCR primers: 
Gene Orientation Sequence 
Afp Fwd CTTCCCTCATCCTCCTGCTAC 
Afp Rev ACAAACTGGGTAAAGGTGATGG 
Cdx2 Fwd CAAGGACGTGAGCATGTATCC 
Cdx2 Rev GTAACCACCGTAGTCCGGGTA 
Cer1 Fwd CAACCACGAGGAGGCAGAAG 
Cer1 Rev GATCGCTTTCCACATCCCTT 
Chrd Fwd CTGCGCTCAAGTTTACGCTTC 
Chrd Rev AGGGTGTTCAAACAGGATGTTG 
Cxcr4 Fwd GACTGGCATAGTCGGCAATG 
Cxcr4 Rev AGAAGGGGAGTGTGATGACAAA 
Dnmt3a Fwd GAGGGAACTGAGACCCCAC 
Dnmt3a Rev CTGGAAGGTGAGTCTTGGCA 
Dnmt3b Fwd AGCGGGTATGAGGAGTGCAT 
Dnmt3b Rev GGGAGCATCCTTCGTGTCTG 
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Eomes Fwd CCTGGTGGTGTTTTGTTGTG 
Eomes Rev TTTAATAGCACCGGGCACTC 
Esrrb Fwd TTAACGCCATCCCCAAGCGCC 
Esrrb Rev CAAGGCGCACACCTTCCTTCAGC 
Fillagrin Fwd ATGTCCGCTCTCCTGGAAAG 
Fillagrin Rev TGGATTCTTCAAGACTGCCTGTA 
Foxa2 Fwd TCCGACTGGAGCAGCTACTAC 
Foxa2 Rev GCGCCCACATAGGATGACA 
Gata4 Fwd CACCCCAATCTCGATATGTTTGA 
Gata4 Rev GCACAGGTAGTGTCCCGTC 
Gata6 Fwd TTGCTCCGGTAACAGCAGTG 
Gata6 Rev GTGGTCGCTTGTGTAGAAGGA 
Gfap Fwd CCAGATCCGAGAAACCAGCCTGGA 
Gfap Rev TGAGGTGGCCTTCTGACACGGA 
Gsc Fwd CCCCGGTTCTGTACTGGTG 
Gsc Rev TCTGGGTACTTCGTCTCCTGG 
Hnf4 Fwd CACGCGGAGGTCAAGCTAC 
Hnf4 Rev CCCAGAGATGGGAGAGGTGAT 
Krt1 Fwd TGGGAGATTTTCAGGAGGAGG 
Krt1 Rev GCCACACTCTTGGAGATGCTC 
Krt10 Fwd CGAAGAGCTGGCCTACCTAAA 
Krt10 Rev GGGCAGCGTTCATTTCCAC 
Krt14 Fwd GAGGAGACCAAAGGCCGTTAC 
Krt14 Rev GAGGAGAATTGAGAGGATGAGGA 
Krt18 Fwd GTCAGAGACTGGGGCCACTA 
Krt18 Rev CTCTAAAGTCATCGGCGGCAA 
Lefty1 Fwd CCAACCGCACTGCCCTTAT 
Lefty1 Rev CGCGAAACGAACCAACTTGT 
Lefty2 Fwd CAGCCAGAATTTTCGAGAGGT 
Lefty2 Rev CAGTGCGATTGGAGCCATC 
Map2 Fwd GCCAGCCTCAGAACAAACAG 
Map2 Rev AAGGTCTTGGGAGGGAAGAAC 
Mixl1 Fwd ACGCAGTGCTTTCCAAACC 
Mixl1 Rev CCCGCAAGTGGATGTCTGG 
Nanog Fwd TCTTCCTGGTCCCCACAGTTT 
Nanog Rev GCAAGAATAGTTCTCGGGATGAA 
Nodal Fwd TTCAAGCCTGTTGGGCTCTAC 
Nodal Rev TCCGGTCACGTCCACATCTT 
Oct-04 Fwd AGAGGATCACCTTGGGGTACA 
Oct-04 Rev CGAAGCGACAGATGGTGGTC 
Pax7 Fwd TCTCCAAGATTCTGTGCCGAT 
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Pax7 Rev CGGGGTTCTCTCTCTTATACTCC 
Pdgfra Fwd TCCATGCTAGACTCAGAAGTCA 
Pdgfra Rev TCCCGGTGGACACAATTTTTC 
Pdgfrb Fwd TTCCAGGAGTGATACCAGCTT 
Pdgfrb Rev AGGGGGCGTGATGACTAGG 
Prdm14 Fwd CTCTTGATGCTTTTCGGATGACT 
Prdm14 Rev GTGACAATTTGTACCAGGGCA 
Sox17 Fwd GATGCGGGATACGCCAGTG 
Sox17 Rev CCACCACCTCGCCTTTCAC 
T Fwd CTCGGATTCACATCGTGAGAG 
T Rev AAGGCTTTAGCAAATGGGTTGTA 
Tet1 Fwd ACACAGTGGTGCTAATGCAG 
Tet1 Rev AGCATGAACGGGAGAATCGG 
Tet2 Fwd AGAGAAGACAATCGAGAAGTCGG 
Tet2 Rev CCTTCCGTACTCCCAAACTCAT 
Tet3 Fwd TCTCTGAAGGGTGGATTGTCC 
Tet3 Rev CCCAGCACCGAGTAGCTTTC 
VegfR2 Fwd TTTGGCAAATACAACCCTTCAGA 
VegfR2 Rev GCAGAAGATACTGTCACCACC 
Zeb1 Fwd ACCGCCGTCATTTATCCTGAG 
Zeb1 Rev CATCTGGTGTTCCGTTTTCATCA 
Zeb2 Fwd ACCTTACGAATGCCCAAACTGCA 
Zeb2 Rev ACAGAATTAGGGGAAGAACCCGTCT 
Zfp42 Fwd CCCTCGACAGACTGACCCTAA 
Zfp42 Rev TCGGGGCTAATCTCACTTTCAT 
Zfp521 Fwd GAGCGAAGAGGAGTTTTTGG 
Zfp521 Rev AGTTCCAAGGTGGAGGTCAC 
RT-qPCR ChIP  primers: 
Gene Orientation Sequence 
Cdh1 Ctrl region Fwd TGAGGTCCTAGGTTCCATCTC 
Cdh1 Ctrl region Rev GAAGGCAGGAACTGAACACA 
Cdh R1 Fwd GCTAGGCTAGGATTCGAACGAC 
Cdh R1 Rev TGCAGGGCCCTCAACTT 
Nanog R1 Fwd CAGCCGTGGTTAAAAGATGAATAAAGTG 
Nanog R1 Rev CAGCCGTGGTTAAAAGATGAATAAAGTG 
Nanog Ctrl region Fwd GGTGATACGTTGGCCTTCTAGTCTGAA 
Nanog Ctrl region Rev GGGCAAATTGCAAACTAACTGTATAACCTC 
 
Table 3. RT-qPCR primers. 
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 Results 4.3
 
 
4.3.1 Knockout of Zeb2 impairs ESC differentiation 
 
We generated Zeb2 KO mESCs (deleting critical exon7, Higashi et al., 2002; Van de Putte et al., 2003) 
along with control ESCs (Ctrl; with exon7 floxed in both Zeb2 alleles). In 2i medium, Ctrl and Zeb2 KO 
ESC populations maintain high Nanog and Oct4 (Fig. 19A), proliferate at comparable rates (Fig. 19B) 
and have a high and similar clonogenic capacity (±70%, data not shown), showing that Zeb2 is 
dispensable for pluripotency and self-renewal in ground-state conditions. Because of its known role in 
neural development (Mowat et al., 1998; Miquelajauregui et al., 2007; Seuntjens et al., 2009; Chng et 
al., 2010; van den Berghe et al., 2013) we investigated the neural differentiation (ND) potential of Zeb2 
KO ESCs, subjecting the ESCs as embryoid bodies (EBs) to ND using retinoic acid (modified from Bain 
et al., 1996) (Fig. 18A). In Ctrl EBs the very low Zeb2 mRNA level increased between day (d) 0 and d4 
after 2i withdrawal as well as during the acquisition of neural fate (between d4 and d6) and remained 
high till the end of our 15-day long ND protocol (Fig. 18B). The first Zeb2-positive (Zeb2+) cells are 
detected by immunohistochemistry (IHC) on d6, being intense from d8 (not shown) till the end of the 
experiment (Fig. 18C). Absence of neural progenitor (Nestin), neuronal (BIII-Tubulin, Map2) and 
astroglial (GFAP) markers by immunofluorescence (IF) (Fig. 18D-F) showed that ND was abolished in 
Zeb2 KO EBs. Thus Zeb2 is crucial for mESCs to acquire neural fate, in line with previous observations 
that Zeb2 KD in hESCs makes these cells favor mesendodermal over neuroectodermal fate (Chng et 
al., 2010). To validate whether genetic inactivation of Zeb2 in mESCs would also result in increased 
mesendoderm formation, we subjected the Zeb2 KO ESC to a general differentiation (GD) protocol 
allowing commitment to all cell fates for 15 days, and monitored Zeb2 mRNA/protein in the Ctrl cells 
(Fig. 19C-E), and stained for mesodermal, endodermal and neural markers, respectively (Fig. 19F-H). 
This showed that Zeb2 KO mESC have an impaired early differentiation that is not restricted to ND, but 
affects all three germ layers.  
  
 Gene expression changes in Zeb2 KO mESCs after exposure of the cells to differentiating 
cues were also analyzed documenting 40 marker mRNAs for neuroectoderm, mesoderm, endoderm 
and pluripotency, respectively, by RT-qPCR on d0, 4, 6 and 15 in Ctrl and Zeb2 KO cells, in ND and 
GD. Zeb2 “rescue” ESC lines were included in this analysis (d0 and d15; Fig. 20F,G) by introducing 
Zeb2 (N-terminally tagged with Flag3/Strep-tag) in the R26 locus (see Supplemental Experimental 
Procedures) of Zeb2 KO cells (hereafter named R26_Zeb2), which restored differentiation (for IHC/IF 
and RT-qPCR, see Fig. 20 A-E). The expression heatmap (Fig. 18G) with samples clustered based on 
quantile-normalized expression values showed clear separations between d15 Ctrl and R26_Zeb2 cells 
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both in GD and ND, the d6 Ctrl in ND, and the rest of the samples including d15 Zeb2 KO cells, further 
supporting our initial observation that Zeb2 KO ESCs stay largely uncommitted and display overall 
reduced differentiation capacity. 
 
 
 
Figure 18. Knockout of Zeb2 impairs ESC neural differenitation.  
(for general differentiation, see Fig. 19). A. Scheme of the 15-day ND protocol. B. RT-qPCR of Zeb2 in Ctrl ESCs 
during ND. SD of 2 technical replicates is shown. C. IHC for Zeb2 (brown) in Ctrl embryoid bodies (EBs) (Ctrl) on 
d6 and d15 of ND. D-F. Ctrl and Zeb2 KO (KO) ND-EBs stained for Nestin (red, panel D) on d12, BIII-Tubulin 
(green, panel E) on d15 and co-stained for MAP2 (green) and GFAP (red) on d15 (panel F). Scale bars: 50µm. 
Results shown are from one experiment and are representative for 3 experiments. G. Heatmap for samples 
collected in pluripotency and during ND and GD with clustering based on Spearman correlation distances of 
quantile-normalized RT-qPCR values. 
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Figure 19. Genetic inactivation of Zeb2 in mouse ESCs does neither impair ESC proliferation nor 
Oct4/Nanog production in pluripotency-supporting conditions.   
A. Control (Ctrl) and Zeb2 knockout (KO) ESCs, grown in LIF+2i, were co-stained by indirect IF for Nanog (red) 
and Oct4 (green). Results are representative of three experiments performed. Bar: 25 µm. B. Cell proliferation of 
control (blue) and Zeb2 KO (red) ESCs grown in LIF+2i. SDs are of 3 biological replicates. C. Scheme of the 
general differentiation (GD) protocol. D. Zeb2 mRNA levels increased in Ctrl ESCs, albeit to lower relative levels 
as in ND (Fig. 1B). E. Ctrl EBs were stained for Zeb2 (brown) on d6 and d15 of GD. Scale bars: 50µm. F-H. IHC 
and IF analysis to document differentiation towards mesoderm (Desmin, panel F), endoderm (Hnf4α; panel G) and 
neural cells (BIII-Tubulin; panel H). Scale bars: 50µm. Results shown are from one experiment and are 
representative for 3 experiments. In contrast to Ctrl cells, very few Desmin+ cells were detected in Zeb2 KO EBs 
after d15 in GD, while Hnf4α levels appear reduced in Zeb2 KO EBs. The neural commitment defects first 
observed in ND were re-confirmed in GD as BIII-Tubulin+ cells were absent in Zeb2 KO EBs. 
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Figure 20. The differentiation defect is rescued in R26_Zeb2 ESC lines.  
A-E. IHC and IF of R26_ZEB2 line after 15 days of general (GD) or neural (ND) differentiation A. Zeb2 (brown) in 
GD. B.IBIII-Tubulin (green), ND. C. Oct4 (green) and Cdh1 (red), ND. D. Hnf4a (brown), GD. E. Tet1 (brown). 
Scale bar: 50µm. F. RT-qPCR analysis of marker genes representative for three-lineage differentiation, 
pluripotency and DNA-methylation in Ctrl, Zeb2 KO and R26_Zeb2 lines on d0 (violet) and 15 (green) of ND. 
Results are representative of three experiments performed. SD of two technical replicates is shown. G. RT-qPCR 
of marker genes representative for three-lineage differentiation, pluripotency and DNA-methylation in Ctrl, Zeb2 
KO and R26_Zeb2 lines on d0 (violet) and 15 (green) of GD. Results are representative of three experiments 
performed. SD of two technical replicates is shown. 
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4.3.2 Zeb2 acts preferentially as a transcriptional repressor associated with 
developmental progression 
 
Temporal RNA-seq of both Ctrl and Zeb2 KO ESCs showed in more detail Zeb2-dependent effects on 
early cell-state/fate decisions on the one hand and identify potential mediators of the impaired 
differentiation phenotype downstream of Zeb2 on the other hand. We chose ND where we can 
distinguish at least three stages that correspond in Ctrl cells to (i) ground-state ESCs (d0, very low Zeb2 
mRNA/protein), (ii) multipotent progenitors (d4, low Zeb2) and (iii) early neural progenitors (d6, high 
Zeb2). For each stage we performed RNA-seq for three independent experiments. Principal component 
analysis (PCA) illustrated that both Ctrl and Zeb2 KO on d0 are situated close together, but on d4 they 
already follow different lineage trajectories (Fig. 21A). This coincides with the first induction of Zeb2 
(between d0-d4 in Ctrl, see Fig. 18B) indicating that Zeb2 influences cell-fate decisions very early on 
when cells normally exit from their ground-state and undergo lineage priming. 
 
We next applied a time-series analysis on our RNA-seq data set to identify genes that have a 
different dynamic expression profile in KO vs. Ctrl cells. Gene ontology (GO) analysis (using GSEA-P; 
Subramanian et al., 2005) of genes displaying this different dynamic behavior showed strong negative 
enrichment for various differentiation/developmental categories within the top-10 hits (Fig. 21B) and 
further confirmed that at least the vast majority of Zeb2 KO cells in EBs indeed remain uncommitted 
during differentiation. We also (re-)confirmed that Zeb2 KO cells do not acquire neural fate using 
markers  as Pax6, Zfp521 and Neurog1 (Fig. 22A), and the early-neuroectoderm markers Gbx2 and 
Hoxa1 previously shown to be correctly induced upon differentiation in Zeb2 KD hESCs (Chng et al., 
2010). Gbx2 and Hoxa1 were not induced in Zeb2 KO mESCs, indicating that genetic inactivation of 
Zeb2 results in a more severe neural acquisition phenotype than the KD (Fig. 22A). We examined the 
expression profiles of other cell lineage markers in our RNA-seq data to exclude that Zeb2 KO cells 
would preferentially induce non-neural fates (Fig. 22B-D). Although a small increase in those markers 
was observed in Ctrl EBs, they were either almost absent (for mesoderm, Fig. 22C) or markedly lower 
(for trophectoderm and endoderm; Fig. 22B,D) in Zeb2-deficient EBs.  
 
While this RNA-seq data analysis significantly expands our previous characterization of the 
cells and confirms that Zeb2 inactivation globally affects ESC differentiation potential, it provided the 
possibility to discover potential Zeb2-dependent candidate genes responsible for the impaired 
differentiation of Zeb2 KO ESCs. Therefore we performed pairwise RNA-seq analysis at all three time-
points and identified differentially expressed genes (DEGs) (p-value < 0.01 and log2 Fold Change (FC) 
> 1) Consistent with the divergent PCA trajectories we observed an increase in both number of DEGs 
and their FC over time (Fig. 21C). Remarkably, on d0 when Zeb2 mRNA is almost undetectable and no 
clear cellular phenotype is observed, there are already 742 assignable DEGs, although more than 95% 
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of these DEGs display only small changes (<2 log2 FC). GO-analysis showed that almost all of these 
genes relate to metabolism or cell cycle regulation (not shown).  
 
Upon neural induction the majority of genes that were either up or down on d4 (multipotent 
progenitor stage) maintained this status on d6 (early neural progenitor), 69% and 72%, respectively. 
Numbers of DEGs increased between d4 and d6. To further filter for direct transcriptional regulation by 
Zeb2 we performed a binding motif analysis within promoter regions (2kb up and downstream of the 
transcription start site, TSS) of DEGs. We searched for two motifs, the E-box sequence 5’-CACCTG-3’ 
and the sequence 5’-CACCT-3’, interspaced by maximum 45bp (Remacle et al., 1999) The genes 
upregulated during differentiation in Zeb2 KO cells showed an increase in enrichment for the selected 
Zeb2-binding motif (Fig. 21D, red bars and line), while the opposite trend was observed for the 
downregulated genes (Fig. 21D, green bars and line). Altogether this suggests that during differentiation 
Zeb2 functions preferentially as a transcriptional repressor. 
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Figure 21. Analysis of temporal RNA-seq.  
A. Principal component analysis based on transcripts per million (TPM). B. GSEA-P for DEG in time-series 
analysis. The height of the bar plot represents significance and the corresponding negative enrichment score is 
indicated (blue). C. Bar plot displays numbers of DEGs using pairwise DESeq2 test (|log2FC| > 1 and p < 0.01). 
Colors represent binned absolute log2FC levels. D. Promoter analysis for putative bipartite Zeb2-binding motifs 
(CACCT/CACCTG sequences with maximum gap of 45bp; see main text) of DEGs between Zeb2 KO vs. Ctrl. 
Red bar = selective analysis for upregulated DEG, demonstrates statistical overrepresentation (Fisher’s exact test 
p-value = 1.044e-08). Green bar = selective analysis for downregulated DEG points to underrepresentation. E-H. 
TPM (transcripts per million) bar plots at the indicated time points for pluripotency-related genes (E), selected EMT 
genes (F) and selected methylation-related genes (G) and epiblast (H). 
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Figure 22. Dynamic expression levels in Ctrl and KO cells 
for selected neural (A) endodermal (B), mesodermal (C) trophectodermal (D) genes on d0, d4, d6. Average trend 
for selected genes in Ctrl and KO cells is modeled by simple linear regression line. 
 
 
4.3.3 Zeb2 KO ESCs stall in an epiblast-like state 
 
Zeb2 deficiency leads to impaired differentiation of ESCs and Zeb2 displays a preferential repressive 
function as shown above. We therefore investigated whether the pluripotency network was properly 
silenced in Zeb2 KO ESCs, in particular the genes associated with the naïve state known to be rapidly 
downregulated upon withdrawal of LIF+2i (Leeb et al., 2014). Klf4, Tbx3, Zfp42, Prdm14, Essrb, Nr0b1 
and Dppa3 were all properly downregulated in both Zeb2 KO and Ctrl ESCs (Fig. 21E, upper panel). 
However, a significant set of factors that are part of a larger pluripotency network or involved in initiation 
of differentiation were not at all or only partially downregulated, such as Lefty2, Tcea3, Dppa5a, Utf1 
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and Tdgf1 (Chambery et al., 2009; Jia et al., 2012; Kim et al., 2013; Park et al., 2013; Qian et al., 2015) 
(Fig. 21E,lower panel). This group also included Pou5f1 and Nanog, key players in the acquisition of 
pluripotency and early development (Chambers et al., 2003; Nichols et al., 1998). All genes in the latter 
group contain putative binding sites for Zeb2 within 2kb from their transcription start sites (TSS), 
suggesting that Zeb2 is a candidate direct repressor of (at least some) genes involved in pluripotency 
maintenance. In line with the known role of Zeb2 in EMT (Comijn et al., 2001; Lamouille et al., 2014) we 
observed that in Zeb2 KO cells expression of Cdh1 remains high, Epcam is strongly induced and Cdh2, 
Snai-1/2, Twist1 and Zeb1 were not induced to the same extent in differentiation conditions (Fig. 21F). 
Altogether these observations confirm that these cells have defective EMT consistent with previously 
documented roles of Zeb2, including downregulation of Cdh1, in other cell types.  
 
Both Dnmt3b (Fig. 21H) and Dmt3l (Fig. 21G) have putative Zeb2-binding sites and were 
upregulated in Zeb2 KO during differentiation. Together with other genes they are important for DNA-
methylation at this stage, hence we also monitored the expression of Dnmt1, Dnmt3a and Tet1, Tet2 
and Tet3 (Okano et al., 1999; Jackson et al., 2004; Tahiliani et al., 2009; Ito et al., 2010; Koh et al., 
2011). In addition to the high expression of all three Dnmt3 genes, the Tet1/2 to Tet3 expression switch 
is only partial. It normally occurs during transition from pluripotent stem cells to differentiated cells (Koh 
et al., 2011), but in our case Tet3 induction is limited and Tet1 expression is higher (Fig. 21G). 
 
Although EBs are inherently heterogeneous, all our previous data indicates that at least part of 
the cells in EBs are stalled in an epiblast-like cell state in vitro, but which cannot be propagated as long-
term epiblast-like cells (see e.g.. Hayashi et al., 2012 and references therein). This is further supported 
by a strong increase of expression of the established post-implantation epiblast genes Otx2, Pou3f1 
(Oct6), Dnmt3b, Zic2 and Fgf5 (Buecker et al., 2014; Iwafuchi-Doi et al., 2012) (Fig. 21H). Interestingly, 
we noticed that in addition to Fgf5 the epiblast-linked genes Fgf8 and Fgf4 (Joo et al., 2014) also show 
increased mRNA levels with putative Zeb2-binding sites in the promoter, but whether the maintenance 
of these deviating FGF signals help to maintain the epiblast-like cell state of the Zeb2-deficient ESCs 
remains to be investigated. 
 
 
4.3.4 Pluripotency genes are not repressed during differentiation of Zeb2KO ESCs 
 
Both Pou5f1 (Oct4) and Nanog, two crucial pluripotency-supporting factors maintained in epiblast cells, 
remained high as seen by western blotting and RT-qPCR (Fig. 24A,B) and were present in a large 
fraction of cells in Zeb2 KO ND-EBs till d15 (Fig. 23A,B). Again this observation could be extended to 
GD-EBs (Fig. 24C,D, shown on d15). In addition high numbers of Cdh1+ cells were observed in Zeb2 
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KO EBs (Fig. 23B) and this was also seen at protein and mRNA levels on d15 (Fig. 24A,B). R26_Zeb2 
rescue restored downregulation of Oct4 (and Cdh1) mRNA/protein (Fig. 20C). To confirm that this is the 
direct result of Zeb2-binding a ChIP-qPCR was carried out over the Zeb2-binding motif (Fig. 23C,D). 
This showed enrichment of Flag-tagged Zeb2 (using R26_Zeb2 ESCs) in the promoter of Cdh1 (Comijn 
et al., 2001; Van de Putte et al., 2003) and its new candidate target Nanog in ESCs. 
  
 To document the persistence of the pluripotent state upon differentiation in Zeb2 KO cells, 
we dissociated Ctrl and Zeb2 KO EBs on d15 (either in ND or GD), sorted the living cells and plated 
these at 500 cells/well as single cells in 2i. Alkaline phosphatase (AP)+ ESC colonies derived from EBs 
subjected to differentiation (Fig. 23E,F) were quantified on d9 (Fig. 23G). In a typical experiment, Ctrl 
cells subjected to ND did not give rise to AP+ cells, whereas Zeb2 KO cells in 2i yielded on average 8 
colonies/well. In GD, Ctrl cells gave rise to less than 1 (calculated 0.2) AP+ colony/well, whereas for 
Zeb2 KO cells this was 4 colonies/well on average. Based on AP read-out, this shows they have the 
remarkable ability to re-adapt to 2i, like ESCs and EpiSCs and form AP+ colonies even up to d15 of 
differentiation treatment. Without assessment at single-cell level, we cannot discriminate whether these 
AP+ colonies arose exclusively from epiblast-like or more naïve Zeb2 KO cells since both cell types can 
adapt to 2i. Teratoma formation, using EBs subjected to ND for 12 days showed that Ctrl EBs failed to 
form teratomas, while Zeb2 KO EBs gave rise to teratomas in 4 weeks (Fig. 24E).  
  
 These data show therefore that Zeb2 deletion leads to maintenance of pluripotency even 
after prolonged in vitro differentiation. 
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Figure 23. Pluripotency genes are not repressed during differentiation in the Zeb2 KO ESCs. 
Pluripotency genes are not efficiently downregulated during differentiation in Zeb2 KO ESCs. A. Control (Ctrl) and 
Zeb2 KO (KO) EBs stained for Nanog (brown) on d4, d6 and d15 of ND. B. Ctrl and KO EBs co-stained for Oct4 
(green) and Cdh1 (red) on d4, 6 and 15 of ND. Panels A-B show results from one experiment that is 
representative for 3 experiments. Scale bar: 50µm. C-D. Zeb2 ChIP (using anti-Flag antibody) on Cdh1 (panel C) 
and Nanog promoter (panel D). Results shown are from one experiment and representative for 3 experiments. E-
F. Ctrl and KO ESCs subjected to ND (panel E) and GD (panel F) for 15 days, dissociated and plated at 500 
cells/well in 2i. The resulting ESC colonies (indicated by arrows) were visualized by staining for AP, and panel G 
represents the average number of AP+ colonies obtained after plating the cells. 
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Figure 24. Pluripotency gene expression is not silenced during differentiation in Zeb2 knockout (KO) cells. 
A. Western blot analysis for Cdh1, Oct4 and Nanog in Ctrl and Zeb2 KO (KO) EBs during ND. B. RT-qPCR 
analysis of Ctrl and KO ESCs (D0) and EBs on d15 of ND for Oct4, Nanog and Cdh1. Results are representative 
of three experiments performed. SD of two technical replicates is shown C. Ctrl and Zeb2 KO EBs stained for 
Nanog (brown) on d15 of GD D. Ctrl and KO EBs co-stained for Oct4 (green) and Cdh1 (red) on d15 of GD. 
Panels C-D show results from one experiment that is representative for 3 experiments. Scale bar: 50µm E. 
Teratoma formation assay with EBs subjected to ND for 12 days. 
 
 
4.3.5 The Zeb2 KO embryoid bodies, subjected to neural differentiation, fail to 
maintain the initially acquired DNA-methylation 
 
Zeb2 KO EBs show deregulated expression of the core methylation machinery genes together with 
impaired differentiation. This prompted us to examine the acquisition and maintenance of CpG-
methylation (meCpG) that accompanies irreversible ESC differentiation decision. Retaining the same 
time/sample setups as for RNA-seq and again using ND, single-base profiles were generated of 
methylation by RRBS in both Ctrl and Zeb2 KO on d0, d4 and d6.  
 
The genome of ground-state (d0) ESCs was globally hypomethylated (see also Hackett et al., 
2013). On d4 both cell populations gained methylation in agreement with our observation that they are 
in an epiblast-like (for KO) or multipotent (Ctrl) state. However a significant drop of meCpG was observed 
in the d6 Zeb2 KO cell population, suggesting that part of the CpG methylation is lost again (Fig. 25A). 
The progressive accumulation of meCpG in our Ctrl EBs has a striking resemblance with that observed 
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in vivo (Auclair et al., 2014), i.e. our d0 population profile is similar to blastocyst-stage embryos 
(between E3.5-E4.5), while d4 and d6 Ctrl populations have a similar distribution profile as epiblast 
embryos (E6.5). In contrast KO d6 resembles early-epiblast embryos (E5.5) with a reduction in meCpG 
at both gene bodies and 10kb-flanking regions (Fig. 25B) (Auclair et al., 2014). 
 
We further investigated changes in the (de)methylation process by considering CpGs covered 
in all samples and averaging methylation in 400bp-tiles, with a total of 184564 tiles. This identified 
differentially methylated regions (DMRs) (absolute methylation change >20% and q-value <0.05) in both 
a time and pairwise-dependent manner. Both Ctrl and KO cells significantly gained methylation in 
respectively 33.8% and 33.5% of all tiles between d0 and d4 (Fig. 25C, left panels and Fig. 26A). During 
this period no single significant loss-of-methylation was observed (Fig. 26B). Next, between d4 and d6 
Ctrl cells maintained a very stable level of methylation with only little gain or loss-of-methylation, i.e. 
0.1% of all tiles (Fig. 25C, right top panel and Fig. 26A-B). In agreement with the observed overall lower 
methylation at d6 (see Fig. 25A-B), KO cells had 10 times more tiles (1806 or 1% of all tiles) with 
significant loss-of-methylation and only 90 tiles (0.05% of all tiles) with gain-of-methylation (Fig. 25C, 
right bottom panel and Fig. 26A-B,). Furthermore, analysis of these aforementioned DMR in both Ctrl 
and KO cells revealed that these regions initially acquired methylation in both Ctrl and KO cells at d4, 
but this methylation was only maintained in the Ctrl cells (Fig. 26C). 
 
To investigate whether demethylation was selective for specific genomic regions, we profiled 
the methylation dynamics of enhancers, CpG islands (CGI), canyons, transposable elements (TE), high 
CpG-content (HCP) and low CpG-content promoters (LCP), exons and introns. As reported before 
(Jeong et al., 2014b) resistance to gain-of-methylation occurs for canyons and high-CpG regions (CGI 
and HCP), while all other regions (enhancers, TE, LCP, exons and introns) were susceptible to gain-of-
methylation. In contrast, the Zeb2 KO population is unable to maintain this methylation initially acquired 
in all aforementioned genomic regions (Fig. 25F). 
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Figure 25. Analysis or temporal RRBS during neural differentiation. 
A. Distribution histogram for individual meCpGs on d0, d4 and d6 in Ctrl and Zeb2 KO populations. B. meCpG 
distribution at gene bodies and 10kb-flanking regions of protein-coding genes. C. Density plots for pairwise 
comparisons of meCpG (in 400bp-tiles) between d0-d4 in Ctrl (top) and d4-d6 in KO (bottom) cells. D. Density plot 
for pairwise comparison of meCpG (in 400bp-tiles) on d6 between Ctrl and KO. In C,D the density points increase 
from purple to dark red. E. Enrichment plot of Tet1-binding peaks centered around demethylated regions on d6 in 
a pairwise comparison between Zeb2 KO vs. Ctrl. F. Violin plots showing gain and loss-of-methylation over time in 
identified genomic regions, i.e. enhancers, CpG islands (CGI), canyons, transposable elements (TE), high-CpG 
content promoters (HCP), low-CpG content promoter (LCP), exons, introns, other non-defined genomic regions, 
and globally at the whole-genome (genome) in Ctrl and Zeb2 KO cells. 
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Figure 26. RRBS. 
A-B. Bar plot showing gain (GOM, panel A) and loss-of-methylation (LOM; panel B) between consecutive time 
points in Ctrl and Zeb2 KO ESCs. C. Violin plots to illustrate distribution and dynamic behavior of DMRs (both 
GOM and LOM) over time.  
 
 
4.3.6 Failure to maintain acquired DNA-methylation during neural differentiation is 
associated with Tet1-binding 
 
We have shown that regions that lose methylation in d6 Zeb2 KO populations initially indeed acquired 
methylation comparable to Ctrl (see Fig. 26C). Secondly, we also compared d6 of both Ctrl and Zeb2 
KO populations and as expected observed a similar number of tiles with loss-of-methylation (1938, or 
1% of all tiles) (Fig. 25D). We observed also an increased level of Tet1 (see Fig. 21) and therefore 
asked whether the regions that lose methylation correlate with Tet1-binding. Fig. 25E shows that 
regions that lose methylation are enriched for Tet1-binding by combining analysis of a published ChIP-
seq data for Tet1 in mESCs (Wu et al., 2011) with our region-specific loss of methylation data on d6 
(compared between Ctrl and Zeb2 KO). This strongly suggests that the observed demethylation in the 
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Zeb2 KO cells is an active process mediated by elevated Tet1 levels in agreement with previous 
observations that DNA-demethylation is initiated at Tet1-binding sites (Habibi et al., 2013). 
 
 
4.3.7 Tet1 knockdown in Zeb2 KO ESCs facilitates silencing of Nanog, Oct4 and Cdh1 
and partially rescues the lineage differentiation phenotypes 
 
Tet1 remains high in the Zeb2 KO EBs even on d15 of differentiation in contrast to the normal 
downregulation during ND and GD (Fig. 27A,B). To test whether the high Tet1 levels lead to inefficient 
silencing of Nanog, Oct4 and Cdh1 and hence a block in the differentiation potential of these cells, we 
transduced control and Zeb2 KO ESC lines with a lentivirus expressing shRNA directed against Tet1 
(hereafter called Ctrl_Tet1shRNA, Zeb2KO_Tet1shRNA lines, respectively). Tet1 protein was almost 
undetectable in the Ctrl and Zeb2 KO lines targeted with this Tet1 shRNA (see Fig. 27C and Fig. 27D). 
In 2i conditions, the Tet1 KD lines maintained their undifferentiated characteristics (not shown). 
 
We subjected these Tet1shRNA lines to ND and GD, respectively, along with the same lines 
with a control non-targeting shRNA (Ctrl_CtrlshRNA and Zeb2KO_CtrlshRNA) These control shRNA 
lines behaved as expected in differentiation (Fig. 27E-J), and Zeb2 was indeed absent from 
Zeb2KO_CtrlshRNA and Zeb2KO_Tet1shRNA EBs at the end of GD (Fig. 27H) and ND (data not 
shown). After 15 days Zeb2KO_Tet1shRNA cells subjected to either ND or GD efficiently decreased 
Nanog, Oct4 and Cdh1 mRNA to low levels at the end of GD (Fig. 27E, F; ND, data not shown). In 
Zeb2KO_Tet1shRNA lines subjected to GD, partial rescue of differentiation to mesoderm (Fig. 27I) and 
endoderm (Fig. 27G) was observed, but not to neuroectoderm, (data not shown). Partial rescue of ND 
was observed only when Zeb2KO_Tet1shRNA cells were subjected to ND (Fig. 27J). Thus, Tet1 
remains high in Zeb2 KO cells during differentiation, and forced downregulation of Tet1 in these cells in 
such conditions enables the decrease of Nanog, Oct4 and Cdh1 transcription and partially rescues cell 
differentiation. We conclude that deficiency in Zeb2 during differentiation leads to higher Tet1 levels, 
which are associated with improper reduction of a.o. key pluripotency genes Nanog and Oct4, resulting 
in impaired differentiation.  
	  
 
107 
 
 
Figure 27. Tet1 knockdown in the Zeb2 KO cells facilitates exit from pluripotency and partially rescues 
their differentiation capacity. 
A. RT-qPCR of Tet1 mRNA in Ctrl (blue) and Zeb2 KO (red) lines on d0, d4, d6 and d15 of ND. SD of two 
technical replicates is shown. B. Ctrl and Zeb2 KO EBs stained for Tet1 (brown) on d4, d6 and d15 of GD. C. RT-
qPCR of Tet1 mRNA on d0 (violet) and d15 (green) in Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA, Ctrl_Tet1shRNA and 
Zeb2KO_Tet1shRNA lines. SD of 2 technical replicates is shown. D. Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA 
EBs co-stained for Tet1 (brown) on d15 of GD. Scale bar B,D: 50µm. E-J: Ctrl_CtrlshRNA, Zeb2KO_CtrlshRNA, 
Ctrl_Tet1shRNA and Zeb2KO_Tet1shRNA EBs stained for the indicated markers. E. Nanog (brown) on 15 of GD. 
F. Oct4 (green) and Cdh1 (red) on d15 of GD. G. Hnf4a (brown) on d15 of GD. H. Zeb2 (brown) on d15 of GD. I. 
Desmin (brown) on d15 of GD. J.BIII-Tubulin (red) on d15 of ND. Scale bar: 75µm. E-I: scale bar: 50µm. In all 
panels, results shown are from one experiment and representative for 3 experiments. 
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4.3.8 The neuronal inhibitory gene REST is deregulated in Zeb2 KO ESCs 
 
Repressor element 1 (RE-1) silencing transcription factor (REST) (Chong et al., 1995), also known as 
neuron-restrictive silencer factor (NRSF; Schoenherr and Anderson, 1995) is, as these names suggest, 
a negative regulator of the expression of many genes in non-neural cells during neurogenesis, and the 
Rest KO mouse has bot defects in non-neural as well as neural cells (Chen et al., 1998). REST binds to 
a 21 bp-long sequence, referred to as RE-1 (TCCAGCACCACGGACAGTTCC), in its target loci.  
 
My RNA-seq analysis showed that Rest was moderately, but detectably upregulated in the 
Zeb2 KO EBs during ND (d4 FC=1.70; d6 FC=1.77). I therefore documented Rest mRNA expression 
changes in control and Zeb2 KO cells during 15 days of differentiation. Rest mRNA levels were 
comparable in the two lines during the first 3 days, however from d4 these mRNA levels decreased in 
the control cells, but not in the Zeb2 KO cells where it was maintained at relatively high levels 
throughout. Western blot analysis showed that Rest was abundantly present in these ESCs. The levels 
decreased as the control ESCs differentiated and were undetectable from d8. Zeb2 KO cells thus 
maintained high Rest levels during 15 days of ND. We reasoned that the defect in ND in the Zeb2 KO 
cells would in part be due to the lack of repression activity by Rest. 
 
4.3.8.1 Rest knockdown in the Zeb2 KO ESCs partially rescues neural differentiation 
 
We generated REST knockdown lines by transducing control and Zeb2 KO ESCs, respectively, with a 
lentivirus expressing short hairpin RNA (shRNA) directed against Rest (hereafter called Ctrl_RESTKD, 
Zeb2KO_RESTKD lines, respectively). Rest mRNA levels were found to reduce with this shRNA to 
about 80% of the normal level in the Rest KD lines (Fig. 28A,C). 
 
Next, we differentiated these Rest KD lines along with the same lines that received non-
targeting (negative control) shRNA (Ctrl_CtrlKD and Zeb2KO_CtrlKD) (also used in the Tet1 KD 
experiment; see section 4.3.7). We observed partial rescue of neural differentiation (Fig. 28D) in the 
Zeb2KO_RESTKD line, however pluripotency markers (Oct4 and E-cad) were not significantly 
downregulated in this line (Fig. 28E). This indicated that the expression of these pluripotency-
associated genes is not Rest-dependent. Furthermore, Rest is likely to play a role in the Zeb2 KO ESCs 
that are primed and hence more likely to enter the differentiation program as compared to the ground-
state ESCs where the pluripotency network is stable. 
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Figure 28. Rest knockdown in the Zeb2 KO ESCs partially rescues their neural differentiation capacity. 
A. Western blot analysis of Rest protein levels during ND of control and Zeb2 KO ESCs. B. RT-qPCR analysis of 
Rest mRNA expression during ND in control (in blue) and Zeb2 KO cells (in red). C. Rest was efficiently silenced 
in Ctrl (Ctrl_RESTKD) and Zeb2 KO (Zeb2KO_RESTKD) ESCs D. Ctrl_CtrlKD, Zeb2KO_CtrlKD, Ctrl_RESTKD 
and  Zeb2KO_RESTKD embryoid bodies stained for BIII-Tubulin (green) on 15 of neural differentiation. Results 
are representative of three experiments. E. RT-qPCR of Nanog, Oct4, Cdh2, GFAP expression in Ctrl_CtrlKD, 
Zeb2KO_CtrlKD, Ctrl_RESTKD and  Zeb2KO_RESTKD cells on d0 (in blue) and d15 (in red) of ND. 
 
 
4.3.9 Zeb2 KO ESCs have the capacity to differentiate into three lineages when 
injected into immunodeficient mice 
 
Teratoma formation assays are used to demonstrate multi-lineage differentiation potential of ESCs. We 
subcutaneously injected 106 ESCs into immune-deficient mice (two ESC lines per animal, three animals 
per experiment; obviously one body side injected with one line). Teratomas formed in a period of 5 
weeks. We then examined the gross histology of the control and Zeb2 KO-derived teratomas, 
respectively. Both these lines gave rise to derivatives of mesoderm, endoderm and ectoderm (Fig. 29A). 
This indicated that Zeb2 KO ESCs-when exposed to the specific differentiation queues provided by the 
host animal - regain their neural differentiation capacity, which is lost in vitro. We examined the 
presence of Zeb2 protein in the control and Zeb2 KO-derived teratomas.  
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Control teratomas - as expected - showed high levels of Zeb2 in various tissues, including in 
cells of ectodermal origin. Surprisingly, Zeb2 KO-derived teratomas also contained Zeb2+ cells 
indicating that the host cells mixed with injected ESCs (Fig. 29B). To exclude that the neural tissue 
present in the Zeb2 KO teratomas was derived from the de-differentiated host cells and show that ESCs 
lacking Zeb2 had the capacity to generate neural tissues, we stably transduced Zeb2 KO ESCs with a 
lentivrus encoding GFP (hereafter called Zeb2KO-GFP) and repeated the teratoma formation assays, 
and monitored the GFP+ teratomas. Neural tissue in the Zeb2KO-GFP teratomas was positive for GFP 
indicating that indeed, the Zeb2 KO cells underwent neurogenesis in vivo (Fig. 29C). We further show - 
by IF analysis for BIII-Tubulin (neurons), Olig2 (oligodendrocytes) and GFAP (astrocytes) - that the 
Zeb2 KO derived GFP+ ESCs generate all three neural cell lineages (Fig. 29D).  
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Figure 29. Zeb2 KO ESCS differentiate to endoderm, mesoderm and ectoderm when injected into 
immunodeficient mice. 
A.  H&E analysis of the Ctrl and Zeb2 KO-derived teratomas. Three germ lines are present. B.  Zeb2 staining 
(brown) in Ctrl and Zeb2 KO-derived teratomas C. GFP staining (brown) of the neural tissue in Ctrl-nLacZ and 
Zeb2KO-GFP derived teratomas. D.  IF analysis of BIII-Tubulin (red, left column), GFAP (red, middle column), 
Olig2 (red, right column) and GFP (every column)  of Ctrl-nLacZ and Zeb2KO-GFP-derived teratomas. 
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4.3.10 Zeb2 action in vitro is primarly cell-autonomous 
 
Zeb2 was shown to act both in cell autonomous (van den Berghe et al., 2013) and in cell non-
autonomous fashion (Seuntjens et al., 2009) during forebrain development. Zeb2 KO ESCs show 
defects in in vitro neural and astroglial cell differentiation (see Chapter 3 and Introduction), however, the 
same cells - when injected into immunodeficient mice - are capable of generating neurons, astrocytes 
and oligodendrocytes within the developing teratomas (see Fig. 29), which indicates that the micro-
environment provided by the recipient mouse is sufficient to repress the pluripotency network in the 
Zeb2 KO ESCs and induce and efficiently execute the three-lineage differentiation program. 
 
In order to recreate the wild-type environment that would provide Zeb2 KO ESCs with sufficient 
amounts of growth factors that would lead to ESC-to-neuron cell fate switch in vitro, we performed co-
culture experiment where control ESCs were mixed with Zeb2 KO ESCs in different ratios at the onset 
of ND. To distinguish between the two lines, we provided a stable marking of control ESCs with nuclear 
LacZ (Ctrl-nLacZ; Fig. 30D) and Zeb2 KO ESCs with GFP (Zeb2KO-GFP; Fig. 30E), respectively, using 
lentiviral transfer prior to the co-culture experiment. ESCs were mixed in the following % ratios 
(Ctrl/KO): 100/0, 90/10, 50/50,10/90 and 0/100, respectively. The Ctrl/KO aggregates formed normally 
and were morphologically indistinguishable from the EBs formed by either Ctrl-nLacZ or Zeb2KO-GFP 
ESCs. Zeb2KO-GFP cells were randomly distributed throughout the EBs in the first 2-3 days of 
differentiation. However, on d4 Zeb2 KO cells in the EBs begun to cluster together (See Fig. 30A). 
Control cells migrated to the outside of the aggregates forming their outermost layer, whereas Zeb2 KO 
cells formed tight clusters of GFP+ cells located more centrally within the EBs (Fig. 30 A,B,C,F,G). Initial 
observations suggested that Zeb2 regulated neurogenesis in a cell-autonomous fashion (Fig. 30H,I) 
since no GFP+ neurons (derived from Zeb2KO-GFP ESCs) were present in the aggregates even when 
they were composed of 90% of the control cells and 10% of the Zeb2 KO ESCs (Fig. 30H,I). However, 
after confocal microscopy examination of the aggregates, we discovered that a small percentage of 
Zeb2KO-GFP ESCs differentiated into BIII-Tubulin+ neurons as indicated by a double GFP/BIII-Tubulin 
IF staining (Fig. 30B,C). Interestingly, the majority of Zeb2KO-GFP cells that formed small clusters 
within the Ctrl/KO aggregates stayed undifferentiated as shown by Oct4 IF staining (Fig. 30H,I) even 
after 40 days of the in vitro co-culture (data not shown). We conclude that in vitro Zeb2 controls 
transition from ESC to neuron primarily in a cell-autonomous fashion. 
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Figure 30. Zeb2 action in vitro is primarily cell-autonomous. 
A. Ctrl:50/KO:50 embryoid bodies in culture on d1,d8,d15. B. Maximum projection confocal image of Ctrl:10/KO:90 
embryoid body on d15 of ND. GFP (marking Zeb2KO-GFP cells) shown in green. BIII-Tubulin shown in red C. 
Confocal image of the same EB as in B.; section through three planes. D. X-gal staining of Ctrl-nLacZ ESCs in 
culture. E. Zeb2KO-GFP ESCs in culture. F. Z-stack confocal image of Ctrl:50/KO:50 embryoid body on d15 of 
ND. View from the top. G.  Z-stack confocal image of Ctrl:50/KO:50 embryoid body on d15 of ND. View from the 
side. H. IF staining for GFP (green), Oct4 (red),BIII-Tubulin (white) and Dapi (blue) in the Ctrl/KO aggregates on 
d8 of ND. I. IF staining for GFP (green), Oct4 (red), BIII-Tubulin (white) and Dapi (blue) in the Ctrl/KO aggregates 
on d15 of ND. 
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4.3.11 High percentage Zeb2KO-GFP/CD1 chimeric embryos show severe defects in 
early embryonic development 
 
The ability of ESCs to contribute to chimeric embryos and remain also germline transmission competent 
is one of the key tests for ESC pluripotency. This technique can also be used to study cell potency in 
generating various embryonic lineages. We hypothesized that Zeb2 KO ESCs would contribute to the 
neural tissues of the chimeric embryo with lower efficiency than control ESCs, and the developing 
embryo would preferably use the wild-type CD1 ESCs to build e.g.. the central nervous system. To test 
the pluripotency status of the Zeb2 KO ESCs and to verify if these cells could efficiently contribute to 
this, we performed chimera experiments using CD1 host/acceptor morulae and Zeb2KO-GFP ESCs. 
We used Ctrl-nLacZ ESCs as positive control cells.  
 
We observed that within 24h (when the aggregation embryos reach the blastocyst stage) 
Zeb2KO-GFP ESCs were efficiently incorporated in the chimeric embryos. Interestingly, Zeb2-deficient 
ESCs preferably contributed to the ICM (Fig. 31A). However, dissection at E9.0 revealed that only low 
percentage Zeb2KO-GFP/CD1 chimeric embryos could develop properly (only one low-percentage 
chimera was obtained, see Fig.31B). High-percentage chimeric embryos were severely underdeveloped 
(we obtained 8 severely underdeveloped chimeric embryos; See: Fig. 31B). In contrast, aggregation 
with the control ESC line yielded high numbers of well-developed high-percentage chimeric embryos 
(11 high-percentage and one low-percentage normally-developed chimera; See Fig. 31C).  
 
The high-percentage Zeb2KO-GFP/CD1 chimeric embryos show severe developmental 
defects similar to those of Zeb2 KO embryos (Van de Putte et al., 2003). In the chimera experiments the 
defects are even more pronounced as many of the high-percentage chimeras fail to form a proper 
embryo (see Fig. 31B, left picture). On the other hand, in low-percentage chimeras (Fig. 31B, right 
picture), GFP+ cells can be found in various tissues of the developing mouse embryos indicating that 
Zeb2-deficient ESCs have the pluripotent potential. Nevertheless, Zeb2 is required for proper 
development. 
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Figure 31. Zeb2 is essential for normal embryonic development. 
A. Zeb2KO-GFP/CD1 blastocyst. B. Zeb2KO-GFP/CD1 chimeras. Only chimeras with low percentage of Zeb2KO-
GFP cells are able to develop properly. C. Ctrl-nLacZ/CD1 chimeras develop normally (LacZ staining in blue). 
 
 
4.3.12 Studies on R26-based Zeb2 domain mutant lines suggest that interactions of 
Zeb2 with some of its protein partners may have an inhibitory function on in 
vitro neural differentiation 
 
Zeb2 is a multi-domain DNA-binding TF that interacts with a number of protein partners. The latter 
include activated Smads, the NuRD complex, CtBP co-repressor, and p300 and pCAF activators with 
HAT activity (Postigo et al., 2003; Verschueren et al., 1999; Verstappen et al., 2008).  In addition, our 
laboratory has done extensive proteomics, as well as post-translational modification studies in different 
cell systems and treatment conditions (with TGFβ or BMP), hence the list of candidate Zeb2 partners 
has grown significantly (Conidi et al., unpublished results). Zeb2 and Zeb1 show 43% homology at 
protein level, however the homology is very high within the zinc fingers of both zinc finger clusters (88% 
for the NZF and 93% for the CZF cluster). In our hands, Zeb1 does not detectably bind to activated 
Smads like Zeb2 does via its linear Smad-binding domain (SBD), wherein 4 amino acid are crucial for 
Smad interaction (Conidi et al., 2013). Instead, based on work with fragments of Zeb1 it seems to 
require binding of p300 facilitating the formation of a Zeb1/p300/Smad activating complex (Postigo et 
al., 2003).   
 
Interestingly, early work in Xenopus demonstrated that both Zeb1 and Zeb2 interact with 
transcriptional co-activators p300 and pCAF and co-repressor CtBP-1, indicating that both Zeb TFs can 
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repress certain sets of genes, whilst activating other sets (van Grunsven et al., 2006). To understand 
how Zeb2 functions in pluripotency and in (neural) development I started to generate in collaboration 
with the Gent-based members of the Haigh team (Gent, now Melbourne), i.e. Steven Goossens and 
Tim Pieters, a set of specific Zeb2 domain mutants expressed from the R26 locus (under the control of 
endogenous R26 promoter) in the Zeb2 KO background (Haenebalcke et al., 2013a). So far, the 
following mutants served these rescue attempts: mZeb2 wild-type (R26_Zeb2) (Fig. 32A), hZEB2 wild-
type (R26_ZEB2) (Fig. 32C) and mZeb2 with a 153bp in-frame deletion of the Smad-binding domain 
(R26_Zeb2_dSBD) (Fig. 32D). In addition, we have also inserted mZeb1 in the R26 locus of the Zeb2 
KO ESCs (Fig. 32B).  
 
 
 
Figure 32. Schematic representation of mouse and human Zeb2 and mouse Zeb1 and their domain 
mutants. 
NZF, CZF: Zinc finger clusters, CID: CtBP-interacting domain, SBD: Smad-binding domain, NIM: NuRD-interacting 
domain, HD: Homeodomain-like domain, SUMO: Sumoylation sites A. Wild-type mouse Zeb2 B.  Wild-type mouse 
Zeb1 C. Wild-type human ZEB2 D. Mutant mouse Zeb2 with deletion of Smad-binding domain E. Mutant mouse 
Zeb2 with deletion of zinc fingers at N- and C-terminus F. Mutant mouse Zeb2 with deletion ofNuRD-interacting 
domain. 
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We subjected the R26-based rescue/KO combinatorial lines (Fig. 33A-D) to ND (3 clones per 
mutant line). Both R26_Zeb2 and R26_ZEB2 mutants partially restored the neural differentiation deficit 
caused by the Zeb2 KO background (Fig. 33), and R26-based Zeb2 production partially silenced the 
persisting pluripotency program in those cells (Fig. 34). Neural differentiation rescue was more efficient 
in R26_Zeb2_dSBD and R26_Zeb1 in the Zeb2 KO background indicating that Zeb2-Smad interaction 
might have an inhibitory function on Zeb2-driven neurogenesis, possibly by inhibiting inhibitory actions 
from residual activated Smads in neural development (Fig. 33).  
 
We also verified Zeb2, Zeb1 and the neuronal marker Map2 presence on d0 and d15 in all R26 
mutant lines and we compared them to the control and Zeb2 KO lines (Fig. 35 A,B,C). Zeb2 mRNA 
levels in the control pluripotent ESCs is very low and increase significantly (see elsewhere): the ESCs 
acquire neural fate and high expression on d15. Zeb2 KO and R26_Zeb1 ESCs are negative for Zeb2. 
Zeb2 mRNA expression in R26_Zeb2, R26_ZEB2 and R26_Zeb2_dSBD was elevated already on d0 
(approximately 50x higher than control cells on d0) since the R26 locus is active in ESCs. Transgene 
expression (Zeb2 and Zeb1, respectively) from the R26 locus remained unchanged in R26_Zeb2 and 
R26_ZEB2 lines and was elevated in the R26_Zeb2_dSBD and R26_Zeb1 lines. Theoretically, the R26 
locus is ubiquitously expressed in all tissues during development, but it is known to be a modesty active 
promoter in the brain and neuronal cells. Our RT-qPCR data shows that transgene expression from the 
R26 locus was slightly higher in the lines that underwent neurogenesis most efficiently 
(R26_Zeb2_dSBD and R26_Zeb1, See Fig. 35A,B,C), suggesting that the activity of this locus is higher 
in neural cell types as compared to undifferentiated ESCs. 
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Figure 33.Neural differentiation of R26-based Zeb2 mutant lines. 
Ctrl, Zeb2 KO and domain mutants were subjected to neural differentiation for 15 days and stained for BIII-Tubulin 
(green). Amongst R26 mutants, the best neural differentiation rescue was observed for R26_Zeb2_dSBD and 
R26_Zeb1 lines 
 
 
 
Figure 34. Neural differentiation of R26-based Zeb2 mutant lines. 
Ctrl, Zeb2 KO and domain mutants were subjected to neural differentiation for 15 days and stained for Oct4 
(green) and E-cadherin (red). Amongst the R26 mutants, the lowest E-cadherin and Oct4 levels were observed in 
R26_Zeb1 EBs. 
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Figure 35. Neural differentiation of R26-based Zeb2 mutant lines. 
RT-qPCR analysis of: A. Zeb2 B. Zeb1 C. Map2 mRNA expression on d0 (blue) and d15 (red) of neural 
differentiation.  
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 Discussion 4.4
 
In Chapter 4 we addressed the role of Zeb2 in pluripotency maintenance as well as in pluripotency exit 
and ESC differentiation. Below, we separately discuss the main aspects of Zeb2 biology studied in the 
context of mouse ESCs. 
 
 
4.4.1 Zeb2 is critical for exit from the epiblast state in ESCs and links the pluripotency 
network and DNA-methylation with irreversible commitment  to differentiation. 
 
A summary of the Zeb2 KO phenotype and research highlights are shown in Fig. 36. 
 
Using a knockout approach for Zeb2 in ESCs for the first time with a rescue involving re-introduction of 
R26-locus driven Zeb2 cDNA, we show that Zeb2 is critical for these cells to undergo three-lineage 
differentiation. We propose that Zeb2 drives lineage commitment and specification by its action on 
multiple sets of Zeb2-dependent genes. First, Zeb2 is an important inducer of EMT (Comijn et al., 2001; 
Vandewalle et al., 2005). Zeb2 KO ESCs retain epithelial characteristics when subjected to 
differentiating conditions. Their overall phenotype appears even more severe than the recently 
described knockout in ESCs of another known EMT regulator, Snai1, which still differentiate (Lin et al., 
2014). Second, the downregulation of important pluripotency network regulators depends on Zeb2. In 
contrast to Ctrl cells, Zeb2 KO ESCs retain high Tet1, Oct4 and Nanog during differentiation. In ESCs, 
Tet1 is involved in a positive regulatory loop with Nanog and Oct4. Tet1 co-operates with Nanog, while 
a KD of Nanog weakens Tet1-binding to its target genes (including Oct4, Esrrb). Tet1 was also shown 
to act downstream of Oct4, and downregulation of Oct4 leads to decreased Tet1 expression (Ito et al., 
2010; Koh et al., 2011; Costa et al., 2013; Gao et al., 2013). Tet1 was recently shown to act 
downstream of histone deacetylase Sirt6 to control ESC fate in differentiating conditions. Also, like in 
our system, the KD of Tet1 allowed silencing of Oct4 and Nanog and rescued the Sirt6 KO 
differentiation phenotype (Etchegaray et al., 2015). Thus, Tet1 has a global inhibitory role in regulating 
a.o. key pluripotency genes during ESC differentiation and this work identifies Zeb2 as an (indirect) 
upstream factor important for achieving correct Tet1 levels. 
 
We also describe a link between Zeb2 and regulation of DNA-methylation status. Acquisition of 
DNA-methyl marks during embryogenesis is thought to be unidirectional (Auclair et al., 2014), but 
studies in ground-state, naïve ESCs and EpiSC, respectively, show that the methylomes are 
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interconvertible in vitro when different culture conditions are applied (Habibi et al., 2013; Hackett et al., 
2013). Our RRBS showed that correct DNA-methylation patterns are initially acquired by Zeb2 KO cells, 
but that this pattern cannot be sustained: indeed, Zeb2 KO cells revert the methylome to a more naïve 
state, which agrees with the maintenance of their undifferentiated phenotype associated with 
persistence of Nanog and Oct4. Remarkably, this reversion in Zeb2 KO cells is facilitated in absence of 
additional cues or signals, such as LIF or 2i. We hypothesize that Tet1 levels are maintained by the key 
pluripotency genes in Zeb2 KO cells. Steady-state high-Tet1 would then actively demethylate the 
genome and contribute to preserving high Nanog and high Oct4 in the mutant cells. Enrichment of Tet1-
binding at regions that lost methylation in the Zeb2 KO further supports this hypothesis. Tet1 KD in 
these Zeb2 KO cells facilitated downregulation of Nanog and Oct4 as well as of Cdh1, but the 
differentiation phenotype was only partially rescued. It is likely that Zeb2 controls other important cell 
fate regulators at multiple stages of differentiation in addition to selected pluripotency genes and Tet1. 
Similar to the described in vivo functions of Zeb2 in myelinogenesis in the embryonic CNS (Weng et al., 
2012), Zeb2 may also counteract genes that are inhibitory for neural conversion during ESC 
differentiation and also act as an activator of other target genes depending on its co-factors (our 
unpublished data; Conidi et al., 2011; Hegarty et al., 2015), which altogether would then promote 
neurogenesis. As the current anti-Zeb2 antibodies do not allow omics-type studies (not shown), further 
more detailed studies will require an endogenous tagging approach to identify its protein partners and 
binding sites at multiple stages of differentiation. 
 
	  
 
122 
 
 
 
Figure 36. Graphical abstract: Zeb2 KO phenotype summary and highlights. 
 
• Zeb2 knockout (KO) ESCs display impaired differentiation in embryoid bodies by stalling in an epiblast-like state. 
• In differentiating conditions EMT, pluripotency, lineage commitment and DNA-(de)methylation genes are deregulated in 
Zeb2 KO embryoid bodies.  
• Zeb2 KO embryoid bodies cannot maintain their initially acquired DNA-methylation marks in neural-stimulating condition. 
• Zeb2 KO embryoid bodies do not effectively downregulate Oct4, Nanog and Tet1 in differentiation conditions; Tet1 
knockdown partially rescues their impaired differentiation. 
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4.4.2 Zeb2 and Rest 
 
Rest is abundant in ESCs in pluripotency-supporting conditions and it is known for its anti-neurogenesis 
actions. It was also shown to be directly activated by Nanog, and depletion of Nanog results in a 
decrease of Rest levels (Loh et al., 2006). Our temporal RNA-seq revealed that Rest was not properly 
downregulated in the Zeb2 KO EBs. We reasoned that repression of an inhibitory gene for neural 
differentiation could be an additional mode of action by which Zeb2 controls neural lineage commitment 
and differentiation.  
 
Knockdown of Rest in the Zeb2-deficient ESCs indeed restored some of their neurogenic 
capacity. Interestingly, forced downregulation of Rest did not cause a significant loss of pluripotency 
gene expression (unlike for Tet1 KD, which resulted in efficient downregulation of Nanog and Oct4). We 
hypothesize that knockdown of Rest in the Zeb2 KO ESCs was able to rescue neural differentiation only 
in a small population of these cell cultures and in which the pluripotency genes were already 
destabilized and, hence, these cells were able to respond to the permissive conditions caused by 
knockdown of Rest.  
 
Our data shows that Zeb2 regulates neurogenesis via at least two action modes: on the one 
hand it is critical for the correct control of Tet1 levels and on the other hand Zeb2 ensures efficient 
downregulation of Rest. It may be that Nanog (which we believe is a direct target of Zeb2) is the 
common upstream regulatory TF in these two modes and that the primary function of Zeb2 is to repress 
Nanog. It would be interesting to combine the effect of Tet1 and Rest KDs in Zeb2 KO ESCs to see if 
Zeb2 KO cells forced out of their pluripotent state by downregulation of Tet1, would still efficiently 
respond to Rest KD and therefore enter neural differentiation. In addition, generating Nanog KD ESC 
lines in the Zeb2 KO background to investigate the phenotype rescue would also be an interesting 
route. 
 
 
4.4.3 Cell-autonomous action of Zeb2 in vitro 
 
Extrinsic factors are important regulators of cell fate specification (see General Introduction and Chapter 
3 introduction). We asked whether Zeb2 could act in cell non-autonomous way during ESC 
differentiation. For this we performed co-culture differentiation experiments using differentially labeled 
Zeb2 KO and Ctrl ESCs. We observed that Zeb2 action in vitro is primarily cell-autonomous as the Zeb2 
KO cells to a large extend maintained their undifferentiated phenotype even when surrounded by the 
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Ctrl cells. This is in contrast with our data on teratomas: there, Zeb2 KO ESCs subcutaneously injected 
into the recipient mice underwent very efficient differentiation to all three lineages.  
 
It may be that signaling molecules secreted by the Ctrl cells in vitro during differentiation are 
not produced in sufficient quantities and/or are too diluted in the culture medium. It may also be that 
extrinsic factors specifically needed for the cells to silence their pluripotency program, are abundantly 
present in vivo in adult tissues: Zeb2 KO ESCs are then forced to respond to these signals, but these 
are absent (or nearly absent) from the co-culture system. If that is the case, even if the pro-neural 
factors (or in general pro-differentiation factors) are produced by the Ctrl cells, they can only act on 
neural progenitors but not on pluripotent cells, thus the whole, sequential fate decision program 
collapses.  
 
4.4.4  Zeb2 and Smads 
 
We analyzed the function of Zeb2 SBD during neural differentiation of ESCs. We first showed that in 
Zeb2 KO cells in which Zeb2 wild-type cDNA is expressed from the R26 locus the neural differentiation 
capacity is restored. We also demonstrated that insertion of ZEB2 wild-type cDNA results in the 
phenotype rescue, which shows both specificity as well as conservation of the Zeb2 function between 
mouse and human. Next, we demonstrated that Zeb2 mutant cDNA lacking the entire SBD (51 amino 
acids) inserted in the R26 locus restored neural differentiation capacity in the Zeb2 KO cells more 
efficiently than the wild-type Zeb2. This indicates that Zeb2-Smad co-operation, likely via direct 
interaction, during the transition from an ESC to a neural progenitor, has an inhibitory effect on 
neurogenesis.  
 
This is in contrast with our previous data addressing the role of Zeb2-SBD in the ventral 
forebrain. We showed that the Zeb2-SBD is crucial for Zeb2-dependent interneuron migration in the 
embryonic brain. Embryonic brain slices, focally electroporated with a WT Zeb2 expression construct, 
restored partially interneuron migration, whereas this process could not be rescued when the SBD 
deletion construct was used (Conidi et al., 2013). 
 
Recently, Zeb2 was shown to govern myelinogenesis from oligodendrocyte precursor cells in 
te CNS by direct modulation of two Smad signaling pathways (Weng et al., 2012). Activation of Bmp-
Smads has an inhibitory effect on oligodendrocyte specification, while an increase of Smad7 (an 
inhibitory Smad) is required for oligodendrocyte myelinogenesis. Zeb2 interacts with phosphorylated 
Smad1 in the presence of the transcriptional co-activator p300 in the CNS. Zeb2 was also shown to 
bind directly to Id2 and Id4 promoters, which suggests direct transcriptional inhibition. Overproduction of 
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transduced Zeb2 in Bmp-stimulation conditions reverses Bmp-induced suppression of oligodendrocyte 
precursor genes known to drive myelinogenesis. Moreover, Smad7 promotes oligodendrocyte 
maturation and is directly activated by Zeb2 via Zeb2-binding sites in the Smad7 promoter. Another 
interesting observation is that action of Zeb2 and its binding to Smads is stage-dependent. Therefore, 
different Zeb2 co-factors may direct recruitment of Zeb2 to target genes at specific time-points. In 
summary, Weng et al. (2012) showed that Zeb2 is in the center of the protein/transcriptional network of 
oligodendrocyte-dependent myelinogenesis and its actions converge on Bmp-Smad modulation in 
myelinogenesis in the CNS (Weng et al., 2012). 
 
Smad proteins are the intracellular mediators of the meanwhile named canonical Tgfβ/Bmp 
signaling pathway. Smads (Smad1/5) have been shown to act together with the core factors in the 
pluripotency network of ESCs (Chen et al., 2008), but they are dispensable for ESC self-renewal 
(Gomes Fernandes et al., 2016; Morikawa et al., 2016). In human ESCs, ZEB2 is repressed by Smad 
2/3, Oct4 and Nanog (Chng et al., 2010). Upon LIF withdrawal ZEB2 levels increase. It may be that in 
mouse ESCs a similar mechanism exists. Zeb2 first needs to be derepressed by removal of the key 
pluripotency genes and Smads from its promoter. Higher Zeb2 could in turn specifically recognize and 
translocate to sites occupied by Smad proteins (or Zeb2 could be first bound by Smads and next, as a 
complex, it would translocate to the target sites), for example enhancer and promoter regions of the 
core pluripotency factors. If Zeb2-binding sites are present on the Smad-bound genes then it could 
directly regulate target gene transcription or, alternatively, Zeb2 recruited to Smads could subsequently 
recruit the NuRD complex to fine-tune gene expression regulation.   
 
Based on published data and our observation in the ESC system we conclude that Zeb2-Smad 
protein-protein as well as protein-DNA interactions and their significance of directing cell fate decisions 
depend on the cellular context and most probably on the availability of other TFs and transcriptional co-
regulators. It is possible that this interaction can be inhibitory for the initial steps of ESC specification, 
whereas later during development, for processes like interneuron migration it could be necessary. 
 
It would be interesting to develop tools that allow manipulation of Zeb2-Smad binding and 
subsequent readout of these interactions in real-time. This way one would be able to pinpoint exactly 
what steps of what processes depend on intact Zeb2-Smad binding. 
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5 Chapter 5: General Discussion 
 
Cell fate decisions in pluripotency, during development and in disease are orchestrated by a large 
number of diverse factors including extrinsic signaling proteins, transcription factors, non-coding RNAs, 
long-range genomic interactions and various epigenetic modifiers. Together they form an extremely 
complex and dynamic, but highly coordinated network with interconnected regulatory loops and multi-
level modulations. Our laboratory studies how Zeb2 functions in distinct processes in normal 
development and more recently extended these studies to adult tissues and organs, including in injury 
conditions where repair is likely dependent on re-activation of developmental pathways. Remarkably, 
Zeb2 was shown to play a role in a wide variety of cell types and tissues: among others it regulates 
blood cell specification, melanocyte formation, brain development and T-cell and NK cells in the 
immune system, and CNS myelinogenesis and PNS (re)myelination by Schwann cells (see Chapter 1, 
general introduction). Below, we discuss the latest data from our laboratory, with focus on Zeb2-
depedent control of neurogenesis also beyond birth. 
 
The main part of my PhD research aimed at contributing to our emerging understanding 
whether and how Zeb2 functions in pluripotency and during differentiation of stem cells, using ESCs as 
a model system. We have shown that in ESCs Zeb2 is necessary to silence the pluripotency program at 
least in part via Tet1-mediated mechanisms. Upon Tet1 knockdown, Zeb2-deficient cells exit from their 
epiblast-like state, however their differentiation capacity is not fully restored. We hypothesize that Zeb2-
dependent cell fate decisions during ESC differentiation rely on required interaction and/or loss of 
interactions with partner proteins or complexes thereof including e.g.. the NuRD complex (and/or 
individual components of this complex such as Mbd3 or HDAC1), while other new candidate regulators 
such as O-GlcNAc transferase (Conidi et al., unpublished results) or miRs, like the well-studied mir-200 
family that operates in multiple cell types. Below we discuss also selected published data and explain 
how such interactions could contribute to pluripotency maintenance or acquisition of differentiated 
cellular phenotypes that form the core of this PhD research. 
 
 
 Does Zeb2 regulate other processes during brain development and in 5.1
the adult?  
We have shown that in the embryonic brain Zeb2 acts via at least three different mechanisms, 
depending on the location in the developing brain: it fine-tunes Wnt signaling to control hippocampus 
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formation (Miquelajauregui et al., 2007), in brain cortex Zeb2 acts in a cell non-autonomous fashion by 
limiting the expression of Nt3 and Fgf9, which normally ensure proper timing and extend of 
neurogenesis and gliogenesis, respectively (Seuntjens et al., 2009), while in the ventral forebrain Zeb2 
cell-autonomously regulates a.o. Unc5b transcription levels to assure proper cortical interneuron 
guidance and fate (van den Berghe et al., 2013; McKinsey et al., 2013) 
 
In our laboratory we have started to expand studies of Zeb2’s functions in early postnatal and 
in adult neurogenesis (with focus on the generation and function of the SEZ stem cell niche (also 
named the SVZ niche), the rostral migratory stream and olfactory bulb formation and its organization 
and cell diversity. The latest data suggests that Zeb2 is a major player in the establishment in the 
embryo and subsequently the maintenance and function of his neurogenic niche in the adult animal. 
Neuroblasts (also named A-cells) that later will become mature olfactory bulb (OB) interneurons are 
indeed born in the SVZ of the lateral ventricles from B-cells there, via a transit-amplifying cell population 
(the C-cells). The SVZ niche develops mainly from the ventral forebrain, from precursor cells in the 
embryonic LGE. Zeb2 is indeed present both in cells derived from the LGE during development as well 
as in the postnatal SVZ. Genetic inactivation of Zeb2 from LGE cells (using the Gsh2-Cre deleter 
mouse; Van den Berghe et al., 2013) results later in severe decrease in numbers of cells migrating from 
the SVZ to the OB and disorganization of the different OB cellular layers as well as in an overall 
reduced size of the OB at postnatal day 5 (at birth, the OB of these cell-type specific Zeb2 KO mice 
appears to develop normally; Stappers et al., unpublished results). Only a portion of Zeb2 KO cells can 
reach the OB for their subsequent maturation there. Interestingly, the non-targeted cells that reach the 
OB also acquire an abnormal phenotype (characterized a.o. by increased Pax6 expression), suggesting 
that Zeb2 acts in a cell non-autonomous way, likely on top of its cell-autonomous actions, in this 
process. Electroporation of the full-length Zeb2 (cDNA-driven) expression construct in the postnatal 
SVZ (d3) restores the neuronal cell influx to the OB. Conversely, the Zeb2 KO phenotype can be 
induced by electroporation of Cre-expression construct in the Zeb2fl/fl SVZ (Stappers, Seuntjens et al., 
unpublished results). Preliminary RNA-seq data from Ctrl and Zeb2 KO cells (from the lateral wall of the 
SVZ at postnatal day 3) suggests that in absence of Zeb2 SVZ progenitors are misspecified and that 
some of these cells may acquire striatal neuron fate (this fate is established during embryonic 
development) that manifests in the early postnatal life. Taken together, this data shows that Zeb2 
controls production and/or migration of olfactory neuronal cells from the SVZ neurogenic niche. It would 
be interesting to investigate whether Zeb2 is also involved in adult neurogenesis, especially in 
mobilization of neurogenic progenitors upon brain injury. This could also be assessed in the same injury 
studies by transplanting traceable ESCs with Zeb2 mutations, including our Zeb2 KO ESCs in the first 
place. 
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 Does the NuRD complex co-operate with Zeb2 in the establishment of 5.2
the correct chromatin context in embryonic cells, including in Zeb2-
dependent differentiation? 
 
The main focus of my PhD research is on the role of Zeb2 in cellular pluripotency and in early cell fate 
decisions, hence in particular during transition from pluripotent cell to committed progenitor cells of 
(likely) all three lineages. Below, based on recently published studies and our data, I will discuss how 
Zeb2, Dnmts, Tet1 and the NuRD complex (previously identified as an interacting partner of Zeb2: 
Verstappen et al., 2008) could orchestrate/execute cell fate decisions and induce heterogeneity within 
populations of ESCs. 
 
We show that Zeb2 KO ESCs maintain their self-renewal capacity in cell culture, including in 
medium without 2i. Because of the observed phenotype in differentiation, we reasoned that impairment 
in pluripotency exit was the primary cause of defective differentiation in the absence of Zeb2. In order 
for the ESCs to differentiate, their pluripotency program needs to be silenced. Oct4 and Nanog undergo 
transcriptional silencing through DNA-methylation that is maintained upon cell division in somatic cells. 
DNA-methylation is catalyzed by Dnmt proteins. Incomplete methylation caused by ablation of Dnmt3a 
and/or Dnmt3b leads to aberrant silencing of Oct4 and Nanog during cell differentiation and in the 
embryo (Li et al., 2007b) and is still being actively studied in 2i to serum conversion (and vice versa) in 
ESCs in the EC-FP7 project Blueprint, coordinated by H. Stunnenberg (Nijmegen). In our differentiation 
systems the Dnmt3a levels were lower, late during differentiation of the Zeb2 KO ESCs. It would be 
interesting to see if very high levels of Dnmt3a (via its overexpression) in the Zeb2 KO background 
would be sufficient to counteract the high Tet1 levels and silence the pluripotency program in ESCs, 
allowing differentiation to proceed. With other words, this would contribute to the ongoing studies in 
other groups that document how the precise, but also dynamic balance between DNA-methylation and 
DNA-demethylation co-determines these decisions or not.  
 
The NuRD complex plays a crucial role in retaining ESC identity as well as in promoting 
transcriptional heterogeneity and lineage commitment (Kaji et al., 2006; Reynolds et al., 2012). Methyl-
binding CpG proteins (Mbd) 1-4 are components of the NuRD complex (see also General Introduction). 
Mbd1, 2 and Mbd4 recognize and bind to methylated cytosine, whereas Mbd3 does not (Hendrich and 
Bird, 1998; Zhang et al., 1999). Tet1 and Mbd3 binding profiles strongly overlap in pluripotent ESCs. 
Mbd3-bound target genes are enriched for the 5hmC mark and knockdown of Tet1 leads to delocalization 
of Mbd3 binding to its genomic sites, while the total Mbd3 levels do not change. This suggests that 
Mbd3 recognizes and preferentially binds to hydroxylated regions of the genome and that this process 
is Tet1-dependent. Interestingly, Mbd3 knockdown resulted in lower 5hmC levels, showing that Mbd3 
	  
 
129 
also has a global function in establishing and/or maintaining global methylation patterns (Yildirim et al., 
2011). Our Zeb2 KO cells retain high levels of Tet1. If high Tet1 and hence DNA-hydroxylation is 
abnormal in Zeb2 KO ESCs, then Mbd3 recruitment to its genomic sites could also be defective. This 
could also contribute to aberrant gene expression regulation.  
 
Mbd3 is a key component of NuRD (Kaji et al., 2006). It would be of interest to evaluate 
genome-wide NuRD-dependent binding of Zeb2 to its target genes in pluripotency and during 
differentiation and to document the overlap with Tet1-binding and changes in 5hmC levels. Here, an ESC 
line carrying the NuRD-interaction motif (NIM) of Zeb2 would be invaluable. As mentioned before, Zeb2 
is very likely to operate in various modes in pluripotency exit and cell differentiation; its function(s) 
largely would then depend on its protein partners (as shown and discussed above for Zeb2-Smad 
binding). Zeb2 could - via repression of Nanog and other genes connected to the pluripotency network - 
regulate Tet1 levels and hence 5mC/5hmC ratios and the redistribution/dynamics of these marks in the 
genome. 5mC/5hmC redistribution and ratios may dictate which proteins and protein complexes can bind 
to specific loci. Zeb2 could partner with NuRD to directly regulate a number of target genes, it could also 
be guided by the NuRD complex (or Mbd3 alone, which remains to be tested) to the genomic sites 
marked by 5hmC to selectively target gene expression in these loci. Thus we hypothesize that Zeb2-
NuRD interaction may have a profound role specifically in 5hmC-dependent gene expression regulation 
in cultured, including differentiation-induced ESCs, in particular in neural development.  
 
In addition to Mbd3-Tet1 interaction, an alternative mechanism could contribute to the aberrant 
epigenetic status of Zeb2-deficient ESCs: HDACs remove acetyl marks from the histones resulting in a 
more closed chromatin. Hdac1 and Hdac2 are components of the NuRD complex. Knockdown of Hdac2 
during reprogramming promotes iPSCs maturation. Costa et al. showed that knockdown of Hdac2 (but 
not Hdac 1,3 or 8) results in an increase in acetylation of histones. This increase facilitates Tet1-binding 
to Nanog, Oct4, Sall4 and Tcl1 and subsequent DNA hydroxylation (Wei et al., 2015). It was previously 
shown that Tet1 binding depends on Nanog expression (Costa et al., 2013). In line with the study by 
Costa and co-workers showed that the knockdown of Nanog in control or Hdac knockdown ESC lines 
resulted in a downregulation of Tet1 and a decrease in DNA hydroxylation. Knockdown of Tet1 in the 
Hdac knockdown cells blocked iPSC formation. RbAp46 (another component of NuRD) binds to both 
Tet1 and Hdac2. Upon RbAp46 knockdown, iPSC formation was abolished. The authors show that 
Hdac2 is bound to maturation phase-related gene promoters (Nanog, Esrrb, Tcl1, Rex1) in pre-iPSCs, 
whereas the same promoter region was occupied by Tet1 in fully reprogrammed iPSCs. Further, Hdac2 
and Tet1 compete for binding to these regions (Wei et al., 2015). In our Zeb2 KO ESCs Tet1 is 
abundantly present even after LIF withdrawal. We hypothesize that Tet1 occupancy on the DNA is 
reinforced/stabilized by the persistently high Nanog levels. This strong binding does not allow Hdac2 to 
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access these target sites and would keep the chromatin open and hence prone for transcriptional 
activation.  
 
 
 Could high levels of Tet1 increase/stabilize recruitment of Ogt in the 5.3
absence of Zeb2? 
 
O-GlcNAcylation is addition of a single N-acetylglucosamine (GlcNAc) to Serine and Threonine residues 
in target proteins and (also) takes place in the nucleus (Haltiwanger et al., 1992). Two enzymes 
catalyze the addition and removal, respectively, of O-GlcNAc in mammals: O-GlcNAc transferase (Ogt) 
adds the modification and O-GlcNAcase (Oga) removes it (for a review, see Hanover et al., 2010). O-
GlcNAcylation is known to influence protein function and stability. It is involved in nutrient (hence its 
levels are dependent on metabolic status, also because Ogt levels are a.o. controlled by 3 different 
metabolic pathways) and growth factor responses, cell cycle progression and cellular stress. One of the 
most important functions of O-glycosylation is to compete with and possibly prevent protein 
phosphorylation at specific sites (Zeidan and Hart, 2010).  
Ogt is encoded by a single-gene throughout the animal kingdom, is essential for ESC viability 
and was shown to be a part of the pluripotency network in ESCs ( Shafi et al., 2000, van den Berg et al., 
2010; Pardo et al., 2010). Short hairpin-mediated downregulation of Ogt levels results in decreased 
ESC proliferation and self-renewal. Conversely, increase in O-GlcNAcylation during EB formation 
inhibits their differentiation. Both Oct4 and Sox2 interact with Ogt and undergo O-GlcNAcylation that 
decreases rapidly once the ESCs are subjected to differentiation. O-GlcNAcylation regulates Oct4 
transcriptional activity. Key genes of ESC self-renewal network such as Klf2, Klf5, Nr5a2, Tbx3 and Tcl1 
are specifically regulated by O-GlcNAcylated Oct4. In addition, increasing O-GlcNAc levels by Ogt 
overexpression increased reprogramming efficiency (Jang et al., 2012). 
Tet1 directly binds to and is regulated by Ogt and can be O-GlcNAcylated. RNAi-mediated Ogt 
downregulation leads to a reduction in Tet1 and 5hmC levels on Tet1 target genes (e.g.. Lhx2 and 
Pdgrfa) and their de-repression. Conversely, ectopic expression of WT Ogt increases Tet1 levels (Shi et 
al., 2013).  Recently it was shown that Tet1 regulates Ogt recruitment to transcription start sites. Loss of 
Tet1 displaces Ogt binding from its target sites, which leads to an increase of common Tet1-Ogt target 
genes (Vella et al., 2013). Interestingly, Ogt binding to DNA overlaps with Tet1 binding profiles at 
H3K4me3-marked, unmethylated CpG-rich gene promoters (Vella et al., 2013). H3K4me3 was 
previously shown to “protect” CpGs from methylation by inhibiting Dnmts (reviewed in Hashimoto et al., 
2010). This suggests that Tet1-Ogt interaction plays a role in regulating promoter activity and gene 
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transcription regulation (rather than in moderation of DNA hydroxylation), which is consistent with the 
previously postulated dual function of Tet1 in (i) DNA hydroxylation and (ii) transcriptional regulation that 
is independent of Tet1 enzymatic activity (Dawlaty et al., 2011; Williams et al., 2011; Wu et al., 2011; Xu 
et al., 2011). It can be that Tet1 first recognizes and binds to unmethylated CpG regions and 
subsequently recruits various chromatin modifiers to regulate target gene expression. In the Zeb2 KO 
ESCs Tet1 (stabilized by the core pluripotency network factors) would be strongly bound to the 
unmethylated cytosines together with Ogt. Abundance of Tet1 in absence of Zeb2 could alter cellular 
distribution of Ogt and its availability (amongst which a number of isoforms) for other proteins. In 
addition, Ogt could feedback to the pluripotency network and stabilize it. In fact, the situation is even 
more complex, as Zeb2 proteomics has identified Tet1 as a candidate partner protein and Zeb2 binds 
also Ogt and has lectin-affinity (Conidi et al., unpublished results).  
 Ogt could also be involved another type of epigenetic regulation. It was shown that Hdac1 is 
necessary for the full repressor activity of Sin3a (Hassig et al., 1997). Both Hdac1 and Sin3a associate 
with Tet1 in ESCs (Shi et al., 2013). Ogt co-purifies with Tet1 and Tet2, as well as Sin3a and Hdac1 
(Vella et al., 2013). Altogether this data suggests that Ogt is also a part of the Tet1/Tet2/Sin3a/Hdac1 
complex in ESCs.  
 
As mentioned above, our laboratory in a collaboration with E. Soler and F. Grosveld recently 
identified Ogt and Tet proteins as new candidate partners of Zeb2 (Conidi et al., unpublished results). 
Apart from its role in the pluripotency network, Ogt could also be important for assembly and/or 
guidance of various proteins or complexes that regulate the epigenetic status of the cells and hence 
their differentiation. It could be that Zeb2 - depending on the context - associates for example with 
NuRD, or acts together with Hdac1/Sin3a and Ogt (in smaller complexes then) to e.g.. silence gene 
expression. These interactions could depend both on the availability of the substrates as well as on the 
general chromatin structure that could potentially be altered by high levels of Tet1 in the Zeb2 KO cells. 
It would be interesting to perform locus-specific proteomic screens (using targeted chromatin 
purification technique, like  described by Pourfarzad et al., 2013; or a CRISPR-based approach: Waldrip 
et al., 2014) in ESCs as well as in differentiated cells to uncover when/how protein complexes are 
assembled and what the consequences are of their disruption in the context of Zeb2-dependent 
regulation of cell state and/or cell fate decisions. 
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 Are Tet1 and miR-22 the new modulators of previously identified Zeb2-5.4
miR-200 feedback loop in ESCs?  
 
Zeb2 is a major regulator of EMT (see General Introduction). EMT is one of the key events during ESC 
differentiation and in cancer progression (for a review, see Kim et al., 2014). The miR-200 family was 
first shown to inhibit Zeb2 (and Zeb1) in cancer cell lines. In 60 cell lines tested, overexpression of miR-
200 lead to upregulation of E-cadherin and subsequent reduced motility of the cells. Conversely, 
knockdown of miR-200 resulted in the induction of EMT and reduced E-cadherin levels (reviewed in: 
Korpal et al., 2008; Park et al., 2008).  
 
Recently it was shown that miR-200 family members (miR-200a, miR-200b, miR-200c, miR-
141, and miR-429) are mediators of OSKM-based reprogramming (Wang et al., 2013). Exogenous Oct4 
and Sox2 bind to the promoters of miR-141/200c and miR-200a/b/429 cluster, respectively, and induce 
expression of these miRs. Transcriptional activation of the miR-200 family induces MET by inhibiting 
Zeb2. In fact, forced downregulation of Zeb2 during iPSC generation results in a similar phenotype as 
miR-200 overexpression. Conversely, reprogramming is inhibited by overexpression of Zeb2 in the 
system. Together, this data shows that the mir-200--Zeb2 pathway is regulated by Oct4 and Sox2 and 
that modulation of this pathway is crucial for MET and acquisition of pluripotency (Wang et al., 2013). 
 
MiR-200 family expression is silenced by methylation of their promoters. In mammary gland 
tumors activation mir-200 is Tet1-dependent. Hydroxylation and activation of the miR-200 maintains the 
epithelial phenotype of the tumors hence reduces its aggressiveness and metastasis. Tet1 expression 
is inhibited by miR-22. Overexpression of miR-22 in human breast epithelial cell lines (HMEC and MCF-
10A) or in non-metastatic breast cancer cell line (MCF-7) induced a mesenchymal phenotype and, after 
injection into the recipient mice, the MCF-7 line showed metastasis. MiR-22 directly represses Tet1 
what leads to an increase in methylation of miR-200 promoters and their silencing. Thus, miR-22 is an 
important modifier of breast cancer stemness and metastasis and it exerts its function through Tet1-
dependet regulation of miR-200 levels (Song et al., 2013). miR-22 was previously identified as a miR 
whose expression increases during ESC differentiation (Houbaviy et al., 2003). 
 
Recently it was shown that Tet proteins are crucial for reprogramming to pluripotency. MEFs 
deficient in all three Tet proteins do not undergo MET and fail to generate iPSCs. This is due to lack of 
activation of the critical miR-200 family whose promoters stay methylated in absence of Tet proteins. 
Overexpression of Tet2 in the triple-Tet KO cells induced demethylation and partially restored miR-200 
expression and reprogramming capacity. Interestingly, also overexpression of a single miR from the 
miR-200 family (i.e miR-200c) in the triple KO background allows iPSC generation. Together this data 
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show that Tet proteins are essential for reprogramming and they target the miR-200 family that is 
needed for MET transition during this process (Hu et al., 2014). 
 
We hypothesize that deregulation of the miR-200 regulatory loop in the Zeb2 KO cells also 
reinforces their undifferentiated phenotype. Genetic inactivation of Zeb2 removes the repressive marks 
from mirR-200. In addition, high levels of Tet1 retained in the Zeb2 KO cells upon removal of 2i stabilize 
the active epigenetic state of miR-200 promoters. Moreover, Oct4, whose gene is not properly silenced 
in absence of Zeb2, promotes miR-200 expression. It would be interesting to investigate whether the 
Zeb2--miR-200-miR-22--Tet1 regulatory loop exists also in ESCs and whether manipulation of this 
pathway could have a beneficial effect on lineage-specific cell differentiation and reprograming. 
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Chapter 6: Global conclusions and perspectives 
 
 
In my PhD research I studied two main aspects of Zeb2 biology.  
 
In the first part, together with my colleagues, we specifically asked what the functions were of 
Zeb2 in certain aspects of mouse brain cortex development. For the first time in the field, we showed 
that Zeb2 controls expression of extrinsic factors in the upper layers of the cortex and that these 
deregulated factors feedback to the progenitors located in the (Zeb2-negative) ventricular zone to 
control cortex formation via controlling the timing of neurogenesis and gliogenesis.  
 
In the second part we studied in cell culture how Zeb2 regulates cell fate decisions during 
progression from a pluripotent stem cell to a committed progenitor and beyond. We therefore 
documented mesodermal, endodermal and neuroectodermal lineage differentiation. Because of the 
mutations in ZEB2 in humans lead to MOWS, we focused on the role of Zeb2 in transition from a 
ground state ESC to a neural progenitor. We discovered that Zeb2 regulates pluripotency exit at the 
epiblast stage in ESCs and that this process involves downstream action of Tet1. Analysis of the 
methylation status of Ctrl and Zeb2 KO cells at three different time points during differentiation showed 
that Zeb2 KO cells initially correctly acquire methyl marks on the DNA but they cannot maintain those 
marks and revert their methylome to a more naïve state, and that this loss is likely correlated with Tet1 
binding. In addition we also initiated Zeb2 domain studies and we discovered that – unlike in cortical 
interneuron guided migration – the in-frame deletion of the Zeb2 SBD results in more efficient ESC 
differentiation towards neural cells. It would be interesting to expand our studies to other domains of 
Zeb2 and to investigate these interactions in various contexts of development and, subsequently, in 
disease. 
 
 Detailed knowledge of the dynamics of DNA binding of Zeb2, and its precise multi-modal role 
in regulation of gene transcription of specific sets of genes, is still lacking. Crucial will be to perform 
genome-wide and temporal ChIP-seq analysis of Zeb2-binding to its target loci. Based on published 
data on the role NuRD and the links between Tet1 and chromatin status (see General discussion), we 
hypothesize that Zeb2-deficient cells have also aberrant chromatin conformation. It would be interesting 
to document dynamic changes in the chromatin conformation during differentiation of Ctrl, Zeb2 KO and 
Zeb2KO_Tet1shRNA ESCs. This new data, together with our RNA-seq and RRBS data, and the ChIP-
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seq experiments would provide a more comprehensive picture of how Zeb2 functions in cell state and/or 
fate decisions.   
 
 It is known that averaging information from individual cells can often mask crucial information 
about fate decisions in biological systems. In the past years, technological advances took biomedical 
analytical experiments to the single-cell resolution. It is now possible to analyze the transcriptome from 
individual cells as well as investigate the epigenetic status of these (Faddah et al., 2013; Kim et al., 
2015; Klein et al., 2015; Kolodziejczyk et al., 2015; Papatsenko et al., 2015; Smallwood et al., 2014). 
With such data, and notwithstanding the possible increasing confusion these floods of data may cause 
to most of us in the field, one may discover numerous distinct cell types, cell states and their origins in 
populations that thus far seem or are accepted to be relatively homogeneous (reviewed in Trapnell, 
2015). Performing single-cell analysis in control and Zeb2 KO cells in pluripotency and especially during 
early differentiation steps would provide additional valuable information on Zeb2’s role in cell fate 
decisions. Our IHC/IF data shows that the majority of the cells in the Zeb2 KO EBs after 15 days of 
differentiation are still highly positive for Oct4, Nanog and E-cadherin. RT-qPCR and RNA-seq 
expression (population) data indicates that (i) pluripotency gene expression is indeed not 
downregulated, (ii) there is an increase in early differentiation markers such as Otx2 and Fgf5. Only 
single-cell resolution analysis could provide solid proof of the presence of two (or more) cell populations 
within the Zeb2 KO EBs and whether these Nanog/Oct4/Ecad-negative cells are the actual EpiSCs or 
even more developmentally advanced types of cell. The same approach would also be very useful in 
answering the question about the cell non-autonomous function of Zeb2 in our co-culture experiment 
(see Chapter 4.3.9). Based on the GFP signal coming from the labeled Zeb2KO-GFP cells we 
concluded that only a very small percentage of ESCs lacking Zeb2 were able to acquire neural 
phenotype when co-cultured with Ctrl cells. However, from this data we could not exclude that some of 
the Zeb2KO-GFP cells silenced their GFP signal and we could not detect it using simple IF analysis. 
Single-cell analysis would enable us to profile the cells and correlate Zeb2 and GFP levels with neural 
marker gene sets and possibly demonstrate that also in vitro Zeb2 can induce neurogenesis in a cell 
non-autonomous fashion.  
 
 Integrating all levels of regulation (transcriptional, metabolic, epigenetic, extrinsic signals etc) in 
biological systems at a single-cell resolution will provide unbiased classification of cell types within 
organs, tissues and their in vitro counterparts as well as new definitions of previously unknown cellular 
states. It could also contribute to novel insights into plasticity of cell systems. Such data will provide 
information necessary to build to systems-biology models that would more accurately predict cell 
behavior and decisions during normal development, also upon their perturbation, and in disease. 
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Studies in mESCs and early embryos provided very valuable information about how 
pluripotency is established and maintained. It was shown that ESCs can be captured in ground state of 
self-renewal and that this state very strongly resembles E4.5 mouse blastocyst (Boroviak et al., 2014; 
Ying et al., 2008). Pluripotent mouse ESCs can also be propagated as EpiSCs in a more primed state 
that is equivalent to preimplantation epiblast (See General Introduction and: Brons et al., 2007; Tesar et 
al., 2007). Human ESCs under classic hESC culture conditions (Fgf2+Activin) resemble mouse epiblast 
stem cells. “Classic” hESCs show global DNA hypermethylation, relatively high expression of lineage-
specific genes and Oct4 expression driven by its proximal enhancer. Recently a number of publications, 
inspired by the ground state of mouse ESC self-renewal, showed that naïve or possibly even ground 
state of pluripotency could be achieved in hESCs. Naïve state of human ESC self-renewal was obtained 
by transient gene overexpression (NANOG/KLF2 in presence of 2i+LIF: Takashima et al., 2014; 
KLF2/KLF4 or OCT4/KLF4 in presence if 2i+LIF: Ware et al., 2014) and/or by manipulation of extrinsic 
signaling pathways (using a comibination of:LIF, TGFβ1, FGF2, ERK1/2i, GSK3βi, JNKi, p38i: Gafni et 
al., 2013;  using 2i+LIF and Wnt5a: Van der Jeught et al., 2015; using 2i+hLIF supplemented with 
Activin and ROCKi, BRAFi, SRCi: Theunissen et al., 2014). Human ESCs after a relatively short 
transition period, acquire mESC-like features and in some cases show contribution to inter-species 
mouse-human chimeras (Gafni et al., 2013). 
 
Dissecting molecular mechanisms that underlay pluripotency and feed into the balance 
between maintenance or exit from self-renewal, defining and carefully documenting the spectrum of 
pluripotent states in mouse and human embryos as well as in ESCs and iPSCs is of highest importance 
as it broadens our knowledge about how developmental processes, cell differentiation and 
reprogramming are orchestrated and all this together is extremely relevant for research and biomedical 
purposes such as disease modeling, drug screening and cell therapy. 
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